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ABSTRACT 
 
Deafness is a major sensory disorder affecting an enormous number of people 
worldwide.  Loss of the auditory hair cells and their associated spiral ganglion neurons 
in the cochlea causes the vast majority of hearing loss cases.  Therapies currently 
available are unable to address the root cause of the impairment, and as such are 
limited in their effectiveness.  The field of regenerative medicine is emerging as a 
viable option for restoring and repairing lost or damaged cells in the inner ear.   
Human embryonic stem cells have been previously used to generate otic progenitors 
by employing ligands involved in otic placode induction, FGF 3 and FGF 10.  
Canonical Wnt signalling is known to play a major role in the expansion of the otic 
placode.  In this work, I have manipulated the canonical Wnt signalling pathway in 
combination with FGF and explored their effect on otic progenitor differentiation.  An 
initial period of FGF signalling combined with canonical Wnt inhibition was required 
to promote an ectodermal identity in the differentiating human embryonic stem cells, 
with a concomitant increase in the expression of otic markers.  Following this, a phase 
of canonical Wnt activation with an attenuated FGF signal further expanded the 
proportion of otic progenitors, substantially more so than in the standard FGF based 
protocol.  The progenitors derived from this more efficient, developmentally informed 
protocol also possessed the ability to further differentiate into hair cell-like cells and 
in particular, auditory neurons.  Reporter lines were also generated in order to monitor 
otic and hair cell differentiation in real time and visualise the effects of manipulating 
the canonical Wnt signalling pathway with molecular compounds. 
This work involved the development of an updated in vitro protocol capable of readily 
and efficiently inducing the differentiation of otic progenitors from human embryonic 
stem cells.  This could be beneficial in the development of potential cell-based 
therapies for deafness. 
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CHAPTER 1: INTRODUCTION 
 
1.1 Anatomy of the human auditory system and its function 
 
Hearing is one of the five main senses, and can be described as the ability to perceive 
auditory sound information.  In humans this perception of auditory information takes 
place within the ear.  A basic schematic diagram of the anatomy of the human auditory 
system is shown in Figure 1.1.  It is comprised of outer, middle and inner ear 
structures, all of which play a crucial role in the perception of hearing.  Sound pressure 
waves enter the ear by initially being funnelled through the outer ear and along the 
external meatus towards the structures of the middle ear.  The vibrations produced 
from the entering sound are transmitted to the ear drum, or tympanic membrane, 
causing the ossicles of the middle ear (malleus, incus, and stapes) to transfer the 
acoustic vibrations through to the main organ of the inner ear, the cochlea.  The human 
cochlea is a coiled hollow tube divided into three chambers, referred to as the scala 
vestibuli, scala media and scala tympani.  A cross-section through the chambers of the 
cochlea is schematically illustrated in Figure 1.2.  The chambers of the cochlea are 
filled with sodium-rich perilymph (scala vestibuli, scala tympani) or potassium-rich 
endolymph (scala media).  The difference in ionic composition of the three chambers 
generates an electrical and chemical gradient within the cochlea, which aids in the 
mechanotransduction of the sound waves into electrical energy (Cristobal and 
Oghalai, 2008; Kim et al., 2011). 
Housed in the scala media is the organ of Corti, the main sensory epithelium of the 
cochlea.  Comprised of a single row of inner hair cells and three rows of outer hair 
cells (Figure 1.2), they are highly specialised epithelial cells and act to convert sound 
energy into an electrical signal that is then relayed to the brain for hearing perception.  
Each hair cell responds to a different detection of vibration, setting up a tonotopic 
gradient from base to apex of the cochlea.  The tectorial membrane responds to the 
pressure variations induced by sound energy in the endolymph of the scala media, and 
the vibrations are passed into the hair cells where electrical impulses are generated and 
relayed to the afferent sensory neurons (Wan et al., 2013).  The embryological 
development of sensory hair cells and the various other cell types found within the 
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organ of Corti will be discussed later in this chapter.  In the adult ear there are 
approximately 15,000 to 20,000 hair cells per cochlea.  Once induced and matured, 
sensory hair cells become post-mitotically inactive and do not replicate, nor repair 
(Baumgartner and Harper, 2003).  As such, damage to the hair cells via a variety of 
different mechanisms results in permanent, irreversible loss in mammals.  Avian 
species have demonstrated an ability to regenerate damaged or lost hair cells in the 
basilar papilla (the avian equivalent of the mammalian cochlea). 
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Figure 1.1: Schematic diagram of the anatomy of the human auditory system.  
The major components of the outer, middle and inner ear are highlighted.  Image 
adapted from Patel and Groppo (2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outer ear Middle ear Inner ear 
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Figure 1.2: A schematic cross-section through the human cochlea.  The three main 
chambers (scala vestibuli, scala media, and scala tympani) are highlighted.  SV: stria 
vascularis; IHC: inner hair cells; OHC: outer hair cells; AN: auditory nerve; BM: 
basilar membrane.  Image adapted from Cristobal and Oghalai (2008).  
 
 
 
 
 
 
 
 
 
(Perilymph) 
(Perilymph) 
(Endolymph) 
Tectorial membrane 
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1.2 Deafness and hearing impairment 
 
Hearing impairment of some form currently affects over 10 million people in the UK 
alone, which is approximately one in six of the UK population (Action on Hearing 
Loss, 2014).  Worldwide this figure is believed to be over 300 million people affected.  
As the population ages this figure is expected to rise substantially in the coming years.  
Hearing impairment can be as a result of a number of factors, and defects in any part 
of the auditory system can be responsible.  Obstructions to the external meatus or 
middle ear, such as from infections or cerumen build-up, or perforation of the 
tympanic membrane are known as causes of conductive hearing loss.  These cases are 
quite usually mild, easily treatable, and reversible. 
Accounting for the vast majority of the cases of deafness or hearing impairment is 
sensorineural hearing loss (SNHL).  SNHL is produced primarily by the damage to 
and subsequent loss of the sensory hair cells of the organ of Corti, usually with 
consequent degeneration of the spiral ganglion neurons.  Common causes of SNHL 
include noise-induced trauma, use of ototoxic drugs, aging, and genetic disorders. 
 
1.2.1 Noise-induced hearing loss 
 
Noise-induced hearing loss occurs as a result of prolonged and repeated expose to high 
intensity sound.  Emerging in recent years is the implication of reactive oxygen species 
as a causal factor in noise-induced hearing loss.  One of the first studies to report this 
was carried out in guinea pigs.  Prolonged exposure (three hours) to sound of 120 
decibels (dB) resulted in the presence of reactive oxygen species, detectable after just 
five minutes following noise exposure (Yamane et al., 1995).  In mice, reactive oxygen 
species are detectable after just 1 hour of intense noise, and this level was found to be 
at least four-fold above the non-exposed animals (Ohlemiller et al., 1999).  This early 
appearance of reactive oxygen species was shown to remain within the cells of the 
organ of Corti for a number of hours after noise exposure, without decline.  Similarly 
a study conducted by Hu et al. (2002) in the chinchilla reported that the three rows of 
outer hair cells in the organ of Corti are particularly susceptible to reactive oxygen 
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species damage, via the induction of apoptotic pathways.  Following one hour of 110 
dB noise, the nuclei of the outer hair cells was found to be morphologically typical of 
cells undergoing apoptosis (condensed, fragmented nuclei) and caspase-3, a marker of 
apoptosis, was detected.  Interestingly the induction of the apoptotic pathways 
remained in the outer hair cells for up to three days following the one hour noise 
exposure period. 
As a result of these findings the administration of anti-oxidant compounds has been 
extensively tested as a potential preventative therapy for noise-induced hearing loss.  
Anti-oxidants such as glutathione (Ohinata et al., 2000), ascorbic acid (Heinrich et al., 
2008), and N-acetylcysteine (Kopke et al., 2007) have been demonstrated to reduce 
the severity of noise-induced hearing loss as a result of reactive oxygen species 
significantly when administered prior to noise exposure. 
 
1.2.2 Exposure to ototoxic drugs 
 
Aminoglycosides (for example neomycin, gentamicin, streptomycin) are a group of 
antibiotics, commonly used primarily in developing countries.  They are also often 
used in the treatment of chronic pulmonary infections of cystic fibrosis patients 
(Davies et al., 2007), and in some cases of difficult to treat urinary tract infections 
(Greer et al., 2008).  Ototoxicity of these type of antibiotics is believed to be a result 
of induced apoptosis, particularly in the outer hair cells.  Suzuki et al. (2008) 
investigated the time course of apoptosis in the guinea pig induced by administration 
of intratympanic gentamicin.  As in noise-induced hearing loss it was found that 
reactive oxygen species are the cause of the increase in apoptosis.  Evidence of outer 
hair cell apoptosis was apparent at just 12 hours post-administration, with the severity 
increasing until 48 hours.  Cisplatin, a commonly used chemotherapeutic in various 
forms of cancer has also previously been shown to have ototoxic side effects.  As with 
the aminoglycosides reactive oxygen species-induced apoptosis is believed to be the 
major cause of hair cell damage (Dehne et al., 2001). 
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1.2.3 Aging and congenital causes of sensorineural hearing loss 
 
Throughout the years of life, genetic predispositions and various environmental causes 
(including smoking, exposure to loud noises, and administration of ototoxic drugs) all 
contribute to age related SNHL.  SNHL is the major sensory disorder reported in the 
elderly (Fujimoto and Yamasoba, 2014), and is thought to affect over half of the over 
65 year old population in the United States (Gopinath et al., 2009).  Once again 
oxidative stress and mitochondrial dysfunction have been implicated as causative 
factors.  A study carried out in the senescence-accelerated mouse prone 8 (SAMP8) 
model (Menardo et al., 2012) demonstrated that these mice have deficient levels of 
antioxidants, increased production of reactive oxygen species and resulting apoptosis 
in the hair cells of the organ of Corti. 
Approximately 50% of all congenital cases of hearing loss are of a genetic cause, and 
mutations in a large number of different genes have already been identified (Duman 
and Tekin, 2012).  Mutations in the GJB2 gene are considered to be the major genetic 
dysfunction associated with SNHL.  GJB2 encodes for connexin 26, a component of 
gap junctions which play a role in connecting all of the different cell types together in 
the organ of Corti (Kikuchi et al., 2000).  Mutations in this gene result in inefficient 
potassium ion cycling within the endolymph; a requirement for effective sensory 
transduction.  Mutations in genes associated with cellular organisation (MYO3A, 
MYO6, MYO15A) and neuronal transmission (OTOF) have also been identified.  
Another of the major genetic causes is Usher syndrome (Reiners et al., 2006) which is 
also known to be the most frequent cause of combined deafness and blindness.  This 
is caused in part by mutations in a number of key markers found in the hair cells of 
the inner ear and the retina, for example MYO7A. 
The tectorial membrane (Figure 1.2) has connected attachments to the distal tips of the 
outer hair cells in the normal inner ear.  Vibrational movements of the tectorial 
membrane as a result of sound induced pressure waves cause displacement of the outer 
hair cell tips, generating the mechanoreceptor-induced electrical signals.  Genetic 
defects within the tectorial membrane, therefore, may also lead to cases of deafness.  
One of the major protein components of the tectorial membrane is α-tectorin, encoded 
by the TECTA gene (Alasti et al., 2008).  Various mouse knockout studies (Legan et 
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al., 2000; Legan et al., 2005; Xia et al., 2010) have demonstrated that disruption to the 
α-tectorin protein results in a shortened tectorial membrane that becomes detached 
from the underlying outer hair cells of the organ of Corti, resulting in a decreased 
ability of the outer hair cells to act as cochlear amplifiers. 
In addition, it is not just the hair cells of the organ of Corti which are responsible for 
cases of hearing loss when damaged; supporting cells are also gradually being 
implicated.  Damage to the organ of Corti during noise-induced trauma or as a result 
of ototoxicity from aminoglycoside drugs, leads to degeneration and loss of the 
various types of supporting cells, with broad implications to hearing.  For example, 
supporting cells are sources of neurotrophic factors which aid in spiral ganglion 
neuron survival and growth, and as such, damage to these cell types can potentially 
lead to neuronal death and receding. 
The stria vascularis (Figure 1.2) is another contributor to age-related hearing loss 
cases.  The endolymph potential within the cochlea is generated as a result of 
potassium ion release from the hair cells of the organ of Corti (Hibino and Kurachi, 
2006).  Potassium ions are circulated from the hair cells, via the perilymph, to the 
endolymph of the scala media through the stria vascularis.  The KCNJ10 gene encodes 
for an inward rectifier potassium channel known as Kir4.1 (Chen and Zhao, 2014) and 
is the only potassium inward rectifier channel found within the stria vascularis.  
Human mutations within the KCNJ10 gene therefore lead to disruption to the 
endolymph potential within the cochlea and hearing loss ensues.  Patients with 
mutations within this gene can suffer from EAST syndrome (Thompson et al., 2011), 
involving epilepsy, ataxia, sensorineural deafness and renal tubulopathy.  Further 
evidence of the importance of the Kir4.1 channel in normal hearing was demonstrated 
by a KCNJ10 knockout mouse model (Kofuji et al., 2000).  Homozygous knockout 
mice experienced a loss of endolymphatic potassium ions, and a consequent loss of 
the endolymph potential, with later degeneration of the spiral ganglion neurons.  These 
effects could be rescued by co-expression of wild type KCNJ10 (Sala-Rabanal et al., 
2010).  
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1.3 Currently available treatments for sensorineural hearing loss 
 
The therapeutic options currently available for sensorineural hearing loss are very 
limited, circumscribed to prosthetic devices such as hearing aids and cochlear 
implants.  Hearing aids act by amplifying acoustic signals to make sounds louder and 
clearer for the wearer.  As such they are only suitable for mild hearing impairment and 
require some degree of functionality in the hair cells and neurons in the inner ear, and 
intact auditory pathways to the brain.  For the more profoundly deaf, as a result of 
damage or permanent loss of the sensory hair cells, hearing aids are inadequate.  Loss 
of the inner or outer hair cells results in no mechanotransduction of sound pressure 
waves emanating from the tectorial membrane, and thus the spiral ganglion neurons 
do not receive any electrical signals to relay to the brain.  Cochlear implantations are 
a potential therapy for patients with this kind of profound hearing loss.  Cochlear 
implants act by providing electrical stimulation to the spiral ganglion neurons, in place 
of the lost or damaged hair cells.  This artificial stimulation therefore can only be 
beneficial to the patient if spiral ganglion neurons are intact and at a suitable density 
for relaying the sound information to the higher auditory processes (Lenarz et al., 
2013).  Unfortunately loss of sensory hair cells on cases of SNHL can sometimes be 
associated with subsequent receding or loss of the spiral ganglion neurons (Otte et al., 
1978; Webster and Webster, 1981), making cochlear implantation an ineffective 
therapeutic option.  In these patients the only viable alternative is the use of the brain 
stem implant, where an electrode is inserted close to the cochlear nucleus and 
stimulates the central pathway directly.  However this technology is still in its early 
days and the clinical results thus far are not very satisfactory (Merkus et al., 2014). 
Given the current limitations, research is actively looking for new therapeutic 
alternatives using different systems. 
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1.4 Potential future therapies for hearing impairment 
1.4.1 Gene therapy 
 
Studies investigating potential gene therapy treatments for deafness and hearing 
impairment are a major source of current research.  The connexin 26 (Cx26) encoding 
gene GJB2, accounting for approximately half of all cases of congenital and inherited 
deafness, is a common target for a possible gene therapeutic strategy.  A proof of 
principle study carried out by Crispino et al. (2011) used bovine adeno-associated viral 
vectors to successfully deliver recombinant Cx26 protein to in vitro explants sourced 
from Cx26 knockout mice.  In a more advanced recent study, adeno-associated viral 
vectors were utilised for the delivery of Cx26 protein directly to the scala media of 
conditional Gjb2 knockout mice in vivo (Yu et al., 2014).  It was observed that 
intercellular gap junctions were restored in the supporting cells of the knockout mice, 
leading to significantly lower levels of cell death within the organ of Corti and a 
reduction in the loss of associated spiral ganglion neurons. 
Transmembrane channel-like proteins 1 and 2 (TMC1, TMC2), expressed in both inner 
and outer hair cells, are known to play a crucial role in normal functional maturation 
of the hair cells, although the exact method of this functionality is still unknown 
(Marcotti et al., 2006).  Kawashima et al. (2011) reported murine Tmc1 and Tmc2 gene 
expression is associated with mechanotransduction of the hair cells, and targeted 
deletion of these genes caused a deaf phenotype in the knockout mice.  Adenoviral 
delivery of exogenous TMC proteins were found to be able to restore hair cell 
mechanotransduction and normal levels of electrophysiology. 
For noise- or age-related hearing loss, gene therapy with ATOH1 (a basic helix-loop-
helix transcription factor, crucial and necessary for hair cell induction in the 
developing organ of Corti) is a promising therapeutic target.  Yang et al. (2012) 
exposed guinea pigs to excessive noise in order to cause trauma to the hair cells of the 
organ of Corti.  One week after noise-induced hearing loss was confirmed, adenoviral 
vectors were used to deliver an Atoh1-GFP (green fluorescent protein) construct to the 
cochlea.  Interestingly Atoh1 gene-driven GFP expression was not found in any of the 
hair cells of the damaged organ of Corti, but was found in the supporting cells.  Despite 
this the stereocilia of the hair cells appeared restored, compared to the untreated noise-
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damaged cochleae, and great improvements in hearing thresholds were achieved.  It is 
hypothesised that over-expression of Atoh1 in the supporting cells may have resulted 
in secretion of trophic factors which induced repair of the hair cells and stereocilia. 
Other recent studies involving adenoviral vector delivery of Atoh1 as a possible 
therapeutic target include that by Atkinson et al. (2014).  In this study viral vectors 
were used to infect mature guinea pigs with aminoglycoside-damaged cochleae with 
vectors containing either the Atoh1 gene alone, or Atoh1 in combination with 
neurotrophic factors such as BDNF (brain-derived neurotrophic factor) or NT-3 
(neurotrophic factor-3) four days post-deafening.  Functional hearing tests were 
conducted in the animals three weeks post viral infection.  It was observed that in the 
organ of Corti of aminoglycoside treated animals, a significant increase in the number 
of hair cells was seen following Atoh1 gene therapy, marked by an increase in the 
number of cells expressing myosinVIIa (a characteristic marker of hair cells).  
Unfortunately, but interestingly, hearing function in the deafened animals was not 
recovered following Atoh1 or Atoh1 with neurotrophic factor gene therapy. 
Lack of recovery of functional hearing with Atoh1 gene therapy in the guinea pig study 
highlights the potential pitfalls and limitations of gene therapy within the inner ear.  
When using a viral vector delivery method it is difficult to be able to target the exact 
cell type of interest.  All of the cells exposed to the viral vectors will have the potential 
for uptake of the vector, however the rate of uptake will be different between cell 
types, and not all cells will uptake the vector equally (Chien et al., 2015).  Therefore 
it is possible for viral vector delivery to the organ of Corti to be scattered and lacking 
a uniform pattern, which has the potential to lead to disorganised gene delivery and a 
limited functional effect as a consequence.  In addition the route of administration of 
gene therapy may also been a limiting factor for the inner ear.  According to 
Kawamoto et al. (2001) and Praetorius et al. (2003), a cochleostomy approach for gene 
delivery (a commonly used method of gaining access to the scala media) can itself be 
associated with a higher incidence of sensorineural hearing loss.  Therefore, for gene 
delivery as a potential future therapy for deafness, methods of minimising the potential 
damage of the surgical approach must also be investigated simultaneously. 
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1.4.2 Neurotrophic factors  
 
Neurotrophic factors including BDNF and NT-3 have been previously shown to be 
expressed in the organ of Corti during development (Pirvola et al., 1994; Wheeler et 
al., 1994), and also expression the BDNF and NT-3 receptors have been identified in 
the spiral ganglion neurons (Ernfors et al., 1992; Pirvola et al., 1992).  Spiral ganglion 
neuron loss can be as a result of direct damage to the cells or synapses, or secondary 
to the loss of support provided by neurotrophic factors, such as BDNF and NT-3.  
Current opinion on the source of release of these neurotrophic factors is divided; hair 
cells (Ernfors et al., 1995) or the supporting cells (Zilberstein et al., 2012) of the organ 
of Corti.  Irrespective of the source, spiral ganglion loss as a result of hair cell damage 
can dramatically reduce the effectiveness and suitability for cochlear implantation, and 
many studies have been carried out to determine if gene delivery of neurotrophic 
factors can improve the survivability of the spiral ganglion neurons following hair cell 
injury.  For example, Wise et al. (2010) delivered BDNF or NT-3 in adenoviral vectors 
to the scala media of guinea pig cochleae damaged by aminoglycoside administration.  
Spiral ganglion neuron densities were found to be significantly increased with viral 
vector delivery of the neurotrophic factors compared to untreated damaged cochleae, 
especially within the basal turn.  Connexin 26 null mice (as a result of Gjb2 gene 
mutations) have rapid hearing loss throughout the first weeks of life due to the loss of 
non-sensory cells in the organ of Corti.  Loss of the spiral ganglion neurons quickly 
follows leading to severe hearing impairments.  Adenoviral vector delivery of the 
BDNF gene into the scala media of these connexin 26 deficient mice was able to rescue 
the spiral ganglion neurons, particularly in the basal turn of the cochleae (Takada et 
al., 2014). 
 
1.4.3 Cell based therapies 
 
Studies to generate inner ear cell types from stem cell populations for potential 
transplantation as a treatment for deafness and hearing impairment are becoming a 
major research focus.  Reports have been published on the ability to generate hair cells 
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in vitro from murine embryonic stem cells (Koehler et al., 2013; Li et al., 2003; 
Oshima et al., 2010).  Although providing essential evidence of the ability of in vitro 
derivation of hair cell-like cells, these studies all focus on differentiation of embryonic 
stem cells via an embryoid body process.  As such it can be difficult to efficiently 
control the differentiation process.  Attempts to generate functional otic progenitors 
from human embryonic stem (hES) cells has also proven promising (Chen et al., 
2012).  Once derived, otic neural-like progenitors have been shown to have the ability 
to restore auditory function to deafened gerbils by recolonizing the areas of lost spiral 
ganglion neurons initially destroyed by oubain treatment.  
Bone marrow-derived mesenchymal stem cells (MSCs) are another potential source 
of a cellular based therapy for deafness.  Benefits of the use of bone marrow-derived 
MSCs over hES cells currently include the ease of accessibility for harvesting of such 
cells, elimination of potential ethical issues surrounding embryonic stem cells, and the 
ability to create patient-specific therapeutics.  MSCs have also already been used in a 
number of clinical trials for various purposes, including neuronal and cardiac 
regeneration (reviewed in Trounson et al., 2011).  A study carried out Boddy et al. 
(2012) demonstrated how conditioned media from the culturing of human fetal 
auditory stem cells (hFASCs) (Chen et al., 2007; Chen et al., 2009) was able to induce 
the expression of key otic markers such as PAX2, PAX8, GATA3 and SOX2 in human 
bone marrow-derived MSCs.  Not only were markers of the otic placode induced, but 
sustained culturing of the MSCs in this conditioned media was able to induce markers 
of the more mature hair cell and auditory neuronal lineages.  Canonical Wnt signalling 
ligands were identified as a component of the hFASC conditioned media, and the 
inductive role of this on the otic progenitor markers was confirmed by inhibitors of 
Wnt signalling leading to a reduction in otic marker expression in the MSCs.  A 
complimentary study by Duran-Alonso et al. (2012) has also demonstrated the ability 
of this cell type to respond to factor such as retinoic acid and epidermal growth factor 
(EGF) for the induction of hair cell-like markers. 
 
 
 
 
  Chapter 1 
15 
 
1.5 Human pluripotent stem cells  
 
First derived in 1998 from human blastocysts (Thomson et al., 1998), hES cells have 
changed the landscape of research into cellular differentiation and disease modelling.  
In vitro they have the capacity to self-renew and be expanded indefinitely, and have 
the ability to differentiate into the cell types of all three germ layer lineages 
(pluripotency) if provided with the correct molecular cues.  If injected into a mouse 
the hES cells differentiate and form a teratoma, and will also contribute to a chimeric 
animal.  Gene markers of hES cells include the transcription factors POU5F1, 
NANOG, and SOX2.  hES cells may also be identified by the expression of cell surface 
markers such as stage-specific embryonic antigen 3 (SSEA3), TRA-1-60 and TRA-1-
81 (Schopperle and DeWolf, 2007). 
More recent emerging research is being carried out using what has been referred to as 
human induced pluripotent stem cells (hIPS).  The discovery that terminally 
differentiated fibroblast cells could be reprogrammed back to a stem cell-like state 
(Takahashi et al., 2007) via viral vector delivery of just four transcription factors 
(POU5F1, SOX2, KLF-4 and c-MYC), and the resulting hIPS cells having the ability 
to differentiate into any of the germ layer lineages, dramatically improved the prospect 
of using human stem cells in a regenerative capacity.  It allows for the derivation of 
patient-specific therapies, rather than having to tackle the difficult challenge of ethical 
approval of the use of embryonic stem cells, and also potential issues with immune 
rejection.   
Studies have been conducted to highlight the benefits of using hES and hIPS cells as 
a method of exploring cell-based therapies for many diseases, for example the in vitro 
modelling of spinal muscular atrophy (Ebert et al., 2009), and the therapeutic drug 
testing for Rett syndrome (Marchetto et al., 2010).  To further the development of a 
potential cell-based therapy for deafness using hES or hIPS cells and to efficiently 
direct their differentiation towards the otic lineage using developmental cues, it is 
important to understand the events in which the otic placode and inner ear are derived 
in vivo. 
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1.6 Induction of the otic placode and development of the inner ear 
1.6.1 Early embryological development 
 
One of the earliest commitment decisions that must take place in the developing 
embryo is germ layer lineage commitment.  Endoderm, mesoderm, and ectoderm are 
the three germ layers and cell types emanating from these lineages go on to 
differentiate further into cells and tissue types such as the gastrointestinal respiratory 
tract (endoderm), circulatory system and musculature (mesoderm), and the central and 
peripheral nervous system and skin (ectoderm).  This acquisition of the three germ 
layers in mammals takes place via a process known as gastrulation, and the formation 
of the primitive streak.  Cells in the epiblast layer of the early developing embryo 
undergo an epithelial to mesenchymal transition and ingress through the primitive 
streak to form the precursors of mesoderm and endoderm (Williams et al., 2012).  It 
is known that cells which do not undergo ingression through the primitive streak adopt 
an ectodermal fate (Quinlan et al., 1995; Tam et al., 1997), which later becomes 
subdivided into neural and non-neural ectoderm. 
 
 
 
1.6.2 The pre-placodal region develops in the ectoderm 
 
All of the craniofacial placodes (including the ear, eye and olfactory system) initially 
arise from a horse shoe-shaped region of the ectoderm, commonly referred to as the 
pre-placodal region (PPR), and is schematically illustrated in Figure 1.3.  Following 
on from the events of gastrulation the ectoderm is segregated into the neural ectoderm 
and non-neural ectoderm.  Fibroblast growth factor (FGF) signalling has been 
demonstrated to be crucial for the initiation of neural ectoderm, whereas bone 
morphogenetic protein (BMP) and Wnt signalling have been implicated in promoting 
non-neural ectoderm differentiation (Levine and Brivanlou, 2007; Rogers et al., 2009).  
Precursors which will later form cells of each distinct placode region and the neural 
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crest are initially intermingled throughout a region between the neural and non-neural 
ectoderm, referred to as the neural border region.  Studies in the chick, mouse and 
Xenopus have highlighted a number of transcription factors marking this border 
region, including members of the Dlx, Pax, and FoxI families (Hong and Saint-
Jeannet, 2007; Yang et al., 1998). 
Members of the Six (1 and 4), Eya (1 and 2), Dlx and Dach transcription factor families 
are believed to be the key characteristic markers of the PPR, and remain present within 
the placodes after their induction (Brugmann and Moody, 2005).  Six1 has been shown 
to be the master regulator of the induction of the PPR, as deletion of this transcription 
factor results in the downregulation of other PPR-associated transcription factors such 
as Eya1 (Brugmann et al., 2004).  Defects in the inner ear and the olfactory system are 
an additional consequence of deletion of Six1 in the mouse, emphasising the key 
regulatory role of the Six family members in sensory organ development (Zheng et 
al., 2003; Zou et al., 2004).  In humans mutations in the EYA1 gene lead to the onset 
of Branchio-Oto-Renal Syndrome, where the mutation inhibits the ability of EYA1 to 
complex with SIX1, resulting in symptoms such as renal disease and hearing loss 
(Kumar et al., 1997). 
The signalling pathways involved in PPR induction include the concerted combination 
of FGF, BMP and Wnt activity, and the mode of interaction of these three pathways 
was elegantly demonstrated by Litsiou et al. (2005).  In this study the role of head 
mesoderm in supplying some of the PPR inductive factors to naïve ectoderm was 
highlighted, as ablation of the underlying mesoderm caused a loss of expression of 
Six4 and Eya2 in chick studies.  Markers associated with other regions of the ectoderm, 
including Sox3 and Pax7, were unaffected by the mesoderm ablation.  This study also 
reported that an attenuation of both the Wnt and BMP signalling pathways is required 
for PPR marker expression, and alongside active FGF signalling, this combination can 
promote PPR identity in naïve ectoderm, at least in the chick. 
Prior to segregation and specification of each placode, evidence suggests that all PPR 
precursors are initially specified as lens, with FGF signalling acting repressively to 
promote the switch from lens to other placodal fates (Bailey et al., 2006).  Additionally 
it has been proposed by Martin and Groves (2006) that all precursors of the various 
placodes must adopt a pre-placodal fate as an initial step in placode induction. 
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Figure 1.3: Schematic diagram of the pre-placodal region (PPR) of the developing 
ectoderm.  The horse shoe-shaped PPR is subsequently molecularly divided into 
regions which will go on to form each of the craniofacial placodes.  Image adapted 
from Cvekl and Duncan (2007). 
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1.6.3 Induction of the otic placode 
 
The exquisite structures of the auditory and vestibular systems of the human ear, as 
shown schematically in Figures 1.1 and 1.2, all arise from the cells in a simple patch 
of thickened surface ectoderm known as the otic placode.  Many key studies have been 
conducted to ascertain the events taking place in the developing embryo to induce the 
otic placode from the pre-placodal region. 
Proceeding the induction of the PPR is the formation of a common region containing 
the precursors of both the otic and the epibranchial placodal cells, referred to as the 
otic-epibranchial precursor domain (OEPD).  FGF signalling is one of the major 
promoters of the OEPD identity.  Previously it was believed that the induction of the 
otic and epibranchial placodes were separate distinguishable events.  More recent 
evidence however has suggested that these two placodes as part of the OEPD region 
both arise from a Pax2-positive region of the non-neural ectoderm (Streit, 2002; Sun 
et al., 2007).  Studies have revealed the underlying mesoderm and hindbrain as sources 
of FGF signalling for OEPD induction (Freter et al., 2008; Liu et al., 2003; Wright and 
Mansour, 2003).  The inductive FGF ligands appear to be species-dependent, with 
FGF 3 and FGF 8 common to all species, with FGF 10 and FGF 19 specific to the 
mouse and chick, respectively.  Evidence from knockout mutant mice of various FGF 
ligands strengthens the roles of FGFs in OEPD formation. Ablation of FGFs leads to 
the loss of Pax2 expression with subsequently small or even a complete failure in the 
formation of otic vesicles (Alvarez et al., 2003; Wright and Mansour, 2003).  The 
importance of Pax2 expression has also been shown in knockout studies (Sehgal et al., 
2008; Torres et al., 1996), with consequent defective generation of inner ear structures.  
Loss of Pax8 appears to have little effect on the morphology of the structures of the 
mature inner ear, yet Pax8 deficient mice have profound hearing loss (Christ et al., 
2004).  Double mutant mice for both Pax2 and Pax8 (Bouchard et al., 2010) have 
severe early morphological defects, and the inner ear development is halted at the 
otocyst stage. 
After the OEPD region is induced it is required to be segregated into the otic and 
epibranchial placodal regions, and canonical Wnt signalling is a crucial mediator of 
this segregation.  Indeed a number of Wnt ligands are expressed in the hindbrain region 
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surrounding the OEPD (Ohyama et al., 2006; Park and Saint-Jeannet, 2008).  Freter et 
al. (2008) have demonstrated that canonical Wnt signalling has little or no effect on 
the induction of the OEPD region in studies in the chick, but instead functions to 
enhance the otic placode development following FGF signalling.  Intriguingly, it was 
found that unless Fgf 3 and Fgf 19 signalling is attenuated the presence of canonical 
Wnt signalling does not allow the otic placode to differentiate, causing an expansion 
instead of the epibranchial placode, as demarcated by an widening of epibranchial 
associated Foxi2 expression.  Adding further evidence of a synergistic role of FGF 
and canonical Wnt signalling, Urness et al. (2010) reported expression of Wnt 8a in 
the mouse is dependent on FGF signalling, due to a reduction in its expression in the 
Fgf 3/Fgf 10 knockout mouse.  Complementing this was the finding that loss of the 
FGF antagonists Sprouty1 and Sprouty2 in the mouse leads to an increase in Wnt 8a 
expression and consequently, an increase in the size of the otic placode region at the 
expense of the Foxi2-positive epibranchial placode. 
A diagrammatical summary of the interaction of the FGF and canonical Wnt pathways 
can be seen in Figure 1.4.  It must be noted however that the FGF and canonical Wnt 
signalling pathways are not the only pathways implicated in otic placode development.  
Nevertheless the main focus of this work is to investigate whether the links between 
FGF and canonical Wnt signalling on the in vivo induction of the otic placode can be 
utilised in vitro during hES cell differentiation. 
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Figure 1.4: Schematic of the otic-epibranchial precursor domain (OEPD) and 
signalling pathways associated.  The inductive effect of FGFs emanating from the 
neural tube and mesoderm on canonical Wnt signalling aids in the expansion of the 
otic partition of the OEPD, at the expense of the epibranchial placode.  Image adapted 
from Chen and Streit (2013). 
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1.7 The canonical Wnt signalling pathway 
 
In basic terms Wnt signalling can be divided into two broad pathways: canonical and 
non-canonical.  Arguably the canonical Wnt signalling pathway is the most established 
and understood aspect of Wnt signalling, and is the pathway investigated as part of 
this work.  Therefore the mechanisms and modes of action of the canonical Wnt 
signalling pathway will be the main focus. 
The members of the canonical Wnt signalling pathway play a major role in a number 
of essential processes during development of the embryo.  These processes include 
cell differentiation, cell fate determination and cell proliferation (Macdonald et al., 
2009).  β-catenin and its regulation is the main method of action of the canonical Wnt 
signalling pathway.  If β-catenin is translocated to the nucleus it will activate the 
transcription of a number of Wnt target genes.  However in the absence of any Wnt 
signalling, or if Wnt signalling is inhibited, β-catenin is flagged for proteasomal 
degradation, preventing Wnt target gene expression.  A basic schematic representation 
of canonical Wnt signalling is presented in Figure 1.5. 
For Wnt signalling to function secreted Wnt ligands must act through extracellular 
receptors on the target cell surface.  There are 19 members of the Wnt family and 10 
of its Frizzled receptors in the human genome.  Alongside the Frizzled receptors 
canonical Wnt signalling also requires the presence of low-density-lipoprotein related 
protein receptors, or LRPs, in particular LRP5 and LRP6 in order to be able to 
transduce Wnt signals (He et al., 2004; Tamai et al., 2000).  The major activity of the 
LRP5/6 co-receptor transmembrane protein receptors is to bind Axin (Liu et al., 2003), 
which is part of the β-catenin degradation complex.  This degradation complex is 
comprised of an Axin scaffolding protein, glycogen synthase kinase 3 (GSK), casein 
kinase I (CKI), and adenomatous polyposis coli (APC, a tumour suppressor) (Scott 
and Brann, 2013).  When Wnt ligands bind to the Frizzled and the LRP5/6 co-receptor, 
Dishevelled (Dvl) is recruited and LRP6 becomes phosphorylated.  This 
phosphorylation promotes Axin to bind to the transmembrane receptors, resulting in 
the inactivation of the β-catenin degradation complex.  As such β-catenin in the cytosol 
is stabilised and can subsequently be translocated to the nucleus, where it binds to 
TCF/LEF (T-cell factor/Lymphoid enhancer factor) domains and promotes Wnt target 
  Chapter 1 
23 
 
gene transcription (Arce et al., 2006).  Conversely if Wnt signalling ligands are absent, 
LRP6 is not phosphorylated, Axin is not recruited to the membrane receptors and thus 
the β-catenin degradation complex is free to phosphorylate β-catenin and cause its 
ubiquitination and consequent degradation by the proteasome.  
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Figure 1.5: Schematic of the canonical Wnt signalling pathway.  In the absence of 
Wnt ligands cytosolic β-catenin is flagged for proteasomal degradation to prevent 
activation of Wnt target genes in the nucleus.  Conversely the β-catenin degradation 
complex is interrupted in the presence of Wnt ligands, promoting abundant cytosolic 
β-catenin accumulation, and subsequent translocation to the nucleus.  Image adapted 
from Scott and Brann (2013). 
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1.7.1 Canonical Wnt signalling within the developing cochlea 
 
Previously within this chapter the role of canonical Wnt signalling in the induction of 
the otic placode has been discussed.  Extensive research on this early inductive role 
has been carried out, but canonical Wnt signalling is also thought to be implicated in 
further maturation of the cochlea, and this role has been less well characterised.  In an 
attempt to address this, Jacques et al. (2012) identified a possible dual role for 
canonical Wnt signalling in the cochlea.  Firstly canonical Wnt signalling was 
established to still be active, albeit at a low level, within the developing cochlea, as 
shown via a TCF/LEF:H2B-GFP reporter mouse.  Activation of the canonical Wnt 
signalling pathway by exposing organ of Corti explants to lithium chloride (LiCl, a 
GSK3 inhibitor) caused an increase in proliferation, an expansion of Sox2-positive 
cells and also an increase in the number of hair cells.  Conversely, inhibition of 
canonical Wnt signalling with inhibitor-of-Wnt-response-1-endo (IWR-1-endo) 
reduced proliferation, and decreased the number of Sox2-positive cells and hair cells 
within the explants. 
Adding further evidence of the role of canonical Wnt signalling in the mature cochlea 
was the study conducted by Shi et al. (2014).  Temporal disruption of β-catenin was 
shown to inhibit Atoh1 expression resulting in loss of hair cells in vivo, yet inhibition 
of β-catenin following induction of hair cells did not cause a phenotypic change.  
These findings suggest the role of canonical Wnt signalling is to induce the initial 
formation of sensory hairs in the organ of Corti, but it is not required for hair cell 
maintenance or survival. 
 
1.7.2 Potential for regeneration within the organ of Corti 
 
Despite the knowledge that the post-mitotic sensory epithelium of the organ of Corti 
is quiescent, a number of studies have highlighted potential proliferative capacity and 
even the ability to generate hair cells in the mammalian cochlea (Oshima et al., 2007; 
White et al., 2006), although the mechanisms for these findings were not apparent.  
Both Chai et al. (2012) and Shi et al. (2012) attempted to ascertain which cell types in 
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the organ of Corti featured this ability to recover proliferation ability.  The findings of 
both studies identified leucine-rich repeat-containing G-protein coupled receptor 5 
(Lgr5) expressing cells in the mature mouse cochlea, and it was demonstrated that 
these cells are the most likely candidates to impart regenerative capacity.  Lgr5 has 
been previously described as an adult stem cell marker, found in the highly 
proliferative areas of the intestinal crypts, stomach and hair follicles (Barker et al., 
2007; Barker and Clevers, 2010).  Lgr5 expression in the cochlea was found in a small 
number of supporting cells, and most interestingly, overexpression of canonical Wnt 
activity via stabilised β-catenin caused the Lgr5-positive cells to re-enter the cell cycle 
and proliferate.  Direct differentiation of the Lgr5-positive cells into myosinVIIa-
positive hair cells as a consequence of overactive canonical Wnt signalling was also 
observed in both studies, suggesting that Wnt signalling is able to induce both 
proliferation and differentiation in these Lgr5-positive cells.  Overactive canonical 
Wnt signalling inducing hair cell differentiation has previously been demonstrated in 
avians (Stevens et al., 2003).  The exact mechanisms of these actions are still to be 
fully determined but as canonical Wnt signalling has already been shown to act 
upstream of Atoh1 (Shi et al., 2010), the ability to upregulate Atoh1 expression is an 
obvious feature to be investigated further. 
 
 
1.8 Generation of otic progenitors from hES stem cells – a step towards a stem cell 
therapy for deafness 
 
In the Rivolta laboratory an established protocol has been derived to drive the 
differentiation of hES cells into otic placodal-like progenitors (Chen et al., 2012).  A 
basic schematic representation of this differentiation protocol is represented in Figure 
1.6, and detailed steps are highlighted in Chapter 2.  Based on the ligands known to 
play a crucial role in the induction of the otic placode from the ectoderm in vivo, FGF 
3 and FGF 10, a 12 day differentiation period results in the generation of cells 
expressing combinations of characteristic otic markers, including PAX2, PAX8, 
FOXG1 and SOX2.  Approximately 15 – 20% of these cells express high levels of 
these otic marker combinations and it is this population that is believed to represent 
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the otic progenitors.  Amongst a number of cellular and colony morphologies, two 
morphologies of interest are generated: epithelial-like progenitors and neural-like 
progenitors.   These are referred to as otic epithelial progenitors (OEPs) and otic neural 
progenitors (ONPs), respectively.  Subsequently the OEPs can be further differentiated 
into hair cell-like cells and, to a lesser extent auditory neuronal-like cells.  The ONPs 
however are restricted in their differentiation capacity to only have the ability to 
differentiate into auditory neuronal-like cells.  Moreover, and most crucially, ONPs 
transplanted into a gerbil model of neuropathy have shown the ability to engraft, 
further differentiate into auditory neurons, and significantly improve hearing 
thresholds by approximately 46% on average. 
These results highlight the potential benefits of using hES and hIPS cells to pursue a 
cell-based therapy for deafness. 
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Figure 1.6: Standard protocol schematic used to differentiate hES cells into otic 
progenitors in vitro. 
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1.9 Aims 
 
The ultimate aim of this work is to build upon the already established FGF 3 and FGF 
10 based otic differentiation protocol by investigating the effects of manipulating the 
canonical Wnt signalling pathway in combination with the standard otic in vitro 
differentiation protocol.  Differentiation of hES cells with FGF 3 and FGF 10 ligands 
produces otic progenitor cells with approximately 20% efficiency.  Increasing this 
efficiency, and making the current methodology more robust would be invaluable for 
further research into regenerative strategies for deafness.  Simultaneously the ability 
to monitor the induction of otic progenitors by generation of a hES reporter cell line 
will allow for real-time visualisation of the dynamics of otic differentiation, and 
provide an additional readout for the impact of manipulating various signalling 
pathways on otic induction in vitro. 
 
Thus the broad aims of this work are as follows: 
 
 Generation of an in vitro hES reporter line to monitor otic induction using 
SOX2 enhancer sequences which show activity solely in the nasal and otic 
placodes in vivo 
 Investigation of the effects of canonical Wnt signalling manipulation on germ 
layer differentiation of hES cells in vitro  
 Determination of the impact of canonical Wnt signalling manipulation in 
synergy with FGF signalling on induction of pre-placodal identity and otic 
placodal progenitor differentiation from hES cells 
 Exploration of the downstream differentiation capacity of the canonical Wnt 
signalling-manipulated otic progenitors into hair cell-like cells and auditory 
neurons. 
 
30 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 In vitro mammalian cell culture 
2.1.1 Human embryonic stem cell maintenance medium 
 
All human embryonic stem (hES) cell lines used in this study (H14S9, Shef 1 and 
Shef3) were cultured under the exact same conditions.  Cells were maintained in hES 
cell maintenance medium which comprised of Knockout DMEM (Gibco), 20% 
Knockout Serum Replacement (Gibco), 1 mM GlutaMAX (Gibco), 1x MEM non-
essential amino acids (Gibco), 0.1 mM 2-mercaptoethanol (Gibco), and 4 ng/ml basic 
FGF (R&D Systems).  hES cell maintenance media was replenished daily and the cells 
were routinely passaged every five to seven days or when the culture reached 
approximately 80 – 85% confluency, and were maintained usually on mitotically-
inactivated mouse embryonic fibroblast (MEF) feeder cells.  
 
2.1.2 Mouse embryonic fibroblasts 
 
Mouse embryos (E13.5) were decapitated and eviscerated, followed by dissociation 
by trypsinisation, and the cells were cultured in DMEM (Sigma) containing 20% fetal 
calf serum (FCS) (Gibco) to bulk.  MEF cells were then mitotically-inactivated using 
10 µg/ml Mitomycin-C (Sigma).  Stocks of inactivated MEF cells were then frozen 
and placed into liquid nitrogen stores for routine usage over a period of several weeks. 
Tissue culture vessels were coated with EmbryoMax 0.1% Gelatin Solution 
(Millipore) for one hour prior to use.  Cryogenic vials of MEF cells were quickly 
thawed in a 37 °C water bath, transferred to a 15 ml centrifuge tube containing DMEM 
with 10% FCS, centrifuged at 1000 rpm for five minutes, and cell pellet resuspended 
in 1 ml of DMEM with 10% FCS.  Cells were counted using the TC20 Automated 
Cell Counter (Bio-Rad) and seeded into the previously gelatin coated culture vessels 
at a density of approximately 2.5x104 cells/cm2, and maintained at 37 °C with 10% 
CO2.   
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2.1.3 Routine passaging of human embryonic stem cells 
 
When the hES cells reached 80 – 85% confluency (usually between five and seven 
days) the expended culture media was removed, and 1 ml of 1 mg/ml collagenase type 
IV solution (in DMEM) (Gibco) was added and the cells were incubated for six to 12 
minutes to allow time for the hES colony edges to begin lifting away from the 
underlying layer of MEF feeder cells.  The collagenase solution was then removed and 
replaced with 2 ml fresh hES maintenance medium.  Using a 1 ml fine tip Pasteur 
pipette under light microscopy good quality hES cell colonies, with defined borders 
and minimal areas of differentiation, were scraped in order to divide the colonies into 
smaller segments.  Any areas of differentiation were avoided, and minimal scraping 
of MEF cells to avoid carry over into the new culture vessel.  The smaller segments of 
hES colonies were then transferred into a freshly prepared MEF feeder vessel and 
maintained for the following days at 37 °C with 5% CO2.   
 
2.1.4 Maintenance of human embryonic stem cells in a MEF feeder free environment 
 
For the derivation and maintenance of hES reporter lines, MEF feeder free conditions 
were routinely used.  In place of an inactivated MEF feeder layer, Growth Factor-
Reduced Matrigel (BD Biosciences) was used.  Matrigel was initially diluted 1:2 in 
Knockout DMEM and aliquots were frozen for later use.  When required, aliquots 
were thawed at 4 °C and further diluted 1:15 in Knockout DMEM to give a final 
dilution of 1:30 from the stock solution.  Using pre-chilled pipettes the diluted matrigel 
solution was added to the culture vessel (approximately 1 ml per T12.5 flask) and 
incubated for 30 minutes at 37 °C to allow the matrigel layer to set and coat the vessel 
with a thin layer of gel.  Serum-free medium is used in combination with matrigel, and 
this work involved the use of mTeSR1 maintenance medium (STEMCELL 
Technologies).  This was supplied as a Basal Medium and 1x Supplement.  Aliquots 
were frozen for later use.  hES cells maintained in this culture system were passaged 
using the same method as described previously for use with inactivated MEF cells.  
Prior to receiving the small hES colony segments, the excess matrigel was aspirated 
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from the culture vessel.  Cells were maintained at 37 °C with 5% CO2 and were 
passaged every five to seven days. 
 
2.1.5 Maintenance of mouse and human fetal auditory stem cells 
 
Both mouse and human fetal auditory stem cells (FASCs) were maintained in Otic 
Stem Cell Full Medium (OSCFM) which comprised of DMEM/F12 (Gibco) 
supplemented with N2/B27, with 20 ng/ml basic fibroblast growth factor (basic FGF) 
(Peprotech), 50 ng/ml insulin-like growth factor-1 (IGF-1) (R&D Systems), and 20 
ng/ml epidermal growth factor (EGF) (R&D Systems).  Mouse and human FASCs 
were grown on culture vessels previously coated with EmbryoMax 0.1% Gelatin 
Solution.  Cells were passaged when 75 – 80% confluent by either enzymatic 
dissociation with very mild trypsin-EDTA (ethylenediaminetetraacetic acid) 
(0.00625% in Hanks Balanced Salt Solution (Sigma)), or using Enzyme Free 
Dissociation Solution (Millipore).  Using enzyme free or very mild trypsin 
dissociation methods were carried out to avoid potential neuralisation of the FASCs. 
 
2.2 In vitro differentiation experiments 
2.2.1 Otic progenitor derivation from human embryonic stem cells 
 
At least four hours (typically overnight) prior to setting up differentiation of hES cells 
into otic progenitors, culture vessels were coated with mouse laminin I (Cultrex).  
Mouse laminin I was prepared by diluting the stock to a working concentration of 2.5 
µg/cm2 in ice cold phosphate buffered saline (PBS) (Sigma) and 1.5 ml was used to 
coat T12.5 culture flasks.  Polymerisation of the laminin was carried out at 37 °C.  
Undifferentiated hES colonies were assessed for their good quality and any 
differentiated patches or high density MEF feeder cell areas were removed.  The hES 
culture was then washed twice with Hanks Balanced Salt Solution, and the cells were 
then trypsinised for up to five minutes with 0.025% Trypsin-EDTA at 37 °C.  Once 
the hES cells were dissociated into a suspension of single cells, they were transferred 
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to a centrifuge tube containing pre-warmed 0.5 mg/ml Soybean Trypsin Inhibitor 
Solution (Gibco), diluted in DMEM.  The cells in the trypsin inhibitor solution were 
subsequently centrifuged at 1000 rpm for five minutes, the cell pellet was resuspended 
in 1 ml of DFNB (DMEM/F12 with N2 and B27 supplements), and then passed 
through a 100 µM sieve strainer to remove any large clumps of cells.  Cell counts were 
performed in triplicate using the TC20 Automated Cell Counter, and a 10 µl sample 
of cells was diluted 1:2 in Trypan Blue (Bio-Rad) to determine cell viability following 
the trypsinisation process.  Triplicate counts were averaged and cells were seeded into 
the previously laminin coated flasks or dishes at a typical density of 8x103/cm2.  
Differentiating hES cells were seeded and maintained in either the control DFNB 
media, or DFNB supplemented with FGF 3 and FGF 10 (50 ng/ml, R&D Systems) for 
basic otic progenitor differentiation experiments.  Differentiation experiments were 
carried out for 12 days and media was replenished every 2 days. 
 
2.2.2 Manual enrichment of otic progenitor morphologies 
 
Two colony morphologies of interest begin to appear within the differentiating hES 
cultures approximately three to four days into the differentiation process, surrounded 
by extraneous cell types.  These two morphologies are cells with an epithelioid island 
morphology (referred to as otic epithelial progenitors, or OEPs) and cells with a more 
neural-like appearance (referred to as the otic neural progenitors, or ONPs).  To enrich 
for a particular colony type of interest (dependent on the downstream experiments), 
currently the extraneous cell types are manually scraped away using a sterile plastic 
Pasteur pipette under light microscopy, leaving behind only the cell morphologies of 
interest. 
 
2.2.3 Further expansion and differentiation of otic progenitors in vitro 
 
At the end of the 12 day differentiation period manually enriched otic progenitors 
could be further expanded for a finite number of passages if transferred into gelatin 
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coated flasks and maintained in OSCFM.  Mildly diluted Trypsin-EDTA (0.00625%) 
or Enzyme Free Dissociation Solution is used to gently dissociate the progenitors for 
transfer, and to avoid potential triggering of further differentiation. 
OEPs have previously been shown to be able to further differentiate into hair cell-like 
cells, whereas ONPs have the capacity to be pushed to differentiate into auditory 
neurons.  For hair cell-like differentiation, manually purified OEPs at the end of the 
12 day differentiation period were washed with Hanks Balanced Salt Solution, 
trypsinised with 0.00625% Trypsin-EDTA, transferred to a centrifuge tube containing 
0.5 mg/ml Soybean Trypsin Inhibitor and centrifuged at 1000 rpm for five minutes.  
The cell pellet is resuspended in 1 ml of DFNB, sieved through a 100 µM strainer and 
counted.  OEPs were then seeded into previously gelatin coated culture vessels 
containing hair cell induction media at a density of 1x104/cm2.  This media is 
comprised of DFNB supplemented with 10-6 M all-trans retinoic acid and 20 ng/ml 
EGF, and is used to induce the differentiation of hair cell-like cells over a 14 day 
differentiation period. 
The further differentiation of ONPs was carried out by washing the manually enriched 
cells twice with Hanks Balanced Salt Solution, dissociating with 0.125% Trypsin, 
transferring to a centrifuge tube containing 0.5 mg/ml Soybean Trypsin Inhibitor 
Solution and centrifuging at 1000 rpm for five minutes.  Cell pellets were resuspended 
in 1 ml DFNB and sieved through a 100 µM cell strainer and counted.  ONPs were 
then seeded at a density of 4x103/cm2 into gelatin coated flasks containing DFNB 
supplemented with 20 ng/ml basic FGF and 500 ng/ml Sonic hedgehog C24II (R&D 
Systems) (the C24II mutation enhances its potency).  On day 4 of differentiation the 
media is replaced with DFNB containing 20 ng/ml basic FGF, 500 ng/ml Sonic 
hedgehog C24II, 10 ng/ml neurotrophic factor-3 (NT-3, Peprotech) and 10 ng/ml 
brain-derived neurotrophic factor (BDNF, Peprotech).  On day 6 through to day 12 
Sonic hedgehog supplementation is removed (DFNB with basic FGF, NT-3 and 
BDNF only). 
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2.3 Transfection techniques 
2.3.1 Generation of human embryonic stem cell reporter lines by electroporation 
 
The process of the preparation of plasmid DNA for transfection into hES cells is 
described in the following section (2.4).  Electroporation of plasmid DNA into the hES 
cells in order to generate stably transfected reporter lines was carried out in a serum 
and feeder free culture system.  Undifferentiated hES colonies were trypsinised with 
0.025% Trypsin-EDTA for five minutes, transferred into a centrifuge tube containing 
an equal volume of Soybean Trypsin Inhibitor, then centrifuged for five minutes at 
1000 rpm.  The cell pellet was then resuspended in 5 ml of PBS to wash and a 10 µl 
sample was collected for counting, and then the cells were centrifuged again.  The 
pellet was resuspended in Ingenio Electroporation Solution (Mirus Bio) at a 
concentration of 2.5x106 cells/ml and divided into 250 µl aliquots containing 
approximately 6.25x105 cells/aliquot.  10 µg of plasmid DNA (pEGFP-1 NOP-SOX2, 
pEGFP-1 Atoh1nGFP, or pCAG EGFP control) was added to each aliquot, gently 
mixed and transferred to a 4 mm gap electroporation cuvette.  The ECM830 
Electroporator (BTX) was set up to pulse the cells with two pulses of 240 volts for 10 
milliseconds, with a 100 millisecond interval between the pulses.  500 µl of pre-
warmed mTeSR1 was added to the cuvette to collect the electroporated cells, and this 
was transferred to matrigel coated (section 2.1.4) 60 mm dishes containing warm 
mTeSR1.  Y-27632 (ROCK-inhibitor, Sigma) was added to the dishes at a 
concentration of 10 µg/ml to aid the survival of the single hES cells.  24 hours later 
the media was replaced to remove dead cells.  Beginning at 48 hours post-
electroporation, the antibiotic G418 was added at 20 µg/ml to begin to select for stably 
transfected cells.  The pCAG EGFP electroporated cells quickly died as this plasmid 
vector does not confer resistance to G418.  After approximately 21 days of G418 
selection, hES colonies were able to be picked and transferred into new culture vessels 
for further analysis and expansion.  Where possible these hES clones were maintained 
on matrigel as the G418 antibiotic would kill the MEF feeder cells.  Due to the high 
running costs of this serum and feeder free culture system, hES clones were routinely 
passaged onto MEF feeder cells without G418 supplementation prior to setting up 
differentiation experiments.  Every few weeks hES clones on MEF feeders were 
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transitioned back onto matrigel to receive G418 treatment to ensure the plasmid 
integration was not lost. 
 
2.3.2 Transient transfections by lipofection 
 
The otic progenitors and mouse and human FASCs were found to be too sensitive to 
electroporation, and so lipofection was carried out as an alternative.  For this method 
cells were required to be freshly seeded into wells of a culture plate 24 hours pre-
transfection.  Lipofection was done using Lipofectamine with PLUS reagent (Life 
Technologies).  Per transfection a 1.5 ml Eppendorf tube containing 1 ml of Opti-
MEM (Gibco) was mixed with 500 ng of plasmid DNA and 0.5 µl of PLUS reagent.  
This mixture was mixed gently by vortexing and incubated for 15 minutes at room 
temperature. 1 µl of Lipofectamine LTX was then added, gently mixed and incubated 
for one hour at room temperature to allow the formation of lipid:DNA complexes.  The 
1 ml solution was then added directly to the cell types of interest and transfection was 
allowed to take place for six hours.  Following this the media was removed, gently 
washed with Hanks Balanced Salt Solution and replenished with fresh media.  The 
transfection was then usually visualised 24 hours later.    
 
2.4 Plasmid DNA preparation 
2.4.1 Restriction digests of plasmid DNA 
 
For the generation of the H14S9 NOP-SOX2 and H14S9 Atoh1nGFP reporter cell 
lines the pEGFP-1 vector (Clontech) was used for the delivery of the plasmid DNA to 
the hES cells.  For the mNOP-1/2x4 enhancer tandem Sac I and Xba I (New England 
Biolabs) were used to enzymatically digest both the phspEGFPver2 plasmid 
containing the NOP-SOX2 enhancer sequences and the pEGFP-1 vector.  Bgl II and 
BsrG I were used for the Atoh1nGFP-containing plasmid (J2XnGFP) and the pEGFP-
1 vector.  Restriction digests for both reporters were carried out in the same way as 
follows.  1 µg of plasmid DNA (preparation described in section 2.4.4) was 
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enzymatically digested with 1 µl of each restriction enzyme in a total reaction of 50 
µl, containing 1x NEBuffer 3.  The restriction digest took place over 1 hour at 37 °C.  
A 20 minute heat inactivation step at 65 °C was carried out to prevent further digestion.  
The digestions were run in a gel electrophoresis tank for approximately 1 hour at low 
voltage using a 0.8% low melting agarose gel (Sigma) in order to separate out the 
enhancer sequences from their original vectors, and also to prepare the pEGFP-1 
vector.  Ethidium bromide was added to the agarose gels to enable the visualisation of 
the plasmid DNA digests on a UV transilluminator (SYNGENE) to aid in manually 
dissecting out each fragment. 
 
2.4.2 Purification of plasmid DNA and ligation 
 
Ethanol precipitation of the plasmid DNA fragments was then carried out to purify 
and concentrate the DNA for ligation.  For a typical 50 µl digestion 5 µl of 3 M sodium 
acetate and 150 µl of ice cold 100% ethanol were added to the digested DNA in a 1.5 
ml Eppendorf tube and incubated at -80 °C for at least one hour.  Following this step 
the Eppendorf tube is centrifuged at maximum speed (approximately 14,500 rpm) for 
30 minutes.  The supernatant is then removed and replaced with 200 µl of ice cold 
70% ethanol before centrifugation at maximum speed for five minutes.  The 
supernatant is then carefully removed and the DNA pellet allowed to air dry.  
Approximately 10 – 20 µl molecular grade water is then added to resuspend the DNA 
pellet.  Quantification of plasmid DNA was carried out using the Nanodrop 1000 
spectrometry platform (Thermo Fisher Scientific). 
The pEGFP-1 vector backbone plasmid DNA and the enhancer sequences were then 
ligated together to form the plasmid constructs which were transfected into the H14S9 
hES cells in section 2.3.  Ligation reactions were performed with T4 DNA Ligase 
(New England Biolabs) as follows.  Using a 1:3 vector:insert ratio plasmid DNA was 
added to 2 µl T4 DNA Ligase Buffer and made up to 19 µl with molecular grade water.  
1 µl of T4 DNA Ligase was added and the mixture was incubated at 16 °C overnight.  
Heat inactivation at 65 °C for 15 minutes was then carried out and ethanol precipitation 
performed to purify and concentrate the plasmid DNA. 
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2.4.3 Electroporation of plasmid DNA and bacterial propagation 
 
In order to create a stock of pEGFP-1 NOP-SOX2 and pEGFP-1 Atoh1nGFP plasmid 
DNA bacterial culture is required.  XL1-Blue MRF (Minus Restriction) (Strategene) 
strain of electrocompetent bacteria were utilised for this.  50 µl aliquots of XL1-Blue 
MRF cells were thawed on ice, and 1 µl of the plasmid DNA of interest was added to 
the cells and gently pipetted to mix.  The bacteria/DNA mix was transferred to a pre-
chilled 1 mm gap electroporation cuvette, and placed into the ECM830 Electroporator 
(BTX).  A single pulse of 500 volts with a pulse length of eight milliseconds was 
applied to the cells.  The cells were then quickly transferred into 1 ml of pre-warmed 
SOC medium (Super Optimal Broth with Catabolite Repression) (Sigma) and 
incubated at 37 °C with 250 rpm shaking.  After this 100 µl of bacterial culture was 
plated and spread onto LB agar plates (Luria-Bertani) containing 25 µg/ml kanamycin 
(the pEGFP-1 vector confers resistance to kanamycin) and incubated at 37 °C 
overnight.  Bacterial colonies were subsequently picked and inoculated into 15 ml of 
LB broth containing 25 µg/ml kanamycin and left in a shaking 37 °C incubator 
overnight.  This provided an adequate culture for plasmid DNA preparation. 
 
2.4.4 Plasmid DNA preparation for transfection into human embryonic stem cells 
 
From a bacterial liquid culture it is then necessary to extract and purify the plasmid 
DNA in order to use it for transfection into mammalian cells.  This process was done 
using the Plasmid Midi Prep Kit (Qiagen) and following the manufacturers’ protocol.  
In brief, the bacterial cultures were centrifuged at 6000g for 15 minutes at 4 °C to 
pellet the cells.  The pellet is then resuspended in lysis buffers to destroy the bacterial 
cell walls and organelles.  The lysate is then precipitated and centrifuged for 30 
minutes at 20,000g at 4 °C to separate the solid material from the plasmid DNA 
contained within the supernatant.  The supernatant is centrifuged a second time for 15 
minutes and is applied to a Qiagen-100 tip column.  The plasmid DNA binds to the 
column and washing steps are carried out to eliminate any trace of protein or genomic 
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DNA contamination.  The plasmid DNA is then eluted from the column and an ethanol 
precipitation was carried out to purify and concentrate. 
 
2.5 Quantitative real-time PCR (QPCR) analysis 
2.5.1 RNA extraction and cDNA synthesis 
 
Extraction of total RNA was carried out using the RNeasy Micro Kit (Qiagen), 
following the manufacturers’ guidelines.  At the end of differentiation experiments 
cells were washed twice gently with PBS, lysed using the RLT buffer, and precipitated 
using 70% molecular grade ethanol.  The RNA solution was then passed through the 
supplied Micro columns to bind the RNA and allow for washing steps.  Digestion of 
genomic DNA was carried out on the column using DNase I (Qiagen), and RNA was 
eluted from the column using molecular grade water.  Quantification of the yield of 
RNA was done using the Nanodrop 1000 platform. 
For the conversion to complementary DNA (cDNA) 1.5 µg of RNA (wherever 
possible) was used.  In a 12 µl reaction RNA was first primed for reverse transcription 
using 1 µl oligo-dT (Promega) and incubated for five minutes at 65 °C.  Following 
this step 4 µl of First Strand Buffer (Life Technologies), 1 µl 0.1 M dithiothreitol 
(DTT) (Life Technologies), 1 µl RNasin Plus RNase Inhibitor (Promega), 1 µl 100 
mM dNTPs (Bioline), 0.5 µl RNase free water, and 0.5 µl Superscript Reverse 
Trnscriptase III (Life Technologies) was added before incubating for 90 mins at 50 
°C.  A heat inactivation step was carried out at 70 °C for 15 minutes. 
 
2.5.2 QPCR Primers 
 
Forward and reverse primers for QPCR analysis were originally designed by using the 
software PerlPrimer or Primer BLAST (NCBI).  Product lengths were ensured to be 
approximately 200 base pairs or less to remain efficient in QPCR analysis.  In the case 
of POU4F1, SYP and SLC17A7, these primers were found from carrying out literature 
searches.  Primer stocks were resuspended in molecular grade water at a final stock 
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concentration of 100 mM, and diluted to 5 µM working stocks.  Table 2.1 shows the 
list of all QPCR primers used throughout this study.  cDNA from embryoid body 
differentiation experiments (Sarah Jacob Eshtan, Johanna Thurlow) were used as 
positive controls for primer testing and determination of optimal annealing 
temperatures.  The presence of a clean melt curve and product detectable by gel 
electrophoresis confirmed the suitability of a particular primer pair. 
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Table 2.1: Primers used in QPCR analysis.  F: Forward primer; R: Reverse primer 
 
GENE PRIMER SEQUENCE 
AMPLICON 
LENGTH 
AFP 
F: CTT GTG AAG CAA AAG CCA CA 
R: CCC TCT TCA GCA AAG CAG AC 
122 
DLX5 
F: CCC TAC CAG TAT CAG TAT CAC 
R: GTC ACT TCT TTC TCT GGC TG 
155 
EYA1 
F: GTT CAT CTG GGA CTT GGA 
R: GCT TAG GTC CTG TCC GTT 
229 
FOXG1 
F: CTA AAT AGT GAC TGC TTC GCC A 
R: TTT AGG TTG TTC TCA AGG TCT G 
135 
FOXI2 
F: TGA CGC TCA GCC AGA TCT AC 
R: CCT TTA CCT GGG TCG TCC T 
151 
GATA6 
F: AAT ACT  TCC CCC ACA ACA CAA 
R: CTC TCC CGC ACC AGT CAT 
69 
MEOX1 
F: AAA TCA TCC AGG CGG AGA A 
R: AAG GCC GTC CTC TCC TTG 
95 
NANOG 
F: CTC AGC CTC CAG CAG ATG C 
R: TAG ATT TCA TTC TCT GGT TCT GG 
94 
NESTIN 
F:TCC AGG AAC GGA AAA TCA AG 
R: GCC TCC TCA TCC CCT ACT TC 
120 
PAX2 
F: CTT TAA GAG ATG TGT CTG AGG G 
R: CCT GTT CTG ATT TGA TGT GCT 
186 
PAX8 
F: CTT GGC AGG TAC TAC GAG AC 
R: GCA AAC ATG GTA GGG TTC TG 
128 
POU4F1 
F: CGT ACC ACA CGA TGA ACA GC 
R: AGG  AGA TGT GGT CCA GCA GA 
123 
POU4F3 
F: CCC GGT GCT GCA AGA ACC CA 
R: GGC GTC GGG CTT GAA CGG AT 
196 
POU5F1 
F: AGC GAA CCA GTA TCG AGA AC 
R: TTA CAG AAC CAC ACT CGG AC 
142 
RPLPO 
F: GAA GGC TGT GGT GCT GAT GG 
R: CGG GAT ATG AGG CAG CAG TT 
103 
SLC17A7 
F: TGG GTT TCT GCA TCA GCT TTG 
R: TGT ACT GTT GTT GAC CAT GGA TAC G 
74 
SOX2 
F: CCC AGC AGA CTT CAC ATG T 
R: CCT CCC ATT TCC CTC GTT TT 
151 
SYP 
F: GCA GTG GGT CTT TGC CAT CTT 
R: TGA GGG CAC TCT CCG TCT TG 
101 
T 
F: AAC TCC TTG CAT AAG TAT GAG CC 
R: TTT AAG AGC TGT GAT CTC CTC GT 
141 
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2.5.3 SYBR Green 
 
QPCR reactions were carried out using SYBR Green JumpStart Reaction Mix 
(Sigma).  Each sample was represented in triplicate within the QPCR plate.  A 
mastermix comprising of 32 µl SYBR Green JumpStart Mix, 24 µl molecular grade 
water, 6.4 µl of a forward and reverse primer mix (0.5 µM final concentration), and 
1.6 µl of cDNA was split into the three triplicate wells with 20 µl each.  Negative 
control wells containing water in the place of cDNA were run alongside each reaction. 
The basic protocol for each QPCR reaction was as follows.  An initial denaturation 
step at 94 °C for five minutes, then 40 cycles of 94 °C for 30 seconds, an primer pair-
dependent optimal annealing temperature for up to one minute, then an extension 
phase at 72 °C for one minute.  A final extension phase at 72 °C for 10 minutes 
concluded each reaction.  Reactions were done using the iCycler IQ Real-Time PCR 
machine. 
 
The Delta Delta Ct method developed by Livak and Schmittgen (2001) was used to 
quantitate and present QPCR data analysis.  The gene encoding for a ribosomal 
protein, RPLPO, was used as the calibrator gene to determine the value of the Delta 
Cts (the housekeeping reference gene).  For ascertaining the Delta Delta Cts the values 
of gene expression were compared as relative to that of the baseline control condition 
DFNB. 
 
2.6 Immunocytochemistry and image analysis 
 
For the detection of protein expression cells were immunolabelled with a combination 
of antibodies.  Following differentiation experiments, cells were washed once with 
PBS and 4% paraformaldehyde was used for 15 minutes to fix the cells.  
Paraformaldehyde was rinsed off with PBS and the cells were then washed three times 
for five minutes each with PBS containing 0.1% Triton X-100 (PBST) to permeabilise 
the cell membranes.  Non-specific binding sites were then blocked for one hour with 
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PBST supplemented with 5% donkey serum (Sigma), followed by three further washes 
with PBST for five minutes each.  Primary antibody combinations were diluted in 
PBST with 5% donkey serum, applied to the cells and incubated overnight at 4 °C.  
The next day three five minutes washes with PBST were done to remove unbound 
primary antibodies.  Secondary antibodies were diluted in PBST with 5% donkey 
serum and applied to the cells for one hour at room temperature.  Three five minute 
washes with PBS followed before applying DAPI diluted 1:100 in PBS to counterstain 
the nuclei.  Table 2.2 lists the primary and secondary antibodies used in the 
experiments presented in this work. 
Images were taken either manually using the EVOS FL Cell Imaging System (Life 
Technologies) or automatically using the In Cell Analyser 1000 platform (GE 
Healthcare).  For manual counting, cells were compared against secondary antibody-
only control staining and positivity was recorded if staining appeared brighter than the 
secondary antibody-only.  For the In Cell Analyser platform, cells were differentiated 
in 24 well (Vision Plate 24, 4titude) glass bottomed plates (previously laminin coated 
as with plastic culture vessels) and images were taken at x20 magnification.  250 
images per well were taken and analysed using the Developer Toolbox software.  To 
ensure of the reliability of the assay, nuclei were initially identified by DAPI staining 
and nuclear segmentation was carried out to allow the software to automatically 
identify the nucleus.  Nuclear segmentation was subjected to further post-processing 
tools (such as erosion and sieving) to increase the accuracy of nuclear identification.  
For testing of the segregation protocols, nuclei stained with DAPI in control wells 
were counted manually by eye at 20x magnification and this was compared against 
the automated nuclei count.  This process of segmentation provided a nuclear mask 
which was then applied to the green and red channels to determine the level of 
fluorescence intensity within.  As all of the primary antibodies used for In Cell 
Analyser analysis were nuclear markers this allowed for ease of fluorescent detection 
within the area demarcated by the nucleus.  Primary antibody titrations (coupled with 
the secondary antibody) were carried out previously in order to determine a minimum 
and maximum fluorescence intensity detectable by the Developer Toolbox software.  
For each secondary antibody, a secondary antibody-only well was also included to 
allow the software to recognise background levels of fluorescence.   
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Once the fluorescence intensity values had been determined from the images, analysis 
was carried out to determine the positive cells.  If the fluorescent intensity of a cell 
was higher than the 99th percentile value of each secondary antibody-only wells (for 
green and red) then it was considered double positive.  Once the percentage of positive 
cells was determined a more stringent threshold was applied.  This threshold identified 
highly double positive cells if the fluorescent intensity of that cell was higher than the 
75th percentile value of the positive cells in the FGF condition. 
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Table 2.2: Primary and secondary antibodies for immunolabelling. 
 
 
ANTIBODY 
(MANUFACTURER, 
PRODUCT CODE) 
HOST 
SPECIES 
WORKING 
CONCENTRATION 
P
R
IM
A
R
Y
 A
N
T
IB
O
D
IE
S
 
ATOH1 
(Abcam, AB105497) 
Rabbit 
polyclonal 
1:100 
Β-TUBULIN III 
(Covance, MMS-435P) 
Mouse 
monoclonal 
1:100 
FOXG1 
(Abcam, 18259) 
Rabbit 
polyclonal 
1:100 
MYO7A 
(Proteus, 25-6790) 
Rabbit 
polyclonal 
1:100 
NEUROFILAMENT 200 
(Sigma, N4142) 
Rabbit 
polyclonal 
1:100 
NKAα3 
(Santa Cruz, 16052) 
Goat 
polyclonal 
1:75 
PAX2 
(Abcam, 38738) 
Rabbit 
polyclonal 
1:100 
PAX6 
(DSHB) 
Mouse 
monoclonal 
1:100 
PAX8 
(Abcam, 13611) 
Goat 
polyclonal 
1:100 
POU4F1 
(Millipore, AB5945) 
Rabbit 
polyclonal 
1:100 
POU4F3 
(Santa Cruz, 81980) 
Mouse 
polyclonal 
1:100 
SOX2 
(Millipore, AB5603) 
Rabbit 
polyclonal 
1:100 
S
E
C
O
N
D
A
R
Y
 A
N
T
IB
O
D
IE
S
 
Alexa 568 anti-goat 
(Life Technologies, A11057) 
Donkey 
polyclonal 
1:250 
Alexa 488 anti-goat 
(Life Technologies, A11055) 
Donkey 
polyclonal 
1:250 
Alexa 568 anti-mouse 
(Life Technologies, A10037) 
Donkey 
polyclonal 
1:250 
Alexa 488 anti-mouse 
(Life Technologies, A21202) 
Donkey 
polyclonal 
1:250 
Alexa 568 anti-rabbit 
(Life Technologies, A10042) 
Donkey 
polyclonal 
1:250 
Alexa 488 anti-rabbit 
(Life Technologies, A21206) 
Donkey 
polyclonal 
1:250 
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2.7 Statistical analysis 
 
All QPCR data were statistically analysed as multiple sets using a one way analysis of 
variance (ANOVA) approach, with Bonferroni’s multiple comparison applied post-
test.  For In Cell Analyser statistical analysis, a chi-squared test with Yates’ continuity 
correction was applied.  In all figures bar charts represent the mean and error bars 
denote standard deviation of the mean. 
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CHAPTER 3: GENERATION OF HUMAN EMBRYONIC STEM CELL 
REPORTER LINES TO MONITOR OTIC PROGENITOR INDUCTION AND 
HAIR CELL DIFFERENTIATION 
 
3.1 Introduction 
 
3.1.1 Human embryonic stem cells 
 
Since the initial derivation of a number of human embryonic stem (hES) cell lines in 
1998 (Thomson et al., 1998), advances in the knowledge of their capabilities has 
grown significantly.  The ability to direct the differentiation of hES cells towards a 
desired fate lineage has been the subject of a vast amount of recent and current 
research.  Efficiently directing their differentiation has a number of advantages, 
including the study of organogenesis (Narayanan et al., 2013), providing a platform 
for disease modelling and toxicity testing (Sharma et al., 2013), and perhaps most 
excitingly, generating mature cell types for clinical trials and future cellular based 
therapies and regenerative medicine. 
 
3.1.2 Fluorescent reporter lines and gene delivery systems 
 
Technologies in the genetic modification of hES stem cells have also rapidly expanded 
in recent years, most notably in the form of generating cell type-specific promoter-
driven fluorescent reporter lines (reviewed in Giudice and Trounson 2008).  The 
purpose of these is to be able to monitor the differentiation of hES cells into the desired 
derivative in real time microscopy, without having to use traditional destructive 
techniques such as immunocytochemistry or RT-PCR to determine gene expression.  
Fluorescent reporter lines have also proved invaluable in high-throughput screening 
assays to rapidly identify molecules capable of manipulating differentiation towards a 
particular lineage.  As an example of this, a study conducted by Willems et al. (2011) 
involved using expression of a fluorescent reporter gene driven by the cardiac-specific 
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MYH6 promoter as a rapid high-throughput screen for testing 550 small molecules to 
identify new candidates for promoting hES cell-derived cardiomyocyte 
differentiation.  In addition differentiated fluorescent progeny of such reporter lines 
have been easily isolated and expanded for further study and testing for a future use in 
a cellular replacement capacity (Huber et al., 2007; Ovchinnikov et al., 2014; Szebényi 
et al., 2014).  Fluorescent reporter lines used in this area of research have helped to 
increase knowledge of the processes involved in lineage differentiation, and have the 
potential to speed up the process of using human pluripotent stem cells as a source for 
cellular based regenerative medicine.  
Numerous techniques have been developed to create fluorescent reporter lines in hES 
cells, such as random integration of transgenes, or targeted gene knock-ins (by 
homologous recombination).  A study conducted by Xue et al. (2009) generated a 
targeted neuroglial reporter from a hES cell line, whereby one allele of Olig2 (a 
transcription factor important in neuro- and gliogenesis) was replaced by an EGFP 
reporter cassette by homologous recombination.  This allowed the researchers to 
monitor and track Olig2 expression during hES cell neural differentiation.  Random 
integrations of transgenes is another method used to create hES reporter lines.  Noisa 
et al. (2010) carried out a random integration transfection of the H1 (WiCell) hES cell 
line with a plasmid vector containing the second intron of the human nestin gene 
enhancer, a minimal TK promoter and an EGFP reporter sequence.  The resultant 
transfected cell line showed an upregulation of EGFP reporter expression when the 
cells were differentiated in vitro toward a neuroepithelial lineage.  Recently, newer, 
more sophisticated methods of creating reporters such as transcription activator-like 
effector nucleases (TALENs) and clustered regularly interspaced short palindromic 
repeats (CRISPR) (Xue et al., 2014) are beginning to emerge. 
 
3.1.3 Otic placode-specific Sox2 enhancer sequences for generating a human 
embryonic stem cell reporter line 
 
The SOX gene family in mammals contains approximately 20 different genes with 
important roles during embryonic development and maturation.  These genes encode 
for related transcription factors comprising an approximately 80 amino acid DNA-
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binding region known as a High Mobility Group box (HMG-box) (Collignon et al., 
1996).  SOX2 (sex determining region Y)-box 2 is one such member of the SOX family, 
and is known to be one of the key transcription factors essential for hES cell 
pluripotency, along with OCT4 and NANOG (Adachi et al., 2010).  It is also implicated 
in marking various stages of neural and sensory development. 
An enhancer sequence can be defined as cis-acting regulatory DNA elements that can 
act to upregulate the transcription of a target gene or genes important for 
differentiation and development (Plank and Dean, 2014).  Uchikawa et al. (2003) 
analysed a wide genomic region (approximately 50 kilobases) surrounding the SOX2 
locus in developing chicken embryos in order to find corresponding extragenic 
enhancer sequences.    These anticipated enhancer sequences were electroporated into 
stage 4 embryos and activity was monitored using an EGFP reporter system.  Despite 
SOX2 being thought to have a pan-neural expression pattern in early neural and 
sensory placodal development, this study found eight enhancer sequences governing 
SOX2 expression with distinct spatio-temporal specificities.  Two of these enhancers, 
NOP-1 and NOP-2, were identified as having restricted activity solely in the 
developing nasal and otic placodes, suggestive of a similar developmental regulation 
of these placodes by SOX2.  These enhancer sequences were also found to be highly 
conserved between mouse and human (81 and 83% respectively for NOP-1, 77 and 
85% respectively for NOP-2).  Later studies complemented the otic specificity of the 
NOP-1 and NOP-2 enhancers, such as that conducted by Kiernan et al. (2005).  Mouse 
mutants light coat and circling (Lcc) and yellow submarine (Ysb) were studied to 
assess the effects of their complex chromosomal rearrangements and deletions in the 
vicinity of Sox2 on chromosome 3 on the development of sensory regions of the inner 
ear.  The otocysts of these mutant mice, with particular severity in the Lcc mutant, lack 
Sox2 expression whereas expression in the neural tube and other expected areas was 
normal.  This is suggestive of the regulatory enhancer sequences NOP-1 and NOP-2 
being disrupted or translocated leading to loss of otic-specific Sox2 expression and 
subsequent impact on normal inner ear development.  Another study found the 
epigenetic status of these Sox2 enhancers directly affected self-renewal ability of stem 
cells derived from the post-natal organ of Corti.  Inactivation by sequence-specific 
methylation of NOP-1 and NOP-2 enhancer sequences led to a reduction in self-
renewal capabilities (Waldhaus et al., 2012).  These studies combined offer further 
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validation of the specificity of the NOP-1 and NOP-2 enhancers and are therefore 
potential candidates for use in generating an otic placode differentiation reporter 
system. 
 
3.1.4 Human fetal auditory stem cells as a readout for otic placode-specific enhancer 
activity 
 
9-week-old to 11-week-old human fetal cochleae have previously been used to isolate 
a population of multipotent human fetal auditory stem cells (hFASCs) (Chen et al., 
2007 and Chen et al., 2009).  These cells (believed to be equivalent to stage E11.5-
13.5 in the mouse) were found to express characteristic otic progenitor markers (SOX2, 
GATA3), and also typical markers associated with stem cell pluripotency (OCT4, 
NANOG, REX1) and could be maintained in an undifferentiated state for a number of 
passages.  It was also highlighted that these cells, when exposed to specific molecular 
triggers, could readily differentiate into the more mature cell types of the inner ear; 
auditory neurons (as shown by expression of neuronal markers such as 
NEUROFILAMENT 200, NEUROGI, POU4F1) and hair cells (expressing ATOH1, 
POU4F3, MYO7A).  As the human fetal auditory stem cells express the progenitor 
marker SOX2 throughout their undifferentiated state, it was thought that they could be 
used as a positive control for determining the efficiency and activity of the otic 
placode-specific SOX2 enhancer sequences, prior to generating a hES cell reporter 
line. 
 
 
 
3.1.5 An Atoh1 enhancer sequence and its potential as an auditory hair cell 
differentiation reporter system in human embryonic stem cells 
 
Atoh1 (Cath1, Math1 and Hath1 in chicken, mouse and human respectively) is a 
transcription factor with a basic helix-loop-helix structural motif, and plays a crucial 
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role in many pro-neural and non-neural differentiation events throughout embryonic 
development (Mulvaney and Dabdoub, 2012).  For example, Atoh1 expression and 
activity is known to have a key involvement in the differentiation of secretory cells of 
the intestinal tract, initiation of the differentiation of neurons, and also 
mechanoreceptors such as the auditory hair cells of the inner ear. 
In the developing inner ear, Atoh1 expression has been shown in several studies to be 
essential for the induction of hair cell development.  Math1 mutant mice experience 
early postnatal lethality (Ben-Arie et al., 1997), and their cochlear and vestibular 
epithelia are devoid of any detectable hair cells.  Hair cell-specific markers, such as 
calretinin and myosin VI, are also undetectable immunologically, supporting the 
requirement of Math1 in the generation of inner ear hair cells (Bermingham et al., 
1999). 
A 1.4 kilobase Math1 enhancer sequence has been previously identified (Helms et al., 
2000) which has been shown to be sufficient in driving reporter gene expression in a 
number of Math1 expressing domains, and is a highly conserved sequence between 
mouse and human.  Lumpkin et al. (2003) were then able to generate transgenic mouse 
strains using a GFP-expressing reporter construct with a nuclear localising signal 
(Math1/nGFP).  This allowed for the study of Math1 enhancer activity in vivo, using 
the nuclear localising signal to concentrate the GFP for transcription factor co-
immunolabelling.  From the in vivo studies it was found that the Math1/nGFP reporter 
was able to accurately depict Math1 expression in the developing hair cells of the 
auditory and vestibular systems.  Consequently, the Math1/nGFP enhancer reporter 
could be utilised as a method of monitoring hair cell differentiation from otic 
progenitors derived from hES cells in vitro. 
Until now, we do not have a system that will allow us to monitor otic differentiation 
in real time.  Having cells that will report on the generation of progenitors, as well as 
on the generation of the sensory lineages could prove a powerful tool not only to 
expand our understanding of cell fate determination and commitment, but also for the 
screening of molecules that would facilitate the production of these cell types.  In this 
regard, the regulatory sequences for SOX2 and ATOH1 could be highly useful. 
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3.1.6 General objectives of the chapter 
 
The general aims of this chapter will be to generate hES cell reporter lines that will 
allow us to monitor the generation of otic progenitors and, eventually, of sensory hair 
cells by using otic-SOX2 specific enhancers and ATOH1 regulatory sequences. 
Working towards this aim, initially the investigation and characterisation of the 
expression of the otic placode-specific SOX2 enhancers (NOP-1 and NOP-2) and the 
ATOH1 enhancer via transient transfections, and to assess their suitability for use in a 
hES cell reporter line system.  Optimal methodologies for transient and stable 
transfections will also be determined.  Stable lines will then be characterized and 
studied in detail. 
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3.2 Results 
 
3.2.1 Transient transfection of mFASCs, hFASCs and hES cell-derived otic 
progenitors 
 
It was important to characterise the expression activity of the NOP-1 and NOP-2 
enhancer sequences in the mFASCs, hFASCs and hES cell-derived otic progenitors in 
order to assess their suitability for later generating a hES cell reporter line.  A transient 
transfection approach was taken to determine the enhancer activity in these 
populations. 
To successfully carry out transient transfections it was necessary to optimise the 
transfection methodology itself.  The plasmid pCAG-GFP was introduced into the cell 
types of interest (mFASCs, hFASCs, and H14S9 hES cell-derived otic progenitors) by 
electroporation or lipofection.  pCAG is a hybrid construct comprising of the 
cytomegalovirus enhancer fused to the chicken beta-actin promoter and is commonly 
used to drive constitutive expression of high levels of a transgene of interest.  For 
electroporation cells were required to be typsinised into a single cell suspension before 
the introduction of plasmid DNA, followed by seeding them into wells of a 48 well 
plate.  In contrast, for lipofection cells were seeded into wells of a 48 well plate 24 
hours prior to transfection with Lipofectamine LTX and PLUS reagent solution (Life 
Technologies).  Further details of the two transfection methods used can be found in 
Chapter 2. 
All attempts to transfect the different cell populations via electroporation resulted in 
very poor cell viability.  A range of pCAG-GFP plasmid concentrations (from 250 ng 
to 1 µg) and electroporation parameters (Chapter 2) were tested but cell survival 24 
hours post transfection was very poor and no visible GFP expression could be detected 
by fluorescent microscopy.  For lipofection, it was important to investigate whether 
the presence or absence of serum in the culture media during transfection would affect 
cell survival and/or transfection efficiency.  The cell types of interest in this chapter 
are routinely maintained in serum-free based media (OSCFM, see Chapter 2).  24 
hours following lipofection with 500 ng of plasmid DNA the number of GFP positive 
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cells were counted and expressed as a mean percentage of the total number of cells per 
field of view, as shown in Figure 3.1.  As anticipated (Brunette et al., 1992; Ross and 
Hui, 1999) the efficiency of lipofection, denoted by a higher percentage of GFP 
positive cells, was greater when the transfection was carried out in serum-free culture 
media compared to being in the presence of serum, as the presence of serum 
throughout lipofection has previously been shown to be inhibitory.  This was found to 
be consistent across all cell types investigated (mFASCs 23.6% ± 6.2% and 3.1% ± 
1.4%; hFASCs 26.0% ± 5.6% and 2.8% ± 1.6%; H14S9 otic progenitors 30.5% ± 9.1% 
and 3.8% ± 1.2% respectively).  Subsequently, all transient transfections using these 
cell types were carried out via lipofection in a serum-free environment. 
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Figure 3.1: Transfection efficiency of pCAG-GFP using Lipofectamine LTX in 
mFASCs, hFASCs and H14S9 otic progenitors. GFP positive cells counted 24 hours 
post transfection using fluorescent microscopy and presented as the mean percentage 
of GFP positive cells per field of view (10x magnification).  Error bars denote mean 
and standard deviation of all fields of view counted. 
 
m
F
A
S
C
s
h
F
A
S
C
s
H
1
4
S
9
 o
ti
c  
p
ro
g
e n
it
o
rs
0
10
20
30
40
50
C e ll  ty p e
M
e
a
n
 %
 p
C
A
G
-G
F
P
 p
o
s
it
iv
e
 c
e
ll
s
p
e
r 
fi
e
ld
 o
f
 v
ie
w
W ith o u t  s e r u m
W ith  s e ru m
 
 
 
 
 
 
 
 
 
 
 
 
 
  Chapter 3 
58 
 
3.2.2 Otic placode-specific SOX2 enhancer sequences are active in mFASCs, hFASCs, 
and human embryonic stem cell derived otic progenitors 
 
In an attempt to determine the level of activity of the NOP-1 and NOP-2 SOX2 
enhancer sequences (Uchikawa et al., 2003) in different cell populations, a transient 
transfection approach was taken.  Plasmid vectors containing the chicken (referred to 
here as cNOP-1 and cNOP-2) or a tetrameric form of the mouse (mNOP-1/2x4) 
enhancer sequences upstream of a GFP reporter were a kind gift from the Kondoh 
laboratory, where these enhancer sequences were initially identified.  Plasmid 
preparations of these enhancers were carried out as previously described in Chapter 2.  
Briefly, XL1-Blue MRF electrocompetent bacteria were transformed via 
electroporation and cultured in Luria broth containing ampicillin antibiotic to select 
for successfully transformed bacteria.  Plasmid Mini Kit (Qiagen) was used to prepare 
and purify the plasmid DNA.  To ensure the plasmid DNA contained the correct 
enhancer sequences, restriction enzyme mapping was carried out. 
Upon purification of the enhancer sequence plasmid DNA, transient transfections 
were carried out in mFASCs, hFASCs and H14S9 hES cell-derived otic progenitors 
(at day 6 and day 12 of the otic differentiation protocol) using Lipofectamine LTX and 
PLUS reagent in serum-free media.  24 hours post transfection the number of GFP 
positive cells were counted and a percentage of the total number of cells per field of 
view was calculated.  The mean percentages were then normalised to the pCAG-GFP 
control for each cell type and are represented in Figure 3.2.  It was found that the 
mNOP-1/2x4 enhancer sequence was detectably expressed in a very high percentage 
of all of the transfectable cells in mFASCs (100%), hFASCs (93.2%) and day 12 
H14S9 otic progenitors (89.5%).  The individual cNOP-1 and cNOP-2 enhancer 
sequences had lower levels of expression in all the cell types overall, but were 
consistent in expression between mFASCs and hFASCs (34.6% and 25.5% in 
mFASCs, 32.8% and 34.8% in hFASCs, respectively).  In the H14S9 otic progenitors 
investigated at day 6 of the otic differentiation protocol the expression of cNOP-1 and 
cNOP-2 was visibly undetectable.  However a very low expression (8.3%) of cNOP-
1 was detected in the day 12 H14S9 otic progenitors. 
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Figure 3.2:  Transient transfection of NOP1/2 enhancer sequences in mFASCs, 
hFASCs and H14S9 otic progenitors.  Mean percentages of GFP expressing cells 
are presented as normalised from the pCAG-GFP control of each cell type.  Error bars 
denote mean and standard deviation of all fields of view counted (at 10x 
magnification).  Statistical significance determined by one way ANOVA with 
Bonferroni’s multiple comparison post-test.  ns = no significant difference.  
****P<0.0001. 
 
 
m F A S C s
N
o
rm
a
li
s
e
d
 e
ff
ic
ie
n
c
y
(%
 o
f 
p
C
A
G
-G
F
P
 c
o
n
tr
o
l)
p
C
A
G
-G
F
P
cN
O
P
-1
cN
O
P
-2
m
N
O
P
-1
/2
x
4
0 .0
0 .5
1 .0
1 .5
n s
n s
* * * *
* * * *
h F A S C s
N
o
rm
a
li
s
e
d
 e
ff
ic
ie
n
c
y
(%
 o
f 
p
C
A
G
-G
F
P
 c
o
n
tr
o
l)
p
C
A
G
-G
F
P
cN
O
P
-1
cN
O
P
-2
m
N
O
P
-1
/2
x
4
0 .0
0 .5
1 .0
1 .5
n s
n s
* * * *
* * * *
H 1 4 S 9  o t ic  p r o g e n i to r s  -  D a y  6  o f  d if f e r e n tia t io n
N
o
r
m
a
li
s
e
d
 e
f
fi
c
ie
n
c
y
(%
 o
f
 p
C
A
G
-G
F
P
 c
o
n
tr
o
l)
p
C
A
G
-G
F
P
cN
O
P
-1
cN
O
P
-2
m
N
O
P
-1
/2
x
4
0 .0
0 .5
1 .0
1 .5
H 1 4 S 9  o tic  p r o g e n i to r s  -  D a y  1 2  o f  d if f e re n t ia t io n
N
o
r
m
a
li
s
e
d
 e
f
fi
c
ie
n
c
y
(%
 o
f
 p
C
A
G
-G
F
P
 c
o
n
tr
o
l)
p
C
A
G
-G
F
P
cN
O
P
-1
cN
O
P
-2
m
N
O
P
-1
/2
x
4
0 .0
0 .5
1 .0
1 .5
n s
* * * *
 
 
 
 
 
 
  Chapter 3 
60 
 
3.2.3 Using otic placode-specific Sox2 enhancer sequences to generate a stably 
transfected human embryonic stem cell reporter line to monitor otic differentiation in 
vitro 
 
The murine tetrameric form of the nasal and otic placode-specific SOX2 enhancer 
sequences (mNOP-1/2x4) was chosen to generate a stably transfected hES cell 
reporter line.  The tetrameric form of the enhancer visibly boosted the brightness of 
the GFP expression during the transient transfections of the cell types discussed 
previously, when compared to the GFP brightness produced from the single cNOP-1 
or cNOP-2 enhancers.  H14S9 was chosen as the parental cell line, with pEGFP-1 as 
the plasmid vector of choice as it features a selectable marker (G418 antibiotic 
resistance conferred via a neomycin resistance cassette) which is required to select for 
stably transfected cells, and has been successfully employed previously in the 
generation of stable hES cell reporter lines (Lenka et al., 2002; Noisa et al., 2010).  
Detailed information on the generation of the reporter plasmid construct can be found 
in Chapter 2.  Briefly, the mNOP-1/2x4 enhancer tandem along with the heat shock 
protein 68 (hsp68) minimal promoter and EGFP sequence was enzymatically digested 
from the phspEGFPver2 plasmid and ligated into the pEGFP-1 vector.  From here on 
this nasal and otic placode-specific SOX2 plasmid reporter construct will be referred 
to as pEGFP-1 NOP-SOX2. 
Once the plasmid reporter construct was generated it was transfected into the H14S9 
parental hES cell line.  As with the transient transfections discussed earlier in this 
chapter, it was important to determine the optimal transfection conditions and 
methodology for the hES cells (details in Chapter 2).  Electroporation and lipofection 
were tested, with the plasmid reporter construct either being linearised (with the 
restriction endonuclease enzyme ApaLI) or circular.  As a stably transfected cell line 
was required, it was important to transfect the hES cells in a single cell state in order 
to permit clonogenicity.  Once the reporter plasmid was transfected into the cells, 
G418 antibiotic was required to be added to the hES culture media in order to select 
for successfully transfected colonies.  Because of this, transfected cells had to be 
maintained in feeder-free conditions (matrigel as a matrix and mTeSR1 as a 
maintenance medium) due to the sensitivity of the mouse feeders to the G418 
antibiotic.  A kill curve experiment was carried out (Figure 3.3) using the parental 
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H14S9 cell line to determine the optimal concentration of G418 to use for this 
selection.  A kill curve may be defined as the concentration of G418 antibiotic that 
kills all of the parental H14S9 cells within five days of treatment.  A range of 
concentrations were tested (0 – 500 µg/ml) and as demonstrated in Figure 3.3 the 
optimal concentration was found to be 20 µg/ml G418.  During optimisation of the 
transfection methodology, H14S9 hES cells were electroporated or lipofected with 10 
µg linearised or circular pEGFP-1 NOP-SOX2 reporter plasmid DNA.  After an initial 
recovery period of 48 hours post transfection, transfected cells were maintained in 
mTeSR1 medium with the supplementation of 20 µg/ml G418 antibiotic for a further 
21 days.  At the end of this time period, the lipofected hES cells did not produce any 
colonies from linearised or circular plasmid DNA transfection.  Two poorly defined 
colonies had formed from electroporation of the circular plasmid DNA, in contrast to 
12 colonies from linearised plasmid DNA electroporation.  These 12 colonies were 
individually picked and expanded to generate a frozen bank prior to testing reporter 
activity during the in vitro otic differentiation protocol.  The reporter line will 
henceforth be referred to as H14S9 NOP-SOX2. 
An important aspect of the H14S9 NOP-SOX2 reporter line is that the clones are 
morphologically comparable to the H14S9 cell line (Figure 3.4A).  In addition, there 
is no difference in the relative expression of the pluripotency genes (OCT4, SOX2 and 
NANOG) between the parental H14S9 and the H14S9 NOP-SOX2 reporter line (Sarah 
Jacob-Eshtan, unpublished data, Appendix 1).  Interestingly, some of the H14S9 NOP-
SOX2 reporter colonies in the undifferentiated state have a low level of GFP 
expression.  This is not a phenomenon featured in all undifferentiated colonies, and 
where it is present it has a tendency to be found towards the peripheral edges of the 
colonies (Figure 3.4B).  This heterogeneous, low level of expression has been explored 
in a parallel work by Sarah Jacob Eshtan. 
 
 
 
  
 
 
  Chapter 3 
62 
 
Figure 3.3: Kill curve experiment of H14S9 hES cells with G418 antibiotic.  Cells 
were maintained in a 12 well plate format on a matrigel matrix in mTeSR1 medium 
supplemented with 0, 20, 50, 100, 200 or 500 µg/ml G418 antibiotic.  The number of 
cells were counted every 24 hours for five consecutive days.  20 µg/ml G418 antibiotic 
killed all parental H14S9 hES cells by day 5 of treatment and so this concentration 
was used to select for successfully transfected cells. 
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Figure 3.4A: Micrographs of the H14S9 and H14S9 NOP-SOX2 hES cell lines.  
Phase images show that the H14S9 NOP-SOX2 reporter line is morphologically 
similar to its parental H14S9 cell line.  4x magnification.  Scale bars are 1000 µm.  
Figure 3.4B: Micrographs of the H14S9 NOP-SOX2 reporter line expressing 
GFP.  GFP-expressing cells can be seen in some undifferentiated colonies, typically 
concentrated towards the outer perimeter of the colonies.  10x magnification.  Scale 
bars are 400 µm. 
 
3.4A 
 
 
 
3.4B 
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3.2.4 Parental H14S9 and H14S9 NOP-SOX2 reporter line activity during in vitro otic 
differentiation 
As described in detail in Chapter 2, through the supplementation of basal DFNB 
(DMEM, F12, N2 and B27) media with the key signalling ligands FGF 3 and FGF 10, 
undifferentiated hES cells can be induced to differentiate into progenitors of the otic 
lineage.  Amongst various extraneous cell types, two predominant cell types of interest 
are produced during the 12 day differentiation process; epithelioid-like cells (referred 
to as otic epithelial progenitors, or OEPs) and neural-like cells (referred to as otic 
neural progenitors, or ONPs).  These two progenitor populations are morphologically 
distinct, but share a common gene expression profile.  PAX8 (paired box 8), PAX2 
(paired box 2), FOXG1 (forkhead box G1) and SOX2 (sex determining region Y-box 
2) are characteristic markers of otic progenitors.  Previously published work in the 
laboratory (Chen et al., 2012) has demonstrated that a large proportion of the 
differentiated cells (approximately 78% and above) induced by FGF 3 and FGF 10 
signalling co-express combinations of the aforementioned otic markers.  Imaging and 
relative fluorescence intensity data was generated using the In Cell Analyzer 1000 
automated microscopy platform (GE Life Sciences).  When a stringent threshold of 
the 75th intensity percentile was applied, a smaller proportion (approximately 15% to 
20%) of these cells were found to co-express high levels of otic marker combinations 
in the FGF medium condition compared to the DFNB control, and these high 
expressing cells are believed to be the true population of otic progenitors. 
Differentiation experiments using the parental H14S9 hES cells were carried out (as 
detailed in Chapter 2) using control DFNB or with DFNB medium supplemented with 
FGF 3 and FGF 10 (referred to from here on as FGF medium).  Cells were 
differentiated for 12 days and were immunolabelled with the primary antibody 
combinations SOX2/PAX8, SOX2/PAX2 and SOX2/FOXG1 and analysed using the 
In Cell Analyzer 1000 (representative experiment in Figure 3.5A with results of three 
repeat experiments displayed in Figure 3.5A’).  A cell is considered to be positive for 
a particular antibody labelling if the fluorescence intensity value is higher than the 99th 
percentile threshold intensity of the secondary antibody-only control.  The 75th 
fluorescence intensity percentile was then applied to determine the proportion of the 
brightest immunolabelled cells.  Parallel differentiation experiments were set up in 
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order to determine the activity of the H14S9 NOP-SOX2 hES reporter line and to 
ensure of its usefulness and reliability as an in vitro assay for otic induction.  At the 
end of the 12 day differentiation period, the percentage of NOP-SOX2 GFP expressing 
cells was determined (Figure 3.5B).  Cells were also fixed, immunolabelled with 
PAX8, PAX2 or FOXG1 primary antibodies with Alexa 568 secondary antibodies, 
and imaged on the In Cell Analyzer 1000 platform.  The number of positive cells co-
expressing otic markers with NOP-SOX2 reporter GFP were ascertained.  Results 
from three repeat experiments are represented in Figure 3.5B’).  It is also important to 
note that across the three replicate experiments very small numbers of cells were 
positive for NOP-SOX2 GFP with negative antibody staining for PAX2 (based on the 
99th percentile) (0.1% ± 0.02%), PAX8 (0.17% ± 0.07%) or FOXG1 (0.28% ± 0.04%). 
Consistent with the previously published data (Chen et al., 2012) the percentage of 
highly double positive cells in the parental H14S9 was overall greater in the FGF 
treated condition compared to the baseline DFNB condition for all antibody 
combinations investigated.  15.7% ± 1.9% of the cells expressed high levels of SOX2 
and PAX8 (SOX2hiPAX8hi) in the FGF condition compared to 5.9% ± 4.6% in the 
DFNB condition, 20.7% ± 1.2% in FGF compared to 11.7% ± 3.4% in DFNB were 
found to be SOX2hiPAX2hi, and 25.7% ± 3% in FGF compared to 9.6% ± 2.3% in 
DFNB for SOX2hiFOXG1hi (Figure 3.5A and 3.5A’). 
31.0% ± 10.8% of NOP-SOX2 GFP positive cells were found at the end of the 12 day 
protocol in the DFNB condition compared to 42.7% ± 9.7% in FGF medium (n=4 
experiments, Figure 3.5B).  A greater percentage of NOP-SOX2 GFP reporter 
expression co-staining with other key otic markers was found in the FGF treated 
condition compared to the DFNB control (19.6% ± 0.5% and 10% ± 3.7% for NOP-
SOX2/PAX8, 23.6% ± 1.3% and 13.3% ± 1.1% for NOP-SOX2/PAX2, and 22.2% ± 
1.8% and 11.7% ± 2.4% for NOP-SOX2/FOXG1 respectively) (Figure 3.5B’). 
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Figure 3.5A:  Parental H14S9 hES cells differentiated for 12 days in DFNB or 
FGF medium.  Representative experiment displayed below.  Experiments ran in 
parallel to those in Figure 3.5B.  Scatterplots for immunolabelling with SOX2/PAX8 
(green/red), SOX2/PAX2 (green/red) and SOX2/FOXG1 (green/red).  Fluorescence 
intensity of each antibody is displayed on each axis.  The scatter plots are coloured 
according to two different intensity thresholds: 99th percentile points of fluorescent 
intensity in the secondary antibody only control, and 75
th
 percentile points of 
fluorescent intensity seen in the FGF condition labelling. Grey: intensity below 99
th
 
percentile. Green: intensity above the 99
th
 percentile for the green (SOX2) but not red 
channel (PAX8, PAX2 or FOXG1). Red: intensity above the 99
th
 percentile in the red 
channel but not green channel. Purple: cells are double positive, intensity above the 
99
th
 percentile in both channels. Black: cells are highly double positive, intensity is 
above the FGF 75
th
 percentile in both channels.   
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Figure 3.5A’: Parental H14S9 hES cells differentiated for 12 days in DFNB or 
FGF medium.  Bar charts show the percentage of highly double positive cells (with a 
threshold intensity above the 75th percentile) in each condition for the antibody 
combinations SOX2hi/PAX8hi, SOX2hi/PAX2hi, and SOX2hi/FOXG1hi.  The results are 
presented as three experimental replicates combined.  Error bars denote mean and 
standard deviation.  Statistical significance was determined using Chi-square with 
Yates’ continuity correction.  ****P<0.0001. 
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Figure 3.5B: GFP expression in NOP-SOX2 differentiated cells.  H14S9 NOP-
SOX2 reporter cells were differentiated in DFNB or FGF medium for 12 days.  GFP 
positive cells per field of view were counted and presented below as a mean percentage 
of the total number of cells per field.  Error bars denote mean and standard deviation.  
Using an unpaired t-test the differences between the means from DFNB and FGF 
medium are not statistically significant (n=4).  
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Figure 3.5B’: Co-staining of H14S9 NOP-SOX2 differentiated reporter cells.  
Cells were immunolabelled with PAX8, PAX2 or FOXG1 primary antibodies, and the 
percentage of double positive cells (primary antibody and NOP-SOX2 GFP) is shown 
below (n=3).  Error bars denote mean and standard deviation.  Statistical significance 
was determined using Chi-square with Yates’ continuity correction.  *P<0.05, 
****P<0.0001. 
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3.2.5 Cellular morphology and reporter expression in H14S9 NOP-SOX2 otic 
differentiation 
As mentioned previously in this chapter, when hES cells are subjected to our in vitro 
otic differentiation protocol a number of different cell morphologies are produced.  
Two of these morphologies are of particular interest; otic epithelial progenitors (OEPs) 
and otic neural progenitors (ONPs).  As well as their morphological distinctions, the 
downstream applications and differentiation capacities of OEPs and ONPs are also 
discrete.  The OEPs have been previously shown to have a capability to further 
differentiate into hair cell-like cells, whereas the ONPs can readily differentiate into 
the more mature sensory auditory neurons (Chen et al., 2012).  A purified culture of 
either OEPs or ONPs is required in order to further differentiate them.  Currently, the 
methodology in the laboratory for the purification of a particular cell type of interest 
is to manually clean the differentiating cultures.  Usually beginning at day four to six 
of the 12 day differentiation protocol, unwanted cell morphologies are scraped away 
using a sterile plastic Pasteur pipette, and the remaining cell type of interest may then 
be expanded.  There are a number of disadvantages to this current technique of cell 
purification.  It can be labour intensive, prone to subjective bias, and there is no way 
to determine whether the cells being selected are truly otic in nature based on 
morphology alone.  Recent research in the laboratory has sought to look for more 
reliable methods of selecting for the cell types of interest, including identifying cell 
surface markers to sort via flow cytometry.  Unfortunately this research has had very 
limited success so far. 
The H14S9 NOP-SOX2 reporter line can be utilised to provide greater insight into our 
in vitro otic differentiation protocol by offering more detail on the cell morphologies 
produced during differentiation in relation to the reporter GFP expression.  
Differentiating H14S9 NOP-SOX2 cells were monitored throughout the 12 day 
protocol and the emerging colonies were noted for both their morphology (OEP, ONP 
or ‘other’) and GFP expression status (positive or negative) (Table 3.1).  Illustrative 
examples are shown in Figure 3.6. 
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Table 3.1: Colony morphology and NOP-SOX2 GFP expression in a typical 
experiment.  The total number of colonies per field (10 fields counted in total) were 
counted using phase microscopy at day 12 of otic differentiation.  Colonies were then 
noted for their GFP expression status (positive or negative). 
 
 
Colony type GFP positive GFP negative Total GFP positive 
(%) 
OEP 9 7 16 56.3 
ONP 7 11 21 33.3 
Other 4 13 17 23.5 
 
 
 
 
Figure 3.6: OEP and ONP colonies can be NOP-SOX2 GFP positive or negative.  
Illustrative examples of day 12 progenitors differentiated with FGF medium.  4x 
magnification.  Scale bar is 1000 µm. 
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3.2.6 Pax6 expression can be used as a marker of nasal placode progenitors 
OEP and ONP colonies (and other colony morphologies) formed from the H14S9 
NOP-SOX2 hES reporter line during the otic differentiation protocol vary in their level 
of GFP expression (3.2.5).  As the SOX2 enhancer sequence used to create the reporter 
line has been shown to display activity in both the nasal and otic placodes in 
developing chick and mouse embryos (Uchikawa et al., 2003), it was important to 
attempt to distinguish NOP-SOX2 reporter expression in the hES cell-derived 
progenitors as being either nasal or otic.  PAX6 expression has been used in previous 
research as a marker for nasal placodal progenitors, and is known to be restricted from 
the maturing progenitors of the otic placode during development (Bhattacharyya and 
Bronner-Fraser 2008; Grindley et al., 1995; Lleras-Forero et al., 2013). 
In order to assess this H14S9 NOP-SOX2 hES cells were differentiated in either 
baseline DFNB or FGF medium for the standard 12 day otic differentiation protocol.  
Differentiating progenitors were fixed at day 12 of the protocol and immunolabelled 
with a monoclonal PAX6 primary antibody using standard laboratory protocol (see 
Chapter 2 for details) and image analysis was carried out using the In Cell Analyzer 
1000 platform.  Figure 3.7 displays the percentage of NOP-SOX2 GFP/PAX6 double 
positive cells from both DFNB and FGF differentiation conditions.  It was observed 
that 50.13% ± 8.50% of the differentiated cells in the DFNB condition were double 
positive for NOP-SOX2 GFP and PAX6, compared to 27.92% ± 4.70% in the FGF 
treated condition. 
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Figure 3.7: PAX6 expression in H14S9 NOP-SOX2 reporter differentiated for 12 
days in DFNB or FGF medium.  Cells were co-labelled with a monoclonal PAX6 
antibody and the percentage double positive cells (NOP-SOX2 GFP with PAX6 
antibody staining) is presented.  Error bars denote mean and standard deviation.  
Statistical significance was determined using Chi-square with Yates’ continuity 
correction (n=2).  *P<0.05. 
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3.3  Using an Atoh1 enhancer sequence to generate an Atoh1-reporting hES reporter 
cell line 
The 1.4 kilobase Atoh1 (Math1) enhancer sequence identified by the research of 
Helms et al. (2000) coupled to a nuclear localising signal sequence has been shown to 
be sufficient to function as an Atoh1 reporter.  Its patterns of expression during in vivo 
development are found in Atoh1 domains such as Merkel cells of the skin, granular 
cell progenitors in the immature cerebellum, and hair cells of the cochlear and 
vestibular systems of the developing inner ear (Lumpkin et al., 2003).  Expression was 
not solely restricted to Atoh1 domains, however, as some off target areas of expression 
were observed.  Nevertheless, having a hES cell reporter line which could be used to 
monitor the expression of Atoh1 during in vitro hair cell differentiation would be very 
valuable, especially as Atoh1 is believed to be the earliest determinant of hair cell fate 
(Bodson et al., 2010; Hongmiao et al., 2014). 
The Atoh1 enhancer sequence and nuclear localising signal was originally housed in 
the J2XnGFP plasmid (Jane Johnson, TX, USA), containing a minimal beta globin 
promoter sequence but lacking a selectable marker.  As for the NOP-SOX2 reporter 
line, pEGFP-1 (Clontech) was chosen as the vector vehicle for generating a stably 
transfected hES reporter line.  H14S9 was again used as the hES cell line of choice, as 
this particular cell line has repeatedly proved to be the most efficient at inducing OEP 
colony morphology (OEPs rather ONPs have the capacity to be further differentiated 
into hair cell-like cells in vitro in our laboratory). 
The J2XnGFP plasmid construct was enzymatically digested to extract an 
approximately 2.5 kilobase plasmid sequence containing the minimal beta globin 
promoter, Atoh1 enhancer, nuclear localising signal and the EGFP sequence, and this 
was ligated into the pEGFP-1 vector.  Plasmid DNA preparations were carried out 
using XL1-Blue MRF bacteria as previously described in Chapter 2.  The plasmid 
construct will be referred to from here on as pEGFP-1 Atoh1nGFP. 
The murine neuroblastoma cell line Neuro2a has been used in many previous studies 
investigating and manipulating Atoh1 expression and activity (Flora et al., 2009; Jeon 
et al., 2011; Klisch et al., 2011; Shi et al., 2010), and so acted as a control for testing 
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the J2XnGFP and pEGFP-1 Atoh1nGFP plasmid constructs.  As in section 3.2.3, 
lipofection with Lipofectamine LTX and PLUS reagent (Life Technologies) was used 
to transiently transfect the Neuro2a cells with pCAG-GFP plasmid in order to 
determine the transfection efficiency.  53.5% ± 8.1% (mean ± standard deviation, n=2) 
of the Neuro2a cells were GFP positive 24 hours following transfection.  This 
efficiency was then used to normalise the transient transfection efficiency of the 
J2XnGFP and pEGFP-1 Atoh1nGFP plasmid constructs.  Illustrative images are 
displayed in Figure 3.8A and normalised data is shown in Figure 3.8B.  A similar mean 
transfection percentage was observed between the parental J2XnGFP plasmid and the 
pEGFP-1 Atoh1nGFP construct (12.9% ± 2.8% and 15.2% ± 2.1% respectively).  This 
result provided confidence in the efficiency and suitability of utilising the pEGFP-1 
Atoh1nGFP plasmid construct to generate an Atoh1 reporting hES cell reporter line. 
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Figure 3.8A: Transient transfections of J2XnGFP and pEGFP-1 Atoh1nGFP 
plasmid constructs in Neuro2a cells.  Images were taken at 10x magnification 24 
hours post transfection (n=2).  Illustrative example images are displayed below. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BRIGHTFIELD J2XnGFP 
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Figure 3.8B: Transient transfections of J2XnGFP and pEGFP-1 Atoh1nGFP 
plasmid constructs in Neuro2a cells.  Mean percentages of GFP expressing cells are 
presented as normalised from the pCAG-GFP control of each cell type.  Error bars 
denote mean and standard deviation of all fields of view counted (at 10x 
magnification).  Statistical significance determined by one way ANOVA with 
Bonferroni’s multiple comparison post-test.  ns = no significant difference. 
 
 
N
o
r
m
a
li
s
e
d
 e
f
fi
c
ie
n
c
y
(%
 o
f
 p
C
A
G
-G
F
P
 c
o
n
tr
o
l)
p
C
A
G
-G
F
P
J2
X
n
G
F
P
p
E
G
F
P
-1
 A
to
h
1
n
G
F
P
0 .0
0 .5
1 .0
1 .5
n s
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Chapter 3 
79 
 
For generating the stably transfected Atoh1 hES reporter cell line, the same 
transfection parameters optimised for the H14S9 NOP-SOX2 reporter line were used 
(as pEGFP-1 was the vector of choice used for both reporter plasmid constructs).  As 
a reminder, 10 µg of ApaLI-linearised pEGFP-1 Atoh1nGFP plasmid DNA was 
electroporated into a H14S9 single cell suspension and plated onto growth factor 
reduced matrigel.  After a 48 hour recovery period 20 µg/ml G418 antibiotic (as 
determined by the H14S9 kill curve experiment, Figure 3.3) was introduced into the 
maintenance media for a further 21 days to select for transfected clones.  From here 
on the stably transfected reporter cell line will be referred to as H14S9 Atoh1nGFP.  
The stably transfected reporter line is morphologically similar to the H14S9 parental 
cell line (Figure 3.9A).  In a similar finding to that of the H14S9 NOP-SOX2 reporter 
line, some GFP expression could be seen in the undifferentiated state (Figure 3.9B), 
especially concentrated around towards the edges of the colonies.  Not all H14S9 
Atoh1nGFP undifferentiated colonies contained GFP-expressing cells. 
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Figure 3.9A: Micrographs of the H14S9 and H14S9 Atoh1nGFP hES cell lines.  
Phase images show that the H14S9 Atoh1nGFP reporter line is morphologically 
similar to its parental H14S9 cell line.  4x magnification.  Scale bars are 1000 µm.  
Figure 3.9B: Micrographs of H14S9 Atoh1nGFP reporter line.  GFP-expressing 
cells can be seen in some undifferentiated colonies, typically concentrated towards the 
outer perimeter of the colonies.  10x magnification.  Scale bars are 400 µm. 
 
3.9A: H14S9 and H14S9 Atoh1nGFP are morphologically indistinct 
 
 
 
 
3.9B: H14S9 Atoh1nGFP features GFP expression in some undifferentiated 
colonies 
 
 
 
 
 
H14S9 H14S9 Atoh1nGFP 
Atoh1nGFPO 
  Chapter 3 
81 
 
3.3.1 H14S9 Atoh1nGFP reporter line activity during in vitro otic differentiation 
 
Experiments were set up in order to ascertain how the H14S9 Atoh1nGFP reporter 
behaves throughout the first phase of otic differentiation.  Cells were maintained in 
DFNB or FGF medium for the standard 12 day protocol and GFP expression was 
monitored.  The mean percentage of GFP positive cells counted at the end of the 12 
day protocol is displayed in Figure 3.10 showing no statistically significant difference 
in Atoh1nGFP expression between DFNB and FGF medium (22.4% ± 19.7% for 
DFNB and 24.4% ± 16.7% in the FGF condition). 
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Figure 3.10: H14S9 Atoh1nGFP reporter cells differentiated for 12 days in DFNB 
or FGF medium.  GFP positive cells per field of view were counted and presented 
below as a mean percentage of the total number of cells per field.  Error bars denote 
mean and standard deviation.  Statistical significance was determined using Unpaired 
t-test (n=2).  ns = no significant difference. 
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3.3 Discussion 
 
3.3.1 Reporter line generation to monitor otic differentiation and hair cell induction 
in vitro 
 
To date there has been no information published regarding the generation of human 
otic placode specific reporter cell line, and only one published study based on 
reporting the later hair cell differentiation from hES cells (Ronaghi et al., 2014).  Other 
studies of tracking otic development have been carried out in mice and zebrafish, and 
tend to be based on the use of non-otic specific genes and proteins.  For example, a 
few studies have looked at Pax3 expression and its contribution to the developing otic 
placode and otic vesicle (Freyer et al., 2011; Kim et al., 2014; Sandell et al., 2014).  
Despite its acknowledged importance in normal inner ear development (Pax3 null 
mice have severe inner ear morphology malformations) Pax3 expression is not 
exclusive to the inner ear, and is classically used in reporting on neural crest cell 
differentiation and migration (Wang et al., 2008).  Similarly, a recent study by 
Economou et al. (2013) identified a 1.4 kilobase minimal enhancer sequence that was 
used to create an Fgf 10 reporter system in the mouse.  Expression of Fgf 10 has been 
found to play a crucial role in otic placode induction, yet is also involved in the 
development of other tissues such as the limb buds and lungs (Itoh and Ohta, 2014).  
Therefore, despite such reporters displaying potential benefits to the further 
understanding of otic development in in vivo models, their lack of otic exclusivity does 
not make them the most ideal candidates for creating a human embryonic stem cell in 
vitro reporter line. 
Using enhancer sequences which convey otic placode specificity are therefore a much 
more desirable reporter system to utilise.  The SOX2 enhancer sequences (NOP-1 and 
NOP-2) originally identified by Uchikawa et al. (2003) were found to show reporter 
activity solely in the developing otic and nasal placodes of developing chick embryos.   
Following transient transfection of the NOP-1 and NOP-2 enhancer sequences into 
human fetal cochlea-derived auditory stem cells (hFASCs) initially isolated by Chen 
et al. (2007) we observed a very high percentage of the transfectable cells (up to 100% 
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in some cases) expressing tetrameric enhancer driven GFP (Figure 3.2).  This was an 
anticipated finding as the hFASCs are obviously otic in origin and have previously 
been shown to express SOX2 throughout their undifferentiated state.  The high level 
of enhancer driven GFP expression was also noted upon transiently transfecting otic 
progenitors differentiated directly from hES cells.  Taking these results into account 
provided us with the confidence that using these otic placode enhancer sequences to 
generate a hES cell reporter line would be most beneficial and informative as an in 
vitro assay to monitor otic differentiation. 
The H14S9 NOP-SOX2 reporter line created was found to be morphologically 
indistinct from its parental cell line and expression of pluripotency genes was also 
similar between the two lines, ensuring the reporter line still behaved akin to its non-
genetically modified parental hES cell line.  One particular point of interest to note 
was the fact that low levels of GFP expression could be visually detected in some, but 
not all, of the H14S9 NOP-SOX2 colonies in their undifferentiated state, typically 
towards the outer periphery of the colonies (Figure 3.4B).  This phenomenon has also 
been seen in other hES reporter lines, such as the ones generated by Lenka et al. (2002) 
and Noisa et al. (2010).  In these studies, human nestin enhancer sequences were used 
to generate reporter lines, also with pEGFP-1 as the vector vehicle for stable 
transfections.  Despite nestin being known to be a neural stem cell and neuroectoderm 
marker (King et al., 2009) low levels of nestin enhancer driven GFP expression were 
detected in the undifferentiated hES colonies.  The GFP expression increased in 
fluorescent intensity upon neural differentiation and later became confined to neural 
progenitors.  GFP expression in the undifferentiated hES state could be indicative of 
neural lineage commitment or priming bias occurring prior to the onset of neural 
differentiation.  In the H14S9 NOP-SOX2 case this could suggest that the low level of 
GFP expression is indicative of early otic or nasal placode differentiation bias in the 
hES undifferentiated state.  Ongoing work in the laboratory (Sarah Jacob-Eshtan, PhD 
Thesis) has found that the H14S9 NOP-SOX2 reporter cell line features 
subpopulations within the undifferentiated state which are GFP+/SSEA3+ and 
GFP+/SSEA3- (Stage Specific Embryonic Antigen-3).  SSEA3 is a cell surface 
antigen used widely as an undifferentiated pluripotent stem cell marker (Draper et al., 
2002).  Therefore populations of undifferentiated H14S9 NOP-SOX2 hES cells which 
are positive for enhancer driven GFP with or without SSEA3 could indicate a priming 
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bias for otic or nasal placode differentiation.  Indeed, these population of cells when 
put through our otic differentiation protocol yield a greater propensity to differentiate 
into otic progenitors, as characterised by upregulation of PAX2, PAX8 and FOXG1 
when compared to GFP-/SSEA3+ or GFP-/SSEA3- hES cells. 
It should be noted however that the method in which this reporter line was generated 
has some limitations.  Non-targeted transfection of plasmid DNA leads to a random 
insertion of the transgenes without the possibility of controlling for the site of 
integration.  This lack of control can lead to a number of potential problems.  For 
example disruption of DNA sequences at the site of integration which may alter the 
phenotype of the cell or its downstream differentiation capacity, increasing the gene 
copy number, and the exogenous transgene sequence may itself be truncated or 
rearranged leading to a loss of normal expression patterns (Adamson et al., 2011).  
Linearising the plasmid construct prior to transfection as done here can reduce the 
chances of the sequence being rearranged, however.  More sophisticated approaches 
(such as homologous recombination, CRISPR, and TALEN) could have been 
favourable, but due to the time required to optimise such new and emerging techniques 
we decided to begin exploring this topic by employing a  more established random 
integration transgene method. 
 
3.3.2  H14S9 and the H14S9 NOP-SOX2 reporter line respond to our otic 
differentiation protocol 
 
The importance of FGF 3 and FGF 10 on the induction of the otic placode first came 
about through the elegant study by Wright and Mansour (2003) in which it was found 
that Fgf 3 and Fgf 10 mouse mutants fail to form otic vesicles and have aberrant otic 
marker gene expression patterns.  These findings led to the development of our in vitro 
otic differentiation protocol.  Differentiation of hES cells leading to the induction of 
otic progenitors with upregulation of the characteristic otic placode markers PAX2, 
PAX8, FOXG1 and SOX2 following induction by the ligands FGF 3 and FGF 10 has 
previously been demonstrated in our laboratory by the work of Chen et al. (2012) in a 
number of different hES cell lines, and has been corroborated in this study with H14S9 
(Figures 3.5A and 3.5A’).  Using a stringent fluorescent intensity threshold a range of 
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approximately 15% to 25% of the cells differentiated in FGF medium were considered 
to be highly expressive of a combination of otic markers and this population is 
believed to represent the otic progenitors.  In the control DFNB condition a 
significantly lower amount of otic marker co-expression was observed, demonstrating 
that FGF 3 and FGF 10 is required for induction of otic gene expression. 
Analysis of H14S9 NOP-SOX2 differentiation showed there was no significant 
difference between the mean percentage of NOP-SOX2 GFP positive cells in the 
control DFNB and FGF conditions (Figure 3.5B).  However a difference between the 
DFNB and FGF conditions became apparent when looking at the NOP-SOX2 GFP 
expression co-stained with an otic marker antibody.  It was then observed that a range 
of approximately 20% to 25% of the NOP-SOX2 differentiated cells co-stained with 
the otic markers PAX2, PAX8 and FOXG1 when cultured in FGF medium, compared 
to approximately 10% to 13% co-staining in the control DFNB condition (Figure 
3.5B’).   
Considering these data together suggests that the co-expression of NOP-SOX2 
enhancer driven GFP with PAX2, PAX8 and FOXG1 antibody staining denotes the 
true otic progenitors within the differentiated population, and these progenitors are 
represented by the highly otic marker expressing cells differentiated from the parental 
H14S9 line.  As such this data helps to validate the methodology of using a stringent 
fluorescent intensity threshold to identify otic progenitors differentiated from human 
pluripotent stem cells. 
The H14S9 Atoh1nGFP hES reporter was also generated using the transgene 
approach.  This line has the potential to be used as an in vitro hair cell differentiation 
reporter.  Although Atoh1 is not exclusive to the inner ear, it is however one of the 
first and most crucial genes expressed during hair cell induction (Mulvaney and 
Dabdoub, 2012), and thus is a good candidate for a hES cell reporter system.  Certainly 
the enhancer sequence in this study has also been used by Ronaghi et al. (2014) for a 
similar purpose, albeit for a 3D embryoid body-based differentiation study contrasted 
to our monolayer system approach.  As with H14S9 NOP-SOX2 low level Atoh1nGFP 
enhancer driven GFP expression can be seen in some undifferentiated hES colonies 
(Figure 3.9B). 
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3.3.3 Pax6 expression marks nasal placode progenitors 
 
Displayed in Figure 3.5B the mean percentage of NOP-SOX2 GFP expressing cells 
was not significantly different between the control DFNB and FGF conditions.  
Moreover the enhancer driven GFP expressing cells represented a fairly large 
proportion of the differentiated cells at the end of the 12 day protocol (means of 
approximately 31% in DFNB and 42.7% in FGF), with a smaller fraction of the GFP 
expressing cells also co-staining for the other characteristic otic markers, PAX2, PAX8 
and FOXG1.  Due to the NOP-SOX2 enhancers also being active within the 
developing nasal placode, it is possible that the proportion of GFP expressing cells 
which do not co-stain with other otic markers could be progenitors of the nasal 
placode.  The importance of the expression of PAX2 and PAX8 in the developing otic 
placode has been well characterised in a number of different species (Alvarez et al., 
2003; Wright and Mansour, 2003) and importantly they have also been shown to be 
excluded from the developing nasal placode (Streit, 2007).  FOXG1 expression is also 
implicated in otic placode induction (Duncan and Fritzsch, 2013) but also plays a key 
role in nasal placode induction (Duggan et al., 2008). 
A characteristic marker for nasal placode progenitors is PAX6.  A study in the chick 
conducted by Bailey et al. (2006) demonstrated that all craniofacial placodal 
progenitors are initially specified as Pax6-expressing lens, and this default lens state 
is progressively restricted by various signalling molecules to give rise to distinct 
placodal regions.  Fgf 8 signalling was shown to be necessary and sufficient to confine 
Pax6 expression to the nasal placode (Pax6 expression continues in the developing 
lens tissue also), excluded from the otic placode.  When comparing the expression of 
NOP-SOX2-driven GFP co-labelling with a PAX6 antibody, it was observed that 
approximately half of the NOP-SOX2 positive cells in the control DFNB condition 
co-express PAX6, in contrast to approximately 27% of the NOP-SOX2 positive cells 
in the FGF treated condition.  These results imply that treatment with the FGF ligands 
shifts the differentiating cells away from adopting a nasal placode progenitor fate, and 
more towards becoming otic progenitors.  In addition, as the default state of the 
craniofacial placodes is believed to PAX6-positive lens, it is possible that the 
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supplementation of the otic inducing FGF ligands may have played a role in restricting 
the default lens state to allow for otic placodal differentiation to take place. 
 
With the generation of a hES reporter lines, they will allow us to monitor 
differentiation in real time and will also provide a tool for visualising the effects of 
using compounds to improve the efficiency of the in vitro differentiation protocols. 
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CHAPTER 4: MANIPULATION OF WNT SIGNALLING DURING HUMAN 
EMBRYONIC STEM CELL DIFFERENTIATION:  EFFECT ON OTIC 
MARKER AND GERM LAYER GENE EXPRESSION 
 
4.1 Introduction 
 
4.1.1 Germ layer commitment in early development of the embryo 
 
A crucial event in the early developing embryo is the process of gastrulation in which 
the three distinctive germ layers (ectoderm, mesoderm and endoderm) are specified 
by the precise coordination of various morphogenic signals and gradients.  
Gastrulation occurs post-implantation in which stage the embryo is composed of 
mainly epiblast cells, a pluripotent derivative of the inner cell mass.  The in vitro 
derivation of mouse epiblast cells (Brons et al., 2007; Tesar et al., 2007) demonstrated 
that these epiblast cells retain some characteristic markers of mouse embryonic stem 
cells (Oct4 and Nanog, but not Rex1) but do not form chimeric animals when 
transplanted into a pre-implantation inner cell mass.  It is from these epiblast cells that 
a key process of gastrulation occurs; the formation of the primitive streak.  In this 
posterior positioned structure, epiblast cells migrate and undergo an epithelial to 
mesenchymal transition and give rise to mesoderm and endoderm progenitor cell types 
(Tsakiridis et al., 2014).  Epiblast cells positioned anteriorly do not migrate through 
the primitive streak and instead differentiate into neuroectoderm and surface ectoderm 
lineages (Cajal et al., 2012; Lawson 1999).  In combination, anterior-posterior axis 
formation of the embryo is established. 
 
4.1.2 Wnt signalling is essential in gastrulation and primitive streak formation in vivo 
 
There has been an abundance of research into the early events of embryonic 
development leading to the commitment of ectoderm, mesoderm and endoderm 
lineage differentiation from pluripotent epiblast cells.  Canonical Wnt signalling has 
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extensively been shown to play a major role in not only the initiation of gastrulation 
but also the formation of the primitive streak and coordination of axis patterning.   
Expression of the main effector of the canonical Wnt signalling pathway (see Chapter 
1), β-catenin, has been identified in epiblast cells that later go on to establish the 
primitive streak (Mohamed et al., 2004).  Moreover, a hypomorphic Apc 
(adenomatous polyposis coli, a component of the β-catenin degradation complex) 
allele was generated in the mouse (Ishikawa et al., 2003), leading to approximately 
80% attenuation of Apc expression.  This led to increased β-catenin activity and as a 
result, the more anterior ectodermal structures were truncated with concomitant 
expansion of mesodermal and endodermal structures.   
Additional support of the role of canonical Wnt signalling in induction of gastrulation 
events was a study conducted by Huelsken et al. (2000) in which β-catenin-null mouse 
embryos were generated and found to have impaired axis specification with a lack of 
mesoderm or endoderm structure formation, but normal ectodermal development.  
Mice deficient in Wnt3, a canonical pathway ligand, also fail to produce mesodermal 
structures and lack a primitive streak, with little effect on ectoderm (Liu et al., 1999).  
The generation of ectoderm-derived neural crest cells has also been shown to require 
an inhibition of canonical Wnt signals (Steventon and Mayor 2012).  These studies 
highlight the strong role of Wnt signalling in the promotion of mesoderm and 
endoderm differentiation, and thus could be a potential candidate to target for 
improving ectodermal differentiation in vitro. 
 
4.1.3 In vitro ES cell differentiation of primitive streak-like cells mimics events in vivo 
 
Directing the differentiation of hES cells in vitro towards cell types of a particular 
lineage is a major area of research focus currently.  Identifying signalling pathways 
implicated in lineage commitment from knockout and overexpression studies in vivo 
has allowed researchers to manipulate these pathways in pluripotent stem cell 
differentiation to enhance progenitor induction for further study. 
A study carried out by Lindsley et al. (2006) demonstrated that the in vivo activity of 
canonical Wnt signalling is mirrored in in vitro differentiation of mouse ES cells.  
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Canonical Wnt ligands such as Wnt3 and Wnt8a are expressed in the early mouse 
embryo prior to primitive streak formation (Kemp et al., 2005) and were also found to 
have peak expression during early in vitro mouse ES cell differentiation.  With the 
addition of the canonical Wnt signalling inhibitor Dickkopf 1 during the first four days 
of mouse ES cell differentiation, genes associated with primitive streak and 
mesodermal induction (including T/Brachyury) were expressed at a significantly 
lower level than the cells untreated, emphasising the early role of Wnt signalling in 
mesoderm and endoderm differentiation.  Corroborating this early timing for Wnt 
signalling, Turner et al. (2014) developed a Brachyury:GFP mouse ES cell reporter 
line.  GFP expression was increased within three to four days of the addition of 
CHIR99021, a canonical Wnt signalling activator.  Also using mouse ES cells, an 
elegant study by ten Berge et al. (2008) utilised an Axin2 lacZ reporter line to generate 
in vitro embryoid bodies, 3D structures formed from the aggregation of 
undifferentiated ES cells which undergo self-directed differentiation.  Upon treating 
these embryoid bodies early in differentiation with canonical Wnt inhibitors Dickkopf 
1 or Fz8CRD, lacZ reporter expression was either delayed (with Dickkopf 1) or 
abolished altogether (with Fz8CRD).  Moreover, the lacZ reporter expression in the 
embryoid bodies was markedly expanded with the addition of exogenous Wnt3a 
ligand. 
The role of Wnt signalling in gastrulation events has also been advantageous to in vitro 
hES cell differentiation studies.  For example Lian et al. (2013) were able to 
dramatically increase cardiac progenitor differentiation from hES cells from 
approximately 1% in an embryoid body-based assay, to approximately 30 % to 90 % 
if the hES cells were pretreated with a canonical Wnt activator such as CHIR99021 or 
BIO to induce a more primitive streak-like fate. 
 
4.1.4 General objectives of the chapter 
 
Since Wnt activation is necessary for primitive streak formation and generation of 
mesoderm and endoderm, it has been demonstrated that Wnt inhibition will prevent 
these fates and enhance the production of ectoderm.  I therefore hypothesised that this 
would facilitate in the generation of otic placodal progenitor cells.   As such, the aims 
  Chapter 4 
93 
 
of this chapter are to begin investigating if manipulation of the canonical Wnt 
signalling pathway can improve the efficiency of our standard otic differentiation 
protocol.  The effect of canonical Wnt inhibition and activation in the presence of FGF 
3 and FGF 10 in our standard otic differentiation protocol will be ascertained, and the 
outcome of canonical Wnt manipulation on the gene expression of characteristic otic 
markers and markers of germ layer differentiation will be assessed.  Moreover, timing 
of Wnt manipulation in our differentiation protocol will be investigated. 
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4.2 Results 
 
4.2.1 Canonical Wnt signalling inhibition in combination with FGF 3 and FGF 10 
upregulates otic marker gene expression 
 
The various roles of the canonical Wnt signalling pathway in controlling lineage 
specification (endoderm, mesoderm, and ectoderm) during embryogenesis have been 
fairly well characterised (Blauwkamp et al., 2012; Loh et al., 2014; Sokol, 2011).  For 
example, the inhibition of canonical Wnt signalling to promote ectodermal lineage 
differentiation has been extensively researched in both mouse (Verani et al., 2007) and 
human (Nicoleau et al., 2013) embryonic stem cell differentiation studies.  Despite 
this it was important to ascertain the effect of inhibiting canonical Wnt signalling 
during our standard otic differentiation protocol, to determine the outcome of in vitro 
otic and lineage differentiation when Wnt signalling inhibition is carried out in the 
presence of FGF 3 and FGF 10 ligands. 
Two small molecule inhibitors of the canonical Wnt signalling pathway were 
facilitated by Neusentis (Pfizer, Cambridge, UK); PF-01441479 and PF-1404058, 
referred to from here on as PF-1 and PF-2, respectively.  Alongside these small 
molecules a commercially available canonical Wnt inhibitor (Inhibitor of Wnt 
Response-1-endo, IWR-1-endo, Calbiochem) was also tested.  Little information was 
known regarding the molecular activity of PF-1 and PF-2, whereas IWR-1-endo has 
been more extensively used for Wnt manipulation in human pluripotent stem cell 
differentiation studies (Bengoa-Vergniory et al., 2014; Hudson et al., 2012; Karakikes 
et al., 2014).  IWR-1-endo mode of action is to stabilise Axin2, a component of the β-
catenin destruction complex leading to proteasome-mediated proteolysis of 
phosphorylated β-catenin (Chen et al., 2009). 
The decision was made to initially explore the effect of the Wnt inhibitors in the 
backdrop of our current differentiation protocol, which includes FGF 3 and FGF 10 
supplementation from the outset.  Experiments were carried out to determine the effect 
of canonical Wnt inhibition on the differentiation of otic progenitors in FGF medium 
(standard concentration of 50 ng/ml for both FGF 3 and FGF 10) and obtain an optimal 
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working concentration.  PF-1, PF-2 or IWR-1-endo were present from day 0 of 
differentiation (day 0 refers to the initial seeding of the hES cells into differentiation 
conditions) and were maintained throughout the 12 day protocol.  At the end of the 
differentiation protocol RNA was extracted and relative quantification of PAX2, 
PAX8, and FOXG1 gene expression was carried out by quantitative real time PCR 
(QPCR) using SYBR Green (Sigma Aldrich).  Delta Cts were calculated against the 
large ribosomal protein RPLPO housekeeping gene, and Delta Delta Ct values were 
compared against the levels expressed by cells differentiated in the control DFNB 
medium (Livak and Schmittgen, 2001).  Figure 4.1 displays the responses to PF-1, PF-
2 and IWR-1-endo and the effect on the gene expression of PAX2, PAX8 and FOXG1 
in the H14S9 hES cell line.  Dimethyl sulfoxide (DMSO) was the vehicle for all small 
molecule compounds.  A vehicle only control was added to FGF medium to ascertain 
the effects of DMSO.  It was observed that DMSO added to the standard FGF 
differentiation medium did not significantly affect expression of any of the otic 
markers investigated.  This provides confidence that it is the small molecule compound 
itself exerting an effect on gene expression, and not the carrier vehicle.  While 
treatment with each of the compounds showed an upregulation of the otic markers 
tested, they appeared to behave in slightly different ways.  PF-1 for example appeared 
to reach a saturation point of otic upregulation at 50 nM, as higher doses did not elicit 
as good a response with PAX2 and PAX8.  50 nM PF-1, 1 µM PF-2 and 10 µM IWR-
1-endo were chosen for future experiments, as these concentrations overall led to a 
more robust and reproducible upregulation of PAX2, PAX8 and FOXG1.  The optimal 
concentration of IWR-1-endo agrees with published findings in human stem cell 
studies (Chen et al., 2009; Hudson et al., 2012).  5 µM PF-2 and 20 µM IWR-1-endo 
were also tested but these concentrations caused massive cell death in the cultures.   
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Figure 4.1:  Responses to PF-1 (A), PF-2 (B) and IWR-1-endo (C), present 
throughout the 12 day protocol, on the gene expression of PAX2, PAX8, and 
FOXG1 in the H14S9 hES cell line, seeded at 8x103 cells/cm2.  Compounds were 
reconstituted in the vehicle DMSO and a vehicle only control was also included.  Bar 
charts denote mean and standard deviation of gene expression relative to that of the 
DFNB control condition (n=2 independent experiments).  Statistical significance was 
determined by one way ANOVA with Bonferroni’s multiple comparison post-test.  ns 
= no significant difference.   *P<0.05, **P< 0.01, ****P<0.0001. 
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4.2.2 Canonical Wnt inhibition in combination with FGF 3 and FGF 10 upregulates 
gene expression of ectodermal markers, but disrupts gene expression of endodermal 
and mesodermal markers 
 
The effect of disrupting canonical Wnt signalling with various small molecule 
inhibitors present throughout the full 12 days of our otic differentiation protocol giving 
rise to an upregulation of the characteristic otic markers led to the investigation of the 
expression of genes associated with lineage differentiation.  It was anticipated that our 
standard FGF differentiation protocol would drive the differentiating hES cells 
towards an ectodermal fate (as the otic placode is ectodermal in origin).  The effect on 
endoderm and mesoderm differentiation in the FGF condition has not been addressed, 
and the consequence of combining FGF treatment with canonical Wnt signalling 
manipulation on lineage differentiation has also not been investigated in our system. 
With the H14S9 hES cell line, 12 day otic differentiation experiments were carried out 
in control DFNB, FGF, or FGF with 50 nM PF-1, 1 µM PF-2 or 10 µM IWR-1-endo 
supplemented medium.  Gene expression of the three germ layer lineages relative to 
the baseline DFNB condition were quantified by QPCR.  Two gene markers for each 
germ layer were investigated; PAX6 and NESTIN (ectoderm), T and MEOX1 
(mesoderm), and AFP and GATA6 (endoderm) (Figure 4.2).   
It was interesting to observe that compared to the DFNB baseline condition, our 
standard FGF medium led to the upregulation of genes associated with all three germ 
layers.  It was anticipated that the addition of FGF 3 and FGF 10 would induce 
ectodermal differentiation but have no effect of mesoderm and endoderm 
differentiation.  This was not the case however.  Significant upregulation of the 
ectoderm genes PAX6 and NESTIN was observed in the FGF condition as expected, 
yet significant upregulation of mesoderm and endoderm markers was also observed in 
the FGF condition.  When the FGF medium was supplemented with the canonical Wnt 
inhibitors PF-1, PF-2 and IWR-1-endo ectodermal differentiation was enhanced 
further over the FGF condition, particularly PAX6.  However, the gene expression of 
mesoderm and endoderm markers was significantly reduced compared to the FGF 
condition.  This downregulation effect was seen with the supplementation of all three 
canonical Wnt inhibitors (especially IWR-1-endo) in FGF medium for T, MEOX1, and 
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GATA6.  Only supplementation with IWR-1-endo could cause significant 
downregulation of AFP however. 
Following a loss of function/gain of function paradigm an experiment was done to 
determine the effect of activating canonical Wnt signalling throughout the 12 days of 
otic differentiation.  The small molecule compound BIO (6-bromoindirubin-3’-oxime, 
Tocris) is a potent inhibitor of GSK-3β kinase, a component of the β-catenin 
degradation complex.  Inhibition of GSK-3β kinase activity disrupts the proteolytic 
breakdown of β-catenin and so Wnt activity is sustained (Meijer et al., 2003).  BIO is 
well established in the literature and has been used to investigate survival and 
proliferation of hES cells and also lineage differentiation studies (Dravid et al., 2005; 
Tseng et al., 2006).  BIO was tested at a concentration of 2 µM (Chuang et al., 2010).  
Figure 4.3 shows the effect on the gene expression of otic markers PAX2, PAX8 and 
FOXG1 (A), and also markers of ectoderm, mesoderm and endoderm lineage 
differentiation (B).  In contrast to inhibiting canonical Wnt signalling throughout the 
12 day protocol, activating canonical Wnt signalling throughout appears to 
downregulate gene expression of the otic and ectoderm markers, with upregulation of 
markers of mesoderm and endoderm. 
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Figure 4.2:  Gene expression of markers associated with ectoderm (A), mesoderm 
(B) and endoderm (C) lineage differentiation following a 12 day differentiation 
protocol with H14S9 hES cells, seeded at 8x103 cells/cm2.  Small molecule 
compounds were present throughout the protocol from the initial day of seeding.  
Gene expression is presented as relative to that of the DFNB baseline control.  Bar 
charts denote mean and standard deviation of gene expression relative to that of the 
DFNB control condition (n=3 independent experiments).  Statistical significance was 
determined by one way ANOVA with Bonferroni’s multiple comparison post-test.  ns 
= no significant difference.  *P<0.05, **P<0.01, ***P<0.001. 
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Figure 4.3:  Gene expression of otic markers PAX2, PAX8 and FOXG1 (A) and 
markers of ectoderm (PAX6, NESTIN), mesoderm (T, MEOX1) and endoderm 
(AFP, GATA6) (B) following a 12 day differentiation protocol with H14S9 hES 
cells, seeded at 8x103 cells/cm2.  BIO was supplemented into FGF medium and 
maintained throughout.  Gene expression is presented as relative to that of the DFNB 
baseline control.  One experiment was carried out and so statistical significance cannot 
be determined. 
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4.2.3 Timing of canonical Wnt inhibition is critical for upregulation of otic marker 
gene expression 
 
Previous experiments in this chapter have involved supplementing the FGF medium 
with one of three canonical Wnt inhibitor compounds and maintaining this 
supplementation throughout the full 12 day protocol, leading to upregulation of the 
gene expression of the characteristic otic markers.  Since timing and sequence of 
developmental signals is critical to drive a particular process, it was important to 
determine whether it is necessary for canonical Wnt signalling to be inhibited from 
the very start of in vitro otic differentiation in order for it to have its upregulatory 
effect.  Figure 4.4 shows the effect of supplementing the FGF medium with canonical 
Wnt inhibitors from day 4 of the otic differentiation protocol on gene expression of 
PAX2, PAX8 and FOXG1, and Figure 4.5 displays the outcome on the ectoderm (A), 
mesoderm (B) and endoderm (C) germ layer marker gene expression. 
It was observed that inhibiting canonical Wnt signalling with any of the three small 
molecule compounds from day 4 of the standard 12 day otic differentiation protocol 
did not lead to an upregulation of the otic markers or ectodermal lineage markers 
compared to the FGF condition, as seen when canonical Wnt was inhibited from the 
start of the differentiation protocol.  Conversely gene expression of mesoderm and 
endoderm markers, previously seen to be significantly downregulated upon canonical 
Wnt inhibition from the start of differentiation, was significantly upregulated with the 
supplementation of at least one of the small molecule compounds from day 4 of 
differentiation.  This is suggesting the initiation of canonical Wnt signalling inhibition 
must take place from the start of hES cell differentiation in order for it to have a 
positive effect on upregulating gene expression of otic specific markers. 
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Figure 4.4:  Gene expression of otic markers PAX2, PAX8 and FOXG1 following 
a 12 day differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2.  
Canonical Wnt inhibitors were supplemented into the media on day 4 and 
maintained until day 12.  Gene expression is presented as relative to that of the 
DFNB baseline control.  Bar charts denote mean and standard deviation of gene 
expression relative to that of the DFNB control condition (n=3 independent 
experiments).  Statistical significance was determined by one way ANOVA with 
Bonferroni’s multiple comparison post-test.  ns = no significant difference.  *P<0.05, 
**P<0.01, ****P<0.0001. 
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Figure 4.5:  Gene expression of markers associated with ectoderm (A), mesoderm 
(B) and endoderm (C) lineage differentiation following 12 day differentiation 
with H14S9 hES cells, seeded at 8x103 cells/cm2.  Canonical Wnt inhibitors were 
supplemented into the media from day 4 and maintained throughout to day 12.  
Gene expression is presented as relative to that of the DFNB baseline control.  Bar 
charts denote mean and standard deviation of gene expression relative to that of the 
DFNB control condition (n=3 independent experiments).  Statistical significance was 
determined by one way ANOVA with Bonferroni’s multiple comparison post-test.  ns 
= no significant difference.  *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. 
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4.2.4 Canonical Wnt signalling inhibition in combination with FGF 3 and FGF 10 is 
not required for the duration of otic differentiation in vitro 
 
This chapter has thus far demonstrated that inhibition of canonical Wnt signalling must 
occur from the very start of in vitro otic differentiation in order to promote gene 
expression of ectodermal lineage markers and upregulation of gene expression of the 
key otic markers, PAX2, PAX8 and FOXG1.  Concomitantly a downregulation of 
mesoderm and endoderm marker gene expression is also observed when canonical 
Wnt signalling is present for the full 12 days of the protocol.  These effects are 
essentially reversed when inhibition takes place from day 4. 
Further investigating the timing of canonical Wnt inhibition it was important to 
address whether inhibition is required throughout the whole 12 day differentiation 
protocol to have an upregulatory effect on otic marker gene expression.  Experiments 
were set up to inhibit canonical Wnt signalling for different lengths of time.  In 
combination with FGF medium, Wnt inhibition took place from day 0 to day 4, day 0 
to day 6, or day 0 to day 8.  Differentiating cells were maintained in FGF medium only 
following day 4, 6 or 8, respectively until day 12.  Day 0 to day 12 inhibition was also 
included as shown in previous figures.  At the end of day 12, RNA was extracted and 
reverse transcribed.  Subsequent gene expression of PAX2, PAX8 and FOXG1 was 
then quantified relative to the DFNB baseline condition, and is shown in Figure 4.6.  
As the effects on gene expression of PF-1, PF-2 and IWR-1-endo were similar in all 
experiments carried out previously, and with IWR-1-endo being commercially 
available and well established in the literature, all future experiments were carried 
using IWR-1-endo as the canonical Wnt inhibitor of choice. 
Inhibiting canonical Wnt signalling with IWR-1-endo from day 0 to day 4 or day 0 to 
day 6 did not significantly alter gene expression of PAX2, PAX8 or FOXG1 from that 
of FGF medium alone.  Significant upregulation of the otic markers was only found 
between the standard FGF medium and FGF with canonical Wnt inhibition from day 
0 to 8 or day 0 to 12.  Moreover, there was no significant difference on otic marker 
gene expression between inhibiting Wnt signalling from day 0 to day 8 or throughout 
the whole 12 day differentiation protocol (for PAX2 and PAX8.  FOXG1 gene 
expression was significantly higher with 12 days of canonical Wnt inhibition in 
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contrast to eight days however).  Therefore canonical Wnt inhibition is required from 
the initiation of hES differentiation, and must be maintained for at least eight days to 
elicit an upregulatory response of the key otic marker gene expression. 
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Figure 4.6:  Gene expression of otic markers PAX2, PAX8 and FOXG1 following 
a 12 day differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2.  
IWR-1-endo was supplemented at day 0 and maintained to day 4, day 6, day 8 or 
day 12.  Gene expression is presented as relative to that of the DFNB baseline control.  
Bar charts denote mean and standard deviation of gene expression relative to that of 
the DFNB control condition (n=3 independent experiments).  Statistical significance 
was determined by one way ANOVA with Bonferroni’s multiple comparison post-
test.  ns = no significant difference.  *P<0.05, ***P<0.001, ****P<0.0001. 
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4.3 Discussion 
 
4.3.1 Manipulation of the canonical Wnt signalling pathway alters otic and germ layer 
differentiation 
 
It was observed that inhibiting the canonical Wnt signalling pathway throughout the 
12 day otic differentiation protocol with a variety of small molecule compounds 
overall caused an upregulation of otic and ectodermal marker gene expression, with a 
concomitant downregulation of markers of mesodermal and endodermal 
differentiation.  Conversely, a 12 day activation of the canonical Wnt signalling 
pathway provided a vice versa effect; upregulation of mesodermal and endodermal 
marker gene expression, with loss of otic and ectodermal gene expression.  Inhibition 
of canonical Wnt signalling enhancing ectodermal differentiation at the expense of 
mesoderm and endoderm is a well-established finding in vitro and in vivo (Arkell et 
al., 2013).  Gadue et al. (2006) looked at the manipulation of the canonical Wnt 
signalling in an embryoid body study from a Foxa2:GFP (marker of the endoderm 
germ layer lineage) murine embryonic stem cell reporter line.  Canonical Wnt 
signalling inhibition with Dickkopf1 throughout the embryoid body differentiation 
period led to a decrease in Foxa2-driven GFP expression and further loss of primitive 
streak-like differentiation.  Even within inner ear research early Wnt inhibition has 
been used to drive differentiating mouse embryonic and induced pluripotent stem cells 
into a more ectodermal fate to enhance otic differentiation.  Oshima et al. (2010), also 
using an embryoid body protocol, inhibited Wnt signalling with Dickkopf1 to push 
the differentiating cells away from taking on a mesodermal or endodermal lineage, 
and enhancing ectodermal differentiation.  The use of a three dimensional approach to 
induce otic differentiation are emerging as new methodologies to generate otic 
progenitor cells and the more differentiated cell types, such as sensory hair cell-like 
cells in studies in the mouse.  Similar success with human embryonic stem cells has 
yet to be reported. 
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4.3.2 Timing of canonical Wnt signalling inhibition is crucial for upregulation of otic 
gene expression 
 
The upregulation of the otic and ectoderm marker gene expression was found to only 
occur if canonical Wnt signalling is inhibited from the very start of the otic 
differentiation protocol, and this enhancement of gene expression was absent if 
inhibition took place four days into the protocol.  This is consistent with the role of 
Wnt signalling in early gastrulation.  Canonical Wnt signalling having stage specific 
roles has also been demonstrated in numerous other systems.  A rich area of research 
utilising Wnt modulation is the in vitro differentiation of cardiac progenitors from 
embryonic stem cells.  Paige et al. (2010) highlighted the different outcomes of 
activating or inhibiting canonical Wnt signalling early in hES differentiation into 
cardiac progenitors.  Inhibition of canonical Wnt signalling from the start of 
differentiation was found to suppress the expression of mesodermal and early cardiac 
progenitor genes, yet the gene expression of these markers were unaffected or even 
enhanced when canonical Wnt inhibition took place from four days into the 
differentiation protocol.  Similarly, a study (Ueno et al., 2007) used heat-shock-
inducible Dickkopf1 and Wnt 8a transgenic zebrafish lines to ascertain the effects of 
inhibition and activation of canonical Wnt signalling on mesoderm and subsequent 
cardiac differentiation in vivo, respectively.  Mesodermal differentiation was reduced 
in the Dickkopf1 transgenic line, and expanded in the Wnt 8a line when the zebrafish 
embryos were subjected to heat shock early.  Opposing effects were encountered when 
heat shock was applied later into development.  Mouse embryonic stem cells lines 
have also been shown to have similar timing requirements of canonical Wnt 
modulation (Kwon et al., 2007), whereby inhibiting signalling three days into 
embryoid body differentiation had no effect on mesodermal and cardiac progenitor 
induction.  The findings of these studies combined suggest that canonical Wnt 
signalling is tightly controlled and regulated and the effect of manipulation is time and 
stage specific, indicative of a bi-phasic role in germ layer differentiation and 
organogenesis. 
From the multitude of studies carried out to ascertain the role of canonical Wnt 
signalling in generating progenitors of various lineages in vitro, and with the 
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awareness of the key functions of canonical Wnt signalling in inner ear development 
in vivo (Chapter 1), it was of apparent interest to investigate Wnt manipulation within 
our hES cell otic differentiation protocol.  The data presented in this chapter suggests 
a model in which inhibition of canonical Wnt signalling from the start of otic 
differentiation leads to a downregulation of mesoderm and endoderm lineage gene 
expression, with a concomitant upregulation of ectodermal differentiation.  This 
expansion of ectoderm then allows the supplemented FGF 3 and FGF 10 ligands to 
induce progenitors with an upregulated gene expression of the characteristic otic 
markers.  This positive effect on otic differentiation is lost if canonical Wnt is not 
inhibited until four days into the protocol, suggesting that once early mesodermal 
and/or endodermal lineage differentiation has taken place the cells become committed 
to these lineages, at the expense of ectodermal and subsequent otic progenitor 
induction. 
 
With the increasing knowledge of the bi-phasic roles of canonical Wnt signalling 
during embryonic development, it is possible that further manipulation of the Wnt 
signalling pathway could enhance the efficiency of in vitro otic differentiation to 
provide a more developmentally informed protocol. 
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CHAPTER 5: FURTHER FINE TUNING OF IN VITRO OTIC 
DIFFERENTIATION VIA WNT SIGNALLING MANIPULATION 
 
5.1 Introduction 
 
5.1.1 FGF signalling is required for the induction of the pre-placodal region and otic 
placode 
 
The results of Chapter 4 highlighted the ability to direct the differentiation of hES cells 
away from adopting a mesodermal or endodermal fate, and taking on a more 
ectodermal identity.  This was achieved by a combination of FGF 3 and FGF 10 
signalling in conjunction with inhibition of canonical Wnt signalling.  It was 
hypothesised that gastrulation-like events during in vitro hES differentiation were 
blocked by the inhibition of canonical Wnt signalling, and in combination with FGF 
signalling, ectoderm (and subsequently otic placode) differentiation was upregulated.  
It has been shown in many in vivo studies that following the early embryonic process 
of gastrulation the ectoderm is roughly divided into two sections; the neural and non-
neural ectoderm, with a wide intermediate area of overlap between these two 
subdivisions (Fernandez-Garre et al., 2002; Lawson, 1999).  The neural ectoderm will 
give rise to structures such as the neural plate, neural tube and neural crest, whereas 
the non-neural ectoderm division will differentiate into epidermis.  The area of overlap 
between these two divisions, sometimes referred to as the neural plate border, contains 
all the cells that will give rise to the future placodes.  Within this area members of the 
Six and Eya transcription factor families are upregulated, specifically Six1, Six4, Eya1 
and Eya2 (Kobayashi et al., 2000; Schlosser and Ahrens, 2004), and placodal 
precursors become concentrated here in a region referred to as the pre-placodal region 
(PPR) (Chapter 1).  FGF signalling has been implicated as having a necessary direct 
role in the induction of the PPR via its effect on the expression of the Six and Eya 
transcription factors.  Studies conducted in chick (Litsiou et al., 2005) and Xenopus 
(Ahrens and Schlosser, 2005) have identified FGF 8 knockdown or inhibition as a 
causative factor in abolishing PPR induction.  
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Of particular interest to our laboratory is the formation of the otic-epibranchial placode 
domain (OEPD), or pre-otic field.  The OEPD has been identified as a region of Pax2-
positive progenitor cells within the maturing PPR (Sun et al., 2007) which contains a 
mixture of cells which will later give rise to both the otic and epibranchial placodes, 
and also cells of the epidermis (Ohyama and Groves, 2004).  FGF signalling is 
believed to play a major role in the induction of the OEPD, by posteriorising the 
expression of members of the Dlx family of transcription factors to form an area of 
the PPR known as the posterior placode area (PPA).  In the PPA FGF signalling 
promotes Pax8 and Pax2 expression to initiate otic placode formation.  It is believed 
that cells in the PPA receiving prolonged FGF signalling activity take on an 
epibranchial fate, whereas attenuated FGF signalling with concomitant canonical Wnt 
signalling activity from the adjacent neural tube pushes the cells of the PPA to 
segregate and adopt an otic phenotype (Freter et al., 2008).  
The identification of the members of the FGF signalling pathways associated with otic 
placode induction have been well characterised, and there are known species 
differences.  Studies carried out in the mouse have identified a role for neural Fgf 3 
and mesodermal Fgf 10.  The classic study conducted by Wright and Mansour (2003) 
demonstrated the severe decrease in size, or complete lack, of otic vesicle formation 
in Fgf 3 and Fgf 10 mouse mutants.  Later studies in both mouse and chick have 
identified a crucial role for Fgf 8 in otic placode formation.  Ladher et al. (2005) 
identified Fgf 8 expression in the mouse prospective otic placode and also within the 
underlying mesenchyme and endoderm, and mice mutant for Fgf8 were found to have 
reduced expression of Fgf 10, suggesting Fgf 8 is a key regulator of Fgf 10 expression.  
Therefore the role of Fgf 8 in the otic placode induction is indirect, acting by 
controlling the expression of Fgf 10.  Similarly in the chick, endoderm was determined 
to be the source of expression of Fgf 8, a crucial inducer for the expression of Fgf 19 
(Fgf 3 and Fgf 19 are believed to be both necessary and sufficient for otic placode 
induction in the chick).  In zebrafish injection of Fgf 3 and Fgf 8 morpholinos are able 
to prevent the formation and development of otocysts (Maroon et al., 2002). 
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5.1.2 Role of canonical Wnt signalling in otic placode initiation and expansion 
 
The role of FGF signalling in the induction of the otic placode has been extensively 
established.  However the function of canonical Wnt signalling is less well 
characterised to date.  One of the earliest studies elucidating a role for Wnt signalling 
in the development of the inner ear was carried out by Ladher et al. (2000).  Using 
Xenopus embryos, hindbrain-derived Wnt 8c was identified as being able to induce 
the expression of known otic placode markers such as Pax2, Dlx5 and Soho1 when 
exposed to uncommitted presumptive otic ectoderm, but only when exposed in 
combination with Fgf 19.  Later studies such as that conducted by Urness et al. (2010) 
further expanded on the role of canonical Wnt signalling in the otic placode induction.  
Using Fgf 3 and Fgf 10 double mutant mice, microarray analysis was undertaken to 
determine the expression patterns of various otic and ectodermal genes compared to 
wild type animals.  Wnt 8a was found to be significantly downregulated in the double 
mouse mutants, but its expression appeared normal in Fgf 10 mutants and Fgf 3 
heterozygote mutants, suggesting Fgf 3 plays a direct or indirect role in inducing and 
maintaining the expression of Wnt 8a.  Foxi2 was also found to be downregulated in 
the Fgf 3 and Fgf 10 double mutant mice, a similar effect to the inhibition of canonical 
Wnt signalling in the pre-otic field in the mouse (Ohyama and Groves, 2004).  Thus it 
was concluded in this study that the role of Wnt signalling in otic placode induction is 
to act in synergy with FGF signalling, to specify and maintain the otic placode, and to 
restrict the positioning of the otic placode to the dorsal ectoderm.  Following on from 
this Vendrell et al. (2013) supported the findings of Urness et al. (2010) and also 
demonstrated how the absence of Wnt 8a in mutant mice did not affect the initiation 
of the otic placode, but delayed the onset of the expression of key otic markers.  
Similarly absent Wnt 8a expression in zebrafish does not abolish otic placode 
induction, but leads to embryos featuring otocysts of reduced size (Phillips et al., 
2004). 
Strengthening the hypothesis that the role of canonical Wnt signalling is to coordinate 
the positioning and restricting the size of the otic placode, rather than a direct 
involvement in its induction was a study by Ohyama et al. (2006).  Using TCF/Lef 
(Chapter 1) reporter mice it was found that canonical Wnt signalling is active in a 
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subset of the Pax2-positive cells of the pre-otic field.  Conditional inactivation of β-
catenin in this Pax2-positive region lead to the upregulation of the epidermal marker 
Foxi2, with an expansion of Foxi2-positive epidermal cells at the expense of Foxi2-
negative otic cells.  Activation of β-catenin provided the opposing result; an expansion 
of the otic placode, with a reduction in size of the epidermal region.  A schematic of 
this is shown in Figure 5.1. 
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Figure 5.1: Schematic representation of the effect of canonical Wnt signalling on 
the otic placode and surrounding epidermis.  Image adapted from the PhD thesis of 
Sarah Jacob Eshtan.  The otic placode is shown in the exaggerated area coloured green.  
On the left shows the effect on the otic placode if canonical Wnt signalling is inhibited 
leading to otic restriction.  The right side shows the effect of canonical Wnt activation 
expanding the region of the otic placode at the expense of the Foxi2 positive epidermis. 
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5.1.3 General objectives of the chapter 
 
The results of Chapter 4 have demonstrated the ability to push the differentiating hES 
cells into adopting a more ectodermal identity which in turn impacts positively on the 
expression of the key characteristic otic markers.  Expanding upon this further by 
synchronising FGF signalling with manipulation of canonical Wnt signalling may help 
in further improving the efficiency of directing the differentiation of hES cells into 
otic progenitors in vitro.  To date there are no established protocols using hES cells 
for otic differentiation in such a developmentally-informed manner. 
The effect of additional canonical Wnt signalling manipulation will be investigated 
later into the differentiation protocol, following on from the period of canonical Wnt 
inhibition highlighted in Chapter 4.  Gene expression of the classic otic markers will 
be investigated, alongside the expression of characteristic PPR and epidermal markers. 
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5.2 Results 
 
5.2.1 Canonical Wnt signalling activation late in otic differentiation in the presence 
of FGF signalling leads to loss of otic marker gene expression 
 
The results in the previous chapter demonstrated that inhibition of canonical Wnt 
signalling enhanced the induction of ectodermal fate and subsequent expression of otic 
genes when inhibition was carried out from the start of the otic differentiation protocol.  
In addition canonical Wnt signalling needed to be inhibited for at least eight days to 
have this upregulatory effect on the ectodermal and otic marker gene expression.  
Inhibition of canonical Wnt signalling from day four of the protocol showed a 
downregulation or loss of ectodermal and otic gene expression, with differentiation 
favouring a more mesodermal and endodermal fate. 
Taking these data into account it was hypothesised that the increase in ectodermal 
differentiation with canonical Wnt inhibition was permissive for the FGF 3 and FGF 
10 supplemented ligands to induce the otic fate.  The role of Wnt signalling in otic 
placode development is less well characterised than the role of FGF signalling (Freyer 
and Morrow, 2010; Jacques et al., 2012; Vendrell et al., 2013), but activation of the 
canonical pathway is believed to be involved in the expansion of the otic placode size 
once it has been induced (Ohyama et al., 2006).  Therefore it was of most interest to 
determine if the otic marker gene expression could be enhanced further by 
incorporating a period of canonical Wnt activation into the differentiation protocol. 
Otic differentiation experiments were set up comprising of a phase of canonical Wnt 
inhibition for eight days with 10 µM IWR-1-endo, then a switch to activation with 2 
µM BIO for the remaining four days of the protocol.  FGF 3 and FGF 10 ligands were 
supplemented throughout the full 12 days of differentiation.  From here on this 
modified protocol will be referred to as Modified Protocol 1.  Standard DFNB and 
FGF conditions were also included.  At the end of the differentiation period RNA was 
extracted, converted to cDNA and gene expression analysis was carried out by QPCR.  
The DFNB baseline condition was used as the reference calibrator.  For ease of 
understanding Figure 5.2 shows a schematic representation of Modified Protocol 1 (A) 
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and the relative gene expression of the otic markers PAX2, PAX8, FOXG1 and SOX2 
(A’). 
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Figure 5.2:  Schematic representation of Modified Protocol 1 (A).  Gene 
expression of otic markers PAX2, PAX8, FOXG1 and SOX2 following a 12 day 
differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  
Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  
FGF 3 and FGF 10 ligands were supplemented at 50 ng/ml.  Gene expression is 
presented as relative to that of the DFNB baseline control.  Bar charts denote mean 
and standard deviation of gene expression relative to that of the DFNB control 
condition (n=3 independent experiments).  Statistical significance was determined by 
one way ANOVA with Bonferroni’s multiple comparison post-test.  ns = no 
significant difference.  *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. 
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Unexpectedly the combination of FGF ligands and canonical Wnt activation during 
the last four days of the manipulated otic differentiation protocol (Modified Protocol 
1) caused a highly statistically significant downregulation of all otic marker gene 
expression investigated compared to the previous eight day Wnt inhibition protocol 
(Figure 4.6).  In addition, in the case of PAX2 and FOXG1 there was no significant 
difference in the gene expression between the standard FGF and Modified Protocol 1.  
Aware of the published data on the role of canonical Wnt signalling in otic placode 
expansion, these results were surprising.  However the work of Freter et al. (2008) has 
proposed an inhibitory role of continuous FGF signalling during otic placode 
maturation and expansion when canonical Wnt signalling is active.  In this study in 
the chick it was demonstrated that an attenuation of Fgf 3 and Fgf 19 signalling is 
required for otic commitment once the otic placode has been established. 
 
5.2.2 Canonical Wnt activation with removal of supplemented FGF ligands in late otic 
differentiation leads to upregulation of PAX2, PAX8 and FOXG1, with a loss of SOX2 
expression 
 
In light of the data shown by Freter et al. (2008) another alteration to the Wnt 
manipulation protocol was tested.  This protocol involved the initial eight day period 
of FGF 3 and FGF 10 ligand supplementation with canonical Wnt signalling inhibition 
with IWR-1-endo.  For the remaining four days canonical Wnt activation was carried 
out with BIO in the DFNB basal medium.  FGF 3 and FGF 10 were not supplemented 
into the medium during these last four days of the protocol (featured in Modified 
Protocol 1).  This alternate protocol will be referred to from here on as Modified 
Protocol 2, and is schematically represented in Figure 5.3A.  As with previous 
experiments, RNA was extracted at the end of the 12 day differentiation protocol and 
QPCR analysis was carried out to determine gene expression levels of the 
characteristic otic markers, as displayed in Figure 5.3A’. 
The effect of Modified Protocol 2 on the gene expression of PAX2, PAX8 and FOXG1 
was positive, leading to a significant upregulation of these otic markers when 
compared to the FGF and initial eight day Wnt inhibition protocol.  Therefore in this 
case the removal of FGF 3 and FGF 10 ligand supplementation during the canonical 
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Wnt activation phase was beneficial for the differentiation and gene expression of 
these markers.  However a striking feature of this modified protocol is the highly 
significant downregulation of the gene expression of SOX2.  In the Modified Protocol 
1 experiment (Figure 5.2A’) with canonical Wnt activation and FGF 3 and FGF 10 
ligand supplementation, SOX2 gene expression was downregulated alongside the other 
otic markers investigated.  SOX2 gene expression was also downregulated during the 
final four days of Modified Protocol 2 (Figure 5.3A’), when canonical Wnt activation 
takes place with no concomitant FGF ligand supplementation.  These experiments, 
performed side by side, suggested that FGF signalling during the final four days of the 
modified protocols was required at a particular level in order for otic differentiation to 
progress.  Maintaining FGF 3 and FGF 10 at the standard 50 ng/ml concentration 
throughout the phase of canonical Wnt activation with BIO appeared to be inhibitory 
to the gene expression of PAX2, PAX8, FOXG1 and SOX2 (Figure 5.3A’).  However, 
removing supplemented FGF 3 and FGF 10 ligands from the differentiation media 
during canonical Wnt activation (Figure 5.2A’) appeared to have an upregulatory 
effect on PAX2, PAX8 and FOXG1 gene expression, but was still detrimental for 
expression of SOX2.  It could consequently be hypothesised that a “Goldilocks” effect 
of FGF signalling was taking place in otic differentiation; too little was inhibitory, and 
too much was inhibitory for SOX2 expression, a key regulator of downstream 
development of the inner ear structures. 
As Modified Protocol 2 appeared to be the most efficient protocol in the upregulation 
of the majority of the otic marker gene expression, this protocol was looked at in 
greater detail.  To determine if the loss of SOX2 gene expression (and also the 
upregulation of the other otic markers) is just at the level of RNA, it was important to 
also investigate protein expression.  Analysis of the protein expression was done using 
the In Cell Analyser 1000 platform.  Differentiation experiments were carried out with 
H14S9 hES cells subjected to DFNB, FGF and the Modified Protocol 2 conditions.  
Following the 12 day differentiation period cells were immunolabelled with the 
following combinations of primary antibodies (a representative experiment is 
displayed in Figure 5.4): PAX2/PAX8 (A), FOXG1/PAX8 (B) and SOX2/PAX8 (C).  
Results of three independent repeat experiments are shown in Figure 5.4A’.  As 
featured in Chapter 3, the In Cell Analyser platform was used to determine the 
percentage of highly co-expressing cells believed to represent the true otic progenitor 
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population with the differentiating cultures.  Cells were deemed to be highly co-
expressive of the otic marker antibody combinations if their fluorescent intensity 
threshold was above the 75th percentile set within the FGF condition. 
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Figure 5.3:  Schematic representation of Modified Protocol 2 (A).  Gene 
expression of otic markers PAX2, PAX8, FOXG1 and SOX2 following a 12 day 
differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  
Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  
FGF 3 and FGF 10 ligands were supplemented at 50 ng/ml.  Gene expression is 
presented as relative to that of the DFNB baseline control.  Bar charts denote mean 
and standard deviation of gene expression relative to that of the DFNB control 
condition (n=3 independent experiments).  Statistical significance was determined by 
one way ANOVA with Bonferroni’s multiple comparison post-test.  ns = no 
significant difference.  *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. 
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Figure 5.4:  H14S9 hES cells differentiated for 12 days in DFNB, FGF or 
subjected to Modified Protocol 2.  Representative experiment displayed below.  
Scatterplots for immunolabelling with (A) PAX2/PAX8 (green/red), (B) 
FOXG1/PAX8 (green/red) and (C) SOX2/PAX8 (green/red).  Fluorescence intensity 
of each antibody is displayed on each axis.  The scatter plots are coloured according 
to two different intensity thresholds: 99th percentile points of fluorescent intensity in 
the secondary antibody only control, and 75
th
 percentile points of fluorescent intensity 
seen in the FGF condition labelling. Grey: intensity below 99
th
 percentile. Green: 
intensity above the 99
th
 percentile for the green (PAX2, FOXG1, SOX2) but not red 
channel (PAX8). Red: intensity above the 99
th
 percentile in the red channel but not 
green channel. Purple: cells are double positive, intensity above the 99
th
 percentile in 
both channels. Black: cells are highly double positive, intensity is above the FGF 75
th
 
percentile in both channels. 
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Figure 5.4A’: H14S9 hES cells differentiated for 12 days in DFNB, FGF or 
subjected to Modified Protocol 2.  Bar charts show the percentage of highly double 
positive cells (with a threshold intensity above the 75th percentile) in each condition 
for the antibody combinations PAX2hi/PAX8hi, FOXG1hi/PAX8hi, and SOX2hi/PAX8hi.  
The results are presented as the mean of three experimental replicates combined.  Error 
bars denote mean and standard deviation.  Statistical significance was determined 
using Chi-square with Yates’ continuity correction.  ***P<0.001, ****P<0.0001. 
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The results of the three independent experiments presented in Figure 5.4A’ once again 
show a statistically significant upregulation of otic marker protein expression between 
the baseline DFNB control and the FGF treated conditions, as shown previously in 
Chapter 3 (Figure 3.5A’).  The percentage of highly double positive cells for the 
DFNB, FGF and Modified Protocol 2 conditions respectively for each pair of 
antibodies used were as follows: PAX2/PAX8: 12.08% ± 2.02%, 21.20% ± 3.78%, 
and 38.17% ± 2.21%; FOXG1/PAX8: 12.21% ± 4.27%, 21.31% ± 0.97%, and 54.75% 
± 4.03%; SOX2/PAX8: 10.41% ± 1.1%, 20.76% ± 2.53%, and 4.30% ± 1.25%.  By 
looking at these results it was apparent that the difference in gene expression levels 
between the DFNB, FGF and Modified Protocol 2 conditions as shown by QPCR 
(Figure 5.3) was also demonstrated in the percentage of highly double positive cells 
for each otic marker antibody combination.  Compared to our standard FGF 
differentiation protocol Modified Protocol 2 appeared to generate a significantly 
higher proportion of differentiated otic progenitors which highly express the 
characteristic otic markers PAX2, PAX8 and FOXG1, both at the RNA and protein 
levels.  SOX2 RNA and protein expression, however, was significantly downregulated 
when the hES cells were subjected to Modified Protocol 2. 
Subsequently, for further confirmation of the effect of Modified Protocol 2 on the 
expression of SOX2, differentiation experiments were set up using the H14S9 NOP-
SOX2 reporter line.  Reporter line cells were differentiated for 12 days in DFNB, FGF 
or Modified Protocol 2 conditions, followed by immunolabelling with PAX2, PAX8 
or FOXG1 antibodies.  The percentage of differentiated cells co-expressing the otic 
markers with NOP-SOX2 enhancer driven GFP from all three conditions tested are 
displayed in Figure 5.5.  Following the 12 day differentiation period, the percentage 
of cells co-expressing an otic marker alongside NOP-SOX2 enhancer driven GFP 
from each of the tested conditions (DFNB, FGF and Modified Protocol 2 respectively) 
was observed as follows: NOP-SOX2/PAX2: 10.55% ± 1.22%, 21.88% ± 2.02% and 
3.83% ±1.14%; NOP-SOX2/PAX8: 11.58% ± 1.56%, 21.25% ± 2.51%, and 4.62% ± 
1.78%; NOP-SOX2/FOXG1: 13.18% ± 1.70%, 25.46% ± 3.53%, and 3.52% ± 1.51%.  
As with the antibody immunolabelling in Figure 5.4A and 5.4A’ co-expression of any 
of the otic markers with the NOP-SOX2 GFP was significantly lower when the 
reporter hES cells were differentiated in Modified Protocol 2, compared to the DFNB 
baseline and the standard FGF condition.  It can be concluded that the low percentages 
  Chapter 5 
135 
 
seen in Figure 5.5 were as a result of the decreased NOP-SOX2 enhancer reporter 
activity, and thus SOX2 expression.  Expression of PAX2, PAX8 and FOXG1 as seen 
in Figures 5.3A and 5.3A’ was increased during differentiation in Modified Protocol 
2 condition and so this also adds weight to the suggestion that it was indeed solely 
SOX2 expression that was being affected detrimentally in Modified Protocol 2.  The 
consequence of losing SOX2 expression, and its potential impact on downstream 
applications of further maturation and differentiation of the otic progenitors will be 
discussed in the section 5.3. 
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Figure 5.5: Co-staining of H14S9 NOP-SOX2 reporter cells differentiated for 12 
days in DFNB, FGF or Modified Protocol 2 conditions.  Cells were immunolabelled 
with PAX2, PAX8 or FOXG1 primary antibodies, and the percentage of double 
positive cells (primary antibody and NOP-SOX2 GFP) is shown below (n=3 
independent experiments).  Error bars denote mean and standard deviation.  Statistical 
significance was determined using Chi-square with Yates’ continuity correction.  
****P<0.0001. 
 
N
O
P
-S
O
X
2
/P
A
X
2
N
O
P
-S
O
X
2
/P
A
X
8
N
O
P
-S
O
X
2
/F
O
X
G
1
0
1 0
2 0
3 0
4 0
R e p o r te r /a n t ib o d y  c o m b in a tio n s
D
o
u
b
le
 p
o
s
it
iv
e
s
 (
%
) D F N B
F G F
M o d if ie d  P r o to c o l  2* * * *
* * * *
* * * * * * * * * * * *
* * * *
 
 
 
 
 
 
 
 
 
  Chapter 5 
137 
 
5.2.3 FGF ligand supplementation at a lowered dose during canonical Wnt activation 
in late otic differentiation maintains the upregulation of PAX2, PAX8 and FOXG1, 
and rescues SOX2 expression 
 
It has been shown previously in this chapter that in a 12 day differentiation protocol 
maintaining FGF 3 and FGF 10 ligand supplementation throughout the period of Wnt 
inhibition (eight days) and subsequent Wnt activation (four days) (Modified Protocol 
1) led to a loss or downregulation of gene expression of PAX2, PAX8, FOXG1 and 
SOX2 (Figures 5.2A and 5.2A’).  An alternative version of the protocol was tested in 
which FGF 3 and FGF 10 ligands were not supplemented into the media during the 
four day period of canonical Wnt activation (Modified Protocol 2).  From this alternate 
protocol it was observed that gene expression of PAX2, PAX8 and FOXG1 was 
significantly upregulated compared to the standard FGF or any other modifications of 
the protocol tested, yet SOX2 gene expression was significantly downregulated 
(Figures 5.3A and 5.3A’).  Matching the RNA expression these outcomes of Modified 
Protocol 2 were also observed in otic marker protein expression (Figures 5.4A and 
5.4A’), and also upon differentiating the H14S9 NOP-SOX2 reporter cells (Figure 
5.5).  In summary, maintenance of FGF supplementation during the canonical Wnt 
activation phase of the protocol had a negative impact on otic differentiation, whereas 
removal of FGF ligands was beneficial for all otic marker expression except for SOX2, 
suggesting an intermediate level of FGF signalling may be required. 
To address the possibility of an intermediate level of FGF signalling requirement to 
enhance otic differentiation, differentiation experiments were set up as follows.  As 
with the previous incarnations of the protocol, FGF 3 and FGF 10 ligands were 
supplemented into the basal DFNB medium at a concentration of 50 ng/ml with 
concomitant canonical Wnt inhibition with IWR-1-endo at 10 µM, with the hES cells 
differentiating in this condition for eight days.  For the final four days of the protocol, 
cells were maintained in DFNB medium supplemented with the canonical Wnt agonist 
BIO at a concentration of 2 µM, and FGF 3 and FGF 10 supplemented at 25 ng/ml 
(half of the concentration used in the standard otic differentiation protocol and 
previous modifications).  This version of the protocol will be referred to as Modified 
Protocol 3 from here on.  A schematic of the protocol is displayed in Figure 5.6A.  
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Differentiation experiments with Modified Protocol 3 were carried out alongside 
H14S9 hES cells differentiated in DFNB, FGF or Modified Protocol 2 conditions.  
QPCR analysis of otic marker gene expression was carried out and the results are 
displayed in Figure 5.6A’.  It was observed that Modified Protocol 3 reproducibly 
leads to the differentiation of otic progenitors with a significant upregulation of the 
gene expression of the otic markers PAX2, PAX8, FOXG1 and SOX2.  For PAX2, 
PAX8 and FOXG1 the difference in gene expression between Modified Protocol 2 and 
3 was not statistically significant, suggesting the expression of these genes became 
independent of FGF by this stage, and could be sustained with canonical Wnt 
activation.  Moreover, the gene expression of SOX2 in the Modified Protocol 3 was 
rescued and significantly increased over the expression observed from Modified 
Protocol 2.  For SOX2, this result suggests an intermediate level of FGF signalling 
must take place during canonical Wnt activation in order to upregulate and maintain 
its expression.  These results were also seen in the Shef3 hES cell line (Appendix 2). 
The In Cell Analyser 1000 platform was next used to ascertain whether the rescue of 
SOX2 gene expression at the RNA level was mirrored in the protein level via antibody 
immunolabelling.  The standard FGF condition was used as a baseline in these 
experiments and PAX8 was used as the co-expressing marker.  Figure 5.7A displays 
a representative example of the In Cell Analyser results, with three independent 
experimental repeats shown in Figure 5.7A’.  Across the repeat experiments the 
differentiating cells in the FGF condition were observed to have a typical percentage 
of highly double positive cells for the otic marker combination of SOX2 and PAX8 as 
seen in previous experiments (mean of 19.6% ± 2.90%).  The percentage of cells 
highly double positive for this combination of markers from the Modified Protocol 3 
condition, however, was found to be a mean of 53.98% ± 4.47%.  This is a 
considerable rescue and increase of SOX2 protein expression when compared with 
Modified Protocol 2 (Figure 5.4A’), and is consistent with the upregulation of SOX2 
gene expression seen in Figure 5.6 by QPCR analysis.  Representative images from 
the In Cell Analyser are shown in Figure 5.7B. 
Additionally H14S9 NOP-SOX2 reporter hES cells were also differentiated in both 
the FGF and Modified Protocol 3 conditions and PAX2, PAX8 and FOXG1 otic 
marker expression co-labelling with the NOP-SOX2 enhancer driven GFP was 
investigated.  Three experiments were carried out and are displayed in Figure 5.8.  In 
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agreement with the antibody immunolabelling in Figure 5.7, NOP-SOX2 enhancer 
driven GFP co-labelling with PAX2, PAX8 and FOXG1 was significantly increased 
when the cells were differentiated in Modified Protocol 3 compared to the standard 
FGF protocol (Figure 5.8), and is in contrast to the outcome of Modified Protocol 2 
on NOP-SOX2 enhancer activity (Figure 5.5).  The mean percentage of NOP-SOX2 
GFP positive cells with highly positive otic marker antibody immunolabelling for FGF 
and Modified Protocol 3 respectively were observed as follows: NOP-SOX2/PAX2: 
19.59% ± 3.31% and 55.79% ± 7.90%; NOP-SOX2/PAX8: 16.94% ± 1.82% and 
52.31% ± 5.07%; NOP-SOX2/FOXG1: 22.04% ± 2.14% and 59.83% ± 6.73%. 
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Figure 5.6:  Schematic representation of Modified Protocol 3 (A).  Gene 
expression of otic markers PAX2, PAX8, FOXG1 and SOX2 following a 12 day 
differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  
Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  
FGF 3 and FGF 10 ligands were supplemented at 50 ng/ml or 25 ng/ml where 
appropriate.  Gene expression is presented as relative to that of the DFNB baseline 
control.  Bar charts denote mean and standard deviation of gene expression relative to 
that of the DFNB control condition (n=3 independent experiments).  Statistical 
significance was determined by one way ANOVA with Bonferroni’s multiple 
comparison post-test.  ns = no significant difference.  *P<0.05, ***P<0.001, 
****P<0.0001. 
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Figure 5.7A:  H14S9 hES cells differentiated for 12 days in FGF or subjected to 
the Modified Protocol 3.  Representative experiment displayed below.  Scatterplots 
for immunolabelling with SOX2/PAX8 (green/red).  Fluorescence intensity of each 
antibody is displayed on each axis.  The scatter plots are coloured according to two 
different intensity thresholds: 99th percentile points of fluorescent intensity in the 
secondary antibody only control, and 75
th
 percentile points of fluorescent intensity 
seen in the FGF condition labelling. Grey: intensity below 99
th
 percentile. Green: 
intensity above the 99
th
 percentile for the green (SOX2) but not red channel (PAX8). 
Red: intensity above the 99
th
 percentile in the red channel but not green channel. 
Purple: cells are double positive, intensity above the 99
th
 percentile in both channels. 
Black: cells are highly double positive, intensity is above the FGF 75
th
 percentile in 
both channels. 
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Figure 5.7A’: H14S9 hES cells differentiated for 12 days in FGF or subjected to 
Modified Protocol 3.  Bar charts show the percentage of highly double positive cells 
(with a threshold intensity above the 75th percentile) in each condition for the antibody 
combination SOX2hi/PAX8hi.  The results are presented as the mean of three 
experimental replicates combined.  Error bars denote mean and standard deviation.  
Statistical significance was determined using Chi-square with Yates’ continuity 
correction.  ****P<0.0001. 
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Figure 5.7B: Representative In Cell Analyser images.  x20 magnification images 
visually highlighting the difference in fluorescence intensity between the FGF and 
Modified Protocol 3 differentiation conditions on SOX2/PAX8 labelling. 
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Figure 5.8: Co-staining of H14S9 NOP-SOX2 reporter cells differentiated for 12 
days in FGF or Modified Protocol 3 conditions.  Cells were immunolabelled with 
PAX2, PAX8 or FOXG1 primary antibodies, and the percentage of double positive 
cells (primary antibody and NOP-SOX2 GFP) is shown below (n=3 independent 
experiments).  Error bars denote mean and standard deviation.  Statistical significance 
was determined using Chi-square with Yates’ continuity correction.  ****P<0.0001. 
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5.2.4 Removal of FGF ligand supplementation during the eight day period of 
canonical Wnt inhibition leads to inconsistent otic differentiation 
 
In many developmentally informed in vitro differentiation protocols using hES cells, 
researchers have attempted to recapitulate known in vivo events.  Inner ear and otic 
placode differentiation in vitro is no different.  In studies such as those by Koehler et 
al. (2013), Oshima et al. (2010) and Ronaghi et al. (2014), an attempt to first generate 
pre-placodal ectoderm is carried out prior to otic placodal differentiation proper.  In 
these studies FGF signalling is not promoted by ligand supplementation in the initial 
pre-placodal ectoderm differentiation phase.  With the knowledge of this, it was 
important to investigate whether supplementation of FGF 3 and FGF 10 during the 
first eight day phase of Modified Protocol 3 alongside canonical Wnt inhibition is a 
requirement for otic differentiation, or if canonical Wnt inhibition alone is sufficient 
to generate the ectoderm required for otic placodal differentiation to take place.  This 
additional manipulation of the protocol will be referred to as Modified Protocol 4, and 
is schematically represented in Figure 5.9A.  As with the previous modifications three 
independent replicate experiments were set up to differentiate the H14S9 hES cells in 
DFNB, FGF, Modified Protocol 3 and Modified Protocol 4 conditions.  RNA was 
extracted following the 12 day differentiation period and QPCR analysis of PAX2, 
PAX8, FOXG1 and SOX2 gene expression was carried out.  The results are displayed 
in Figure 5.9A’.  No statistically significant gene expression differences were 
observed between the standard FGF condition and Modified Protocol 4, or even 
between Modified Protocols 3 and 4.  This was the case for all otic markers 
investigated.  The large standard deviation in the three independent experiments 
determining the effect of Modified Protocol 4 was due to the large fluctuations in the 
gene expression levels observed.  One of the three experiments produced an increase 
in gene expression of all the otic markers tested, higher than that of Modified Protocol 
3 (the most efficient protocol thus far).  However the following two repeat experiments 
produced gene expression levels approximately at similar, or even lower, levels than 
those produced in the standard FGF condition.  A possible explanation for this could 
be that addition and maintenance of FGF 3 and FGF 10 into the culture media during 
the eight day canonical Wnt inhibition phase is required to stabilise ectodermal 
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differentiation in our system and will be discussed in section 5.3.  As such, Modified 
Protocol 3 will be used from here on as the preferred method of otic differentiation. 
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Figure 5.9:  Schematic representation of Modified Protocol 4 (A).  Gene 
expression of otic markers PAX2, PAX8, FOXG1 and SOX2 following a 12 day 
differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  
Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  
FGF 3 and FGF 10 ligands were supplemented at 25 ng/ml.  Gene expression is 
presented as relative to that of the DFNB baseline control.  Bar charts denote mean 
and standard deviation of gene expression relative to that of the DFNB control 
condition (n=3 independent experiments).  Statistical significance was determined by 
one way ANOVA with Bonferroni’s multiple comparison post-test.  ns = no 
significant difference.  *P<0.05, **P<0.01, ***P<0.001. 
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5.2.5 Canonical Wnt manipulation during otic differentiation promotes pre-placodal 
identity 
 
Introduced in Chapter 1 and in section 5.1 of this chapter, the otic placode arises from 
a patch of thickened surface ectoderm in the developing embryo.  Prior to otic placode 
induction a region containing multipotent progenitors which will later differentiate 
and form cells of all of the craniofacial placodes is induced, known as the pre-placodal 
region (PPR).  Characteristic markers of the PPR include members of the SIX, DLX 
and EYA gene families.  It has been shown previously in this chapter that Modified 
Protocol 3 leads to a strong upregulation of the otic markers PAX2, PAX8, FOXG1 
and SOX2 following a 12 day differentiation of hES cells into otic progenitors.  This 
manipulation of the standard FGF protocol can be considered as being more 
developmentally informed, with basic crucial events of early embryonic development 
being mimicked in vitro.  Therefore it was of interest to determine if markers of the 
PPR are also expressed at key points in the differentiation protocol timeline. 
With H14S9 hES cells differentiation experiments were set up to compare the gene 
expression of SIX1, DLX5 and EYA1 in DFNB, FGF and Modified Protocol 3 
conditions.  RNA was extracted from differentiating cells either at day 8 or at the end 
point of the protocol, day 12.  The additional time point of RNA extraction on day 8 
was carried out to determine the gene expression of the PPR markers at the end of the 
phase of canonical Wnt inhibition, prior to the switch to the phase of canonical Wnt 
activation.  A reminder of the components of Modified Protocol 3 is displayed 
schematically in Figure 5.10A.  As shown in Figure 5.10A’ gene expression of the 
PPR markers SIX1, DLX5 and EYA1 appeared to be slightly upregulated by day 8 of 
FGF treatment and this level was maintained by day 12 in comparison to the DFNB 
baseline control condition, although this apparent upregulation was found not to be 
statistically significant.  However the gene expression of all of the PPR markers 
investigated was significantly upregulated by the end of day 8 of Modified Protocol 3 
compared to the standard FGF protocol.  This upregulation of gene expression of the 
PPR markers appeared to be maintained until day 12. 
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Figure 5.10: Schematic representation of Modified Protocol 3 (A).  Gene 
expression of PPR markers SIX1, DLX5 and EYA1 following an 8 or 12 day 
differentiation protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  
Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  
FGF 3 and FGF 10 ligands were supplemented at 50 ng/ml days 0-8 and 25 ng/ml 
thereafter.  Gene expression is presented as relative to that of the DFNB baseline 
control at day 8 or day 12.  Bar charts denote mean and standard deviation of gene 
expression relative to that of the DFNB control condition (n=3 independent 
experiments).  Statistical significance was determined by one way ANOVA with 
Bonferroni’s multiple comparison post-test.  ns = no significant difference.  *P<0.05, 
**P<0.01, ***P<0.001. 
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5.2.6 Canonical Wnt signalling manipulation increases otic differentiation at the 
expense of epidermis in vitro 
 
Following the initial induction of the otic placode it is believed that canonical Wnt 
plays a key role in the expansion of the placode at the expense of the surrounding non-
neural ectoderm and epidermis (Jayasena et al., 2008; Ohyama et al., 2006).  Foxi2 
(Forkhead box I2) has previously been shown, in chicken (Khatri and Groves, 2013) 
and mouse (Ohyama and Groves, 2004), to initially broadly mark the cranial ectoderm 
and its expression later becomes excluded from the otic placode, and remains a marker 
of the epidermis.  Using the cDNA samples produced from the experiments displayed 
in Figure 5.10, FOXI2 gene expression was determined by QPCR analysis with the 
purpose of establishing any differences in its expression between the baseline DFNB, 
FGF and Modified Protocol 3 differentiation conditions.  This was determined at both 
day 8 and day 12 of the protocols, and is represented in Figure 5.11. 
As with the PPR markers in Figure 5.10, there appeared to be a slight upregulation of 
FOXI2 gene expression in the FGF treated cells compared to be the baseline DFNB 
condition at both day 8 and at day 12, although this was not a statistically significant 
difference.  There was however a highly significant upregulation of FOXI2 gene 
expression in the Modified Protocol 3 treated cells at day 8 of the differentiation period 
compared to the standard FGF protocol.  Moreover, there was no difference in the 
gene expression of FOXI2 between FGF and Modified Protocol 3 when comparing the 
levels observed at day 12 of differentiation.  Interestingly it was observed that a highly 
significant downregulation of FOXI2 expression occurred between day 8 and day 12 
of the Modified Protocol 3 differentiation, suggesting the switch from canonical Wnt 
inhibition to activation (and presumably the decrease in supplemented FGF 3 and FGF 
10 ligands) could be the basis of this downregulation.  These results are in agreement 
with the pattern of FOXI2 expression in vivo, where it is initially present in all the 
cranial ectoderm, to be later excluded from the otic placode. 
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Figure 5.11: Gene expression of FOXI2 following an 8 or 12 day differentiation 
protocol with H14S9 hES cells, seeded at 8x103 cells/cm2 (A’).  Canonical Wnt 
inhibition was via 10 µM IWR-1-endo and activation via 2 µM BIO.  FGF 3 and FGF 
10 ligands were supplemented at 50 ng/ml days 0-8 and 25 ng/ml thereafter.  Gene 
expression is presented as relative to that of the DFNB baseline control at day 8 or day 
12.  Bar charts denote mean and standard deviation of gene expression relative to that 
of the DFNB control condition (n=3 independent experiments).  Statistical 
significance was determined by one way ANOVA with Bonferroni’s multiple 
comparison post-test.  ns = no significant difference.  ****P<0.0001. 
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5.3 Discussion 
 
5.3.1 FGF signalling must be attenuated during late in vitro otic differentiation in the 
presence of canonical Wnt activation 
 
In Chapter 4 an eight day period of canonical Wnt signalling inhibition was used in 
combination with FGF signalling to push the differentiating hES cells into an 
ectodermal fate, resulting in the upregulation of ectodermal and otic marker gene 
expression at the expense of markers of the mesoderm and endoderm lineages.  This 
chapter aimed to expand on this by adding a second dimension to the otic 
differentiation protocol; canonical Wnt activation during the final four days of the 
protocol.  Previous published research in mice has demonstrated a direct role for 
canonical Wnt signalling in the initiation of otic placode development via the ability 
of canonical Wnt signalling to expand the otic progenitor population (Ohyama et al., 
2006), whereas studies carried out in zebrafish (Phillips et al., 2004) suggest that loss 
of Wnt signalling does not affect the otic placode formation itself, but delays its onset.  
In this chapter it was shown that canonical Wnt activation with the small molecule 
compound BIO in combination with the standard concentration of FGF 3 and FGF 10 
ligands (50 ng/ml) during the final four days of differentiation led to a downregulation 
of the gene expression of the characteristic otic markers, PAX2, PAX8, FOXG1 and 
SOX2 (Figure 5.2).  Moreover, removal of FGF supplementation during this period 
rescued the expression of PAX2, PAX8 and FOXG1 and expression levels of these 
genes were observed to be higher than from the standard FGF protocol or from the 
protocol used in Chapter 4 (Figures 5.3, 5.4).  Gene expression of SOX2 however was 
significantly downregulated following the removal of supplemented FGF ligands, and 
this was also demonstrated by a reduction in the H14S9 NOP-SOX2 reporter activity 
(Figure 5.5).  It was then highlighted that an intermediate level of FGF ligand 
supplementation (25 ng/ml) was required with canonical Wnt activation in order to 
rescue the gene expression of SOX2 (Figures 5.6, 5.7). 
These findings are similar to key chick in vivo findings published by Ladher et al. 
(2000) and Freter et al. (2008).  It was identified that Fgf 19 and Fgf 3 from the 
neuroectoderm and mesoderm in the chick are downregulated early in embryonic 
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development, prior to the specification of the otic placode and this finding raised the 
possibility of FGF signalling attenuation as a required event for otic placode 
differentiation to progress (Ladher et al., 2000).  A later study expanded on this theory 
(Freter et al., 2008) and utilised plasmid constructs constitutively driving Fgf 19 and 
Fgf 3 expression in the chick using the Ef1α promoter system.  When electroporated 
into HH4 (Hamilton and Hamburger) stage chick embryos it was found that expression 
of Pax2 in the presumptive OEPD region was much stronger and the region of 
expression was largely expanded when the two FGF constructs were electroporated 
simultaneously, compared to single construct electroporation.  Conversely short-
hairpin interfering RNA (siRNA) used to knockdown Fgf 19 and Fgf 3 led to the loss 
of Pax2 expression and a subsequent reduction in the size of the OEPD region, 
confirming the necessity of these two FGF ligands on initiation of the otic placode.  
However when the two FGF plasmid constructs were sustained, Soho1 and Nkx5.1 
expression (markers present when the otic placode has differentiated and become 
morphologically visible) was absent or significantly downregulated compared to wild 
type chick embryos, suggesting that sustained FGF signalling is detrimental for otic 
placode differentiation.  Canonical Wnt signalling inhibition by electroporation of the 
inhibitor Dickkopf 1 during this time also results in a dramatic loss of the expression 
of Soho1 and Nkx5.1.  Together these results demonstrate the role of canonical Wnt 
signalling in otic placode specification when FGF signalling has been attenuated. 
 
5.3.2 Loss of SOX2 expression with removal of FGF ligands indicates FGF acts 
upstream of SOX2 
 
The significant downregulation of SOX2 expression seen when supplemented FGF is 
removed (Figures 5.3, 5.4, 5.5) indicates that FGF acts upstream of SOX2 and may 
function to directly control its expression.  Indeed this is a phenomenon demonstrated 
in a number of other systems.  For example in the differentiation of osteoblasts 
(Ambrosetti et al., 2008; Mansukhani et al., 2005) FGF signalling has been shown to 
have an inductive role in SOX2 expression.  Also within the morphogenesis of the 
stomach forced expression of FGF 10 has been shown to upregulate the expression of 
SOX2.  Rescued expression of SOX2 is crucial in the differentiation of the otic 
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progenitors in vitro as this will impact on the further differentiation of the progenitors 
into the more mature cell types of the inner ear, as SOX2 is required for the induction 
of the prosensory regions prior to hair cell and auditory neuronal differentiation 
(Kiernan et al., 2005). 
 
5.3.3 FGF is required with canonical Wnt manipulation to promote pre-placodal 
identity and otic differentiation 
 
Published studies have highlighted the roles for FGF signalling in promoting 
ectodermal differentiation and pre-placodal identity in both in vitro (Cohen et al., 
2010; Vallier et al., 2009; Zheng et al., 2010) and in vivo (Kwon et al., 2010; Litsiou 
et al., 2005) studies.  Nevertheless many recent studies attempting to recapitulate in 
vivo events of embryonic development through to otic placodal identity do not initially 
supplement differentiation media with exogenous FGF ligands until later in their 
protocols.  One such example is that carried out by Koehler et al. (2013).  In this study 
mouse embryonic stem cells were force aggregated into embryoid bodies and 
subjected to a scheduled cocktail of various signalling pathway modifiers (BMP 
agonist, TGF-β inhibitor) to promote non-neural ectoderm and pre-placodal cell 
identity.  FGF signalling by way of FGF 2 was not added until day 4 of differentiation.  
Similarly the study conducted by Oshima et al. (2010) also used a mouse embryoid 
body approach to generate otic differentiation.  FGF ligands were not supplemented 
until day 5 in this protocol.  Despite this however, it cannot be ruled out that FGF 
signalling was not taking place in these two protocols.  Embryoid bodies (compared 
to our monolayer approach) feature differentiation of all three germ layers, and 
although embryoid bodies can be directed to generate cells of a desired germ layer, it 
is still possible that FGF signalling could be taking place.  Additionally in the study 
by Koehler et al. (2013) Matrigel is used as a component of the differentiation media, 
which is known to contain a large number of growth factor constituents including 
FGF2, which may act on pre-placodal and otic differentiation. 
Removal of FGF supplementation during the first eight days of differentiation with 
canonical Wnt inhibition (Modified Protocol 4, Figure 5.9) was tested in order to 
ascertain if supplemented FGF signalling is required for enhancing otic differentiation.  
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Inconsistent results were observed.  Although the differentiation experiments were all 
set up at the same starting density, it is entirely plausible that the level of endogenous 
FGF production likely fluctuates between experiments, and possibly the cells 
differentiated in the first Modified Protocol 4 experiment may have produced 
sufficient endogenous FGF signals to induce robust ectodermal differentiation in 
coordination with canonical Wnt inhibition, an effect lacking in the subsequent 
replicate experiments.  Supplementing the culture media with FGF 3 and FGF 10 
during the first phase (Modified Protocol 3) may be acting to stabilise these 
fluctuations and provide a more consistent differentiation process.   
Another interesting finding presented in this chapter is the observation of pre-placodal 
marker (SIX1, DLX5, EYA1) gene expression being upregulated significantly at day 8 
of Modified Protocol 3 (the most consistently efficient differentiation protocol) 
following a period of FGF 3 and FGF 10 supplementation with canonical Wnt 
signalling inhibition.  This finding has also been implicated in in vivo studies in 
Xenopus (Brugmann et al., 2004).  In this study the pre-placodal marker Six1 was 
found to act as a transcriptional activator of other pre-placodal genes to induce the 
formation of the PPR.  Inhibition of canonical Wnt signalling by either co-expression 
of a Wnt receptor antagonist (Frzb-1) or expression of a dominant negative form of 
Wnt 8 was found to robustly upregulate and expand the region of Six1 expression, 
which in turn upregulated Eya1 expression.  Comparably in a β-catenin gain of 
function mouse model Freyer and Morrow (2010) showed that Six1 (and Eya1) were 
significantly downregulated, reducing the size of the PPR.  Upon expression of the 
pre-placodal markers it is believed that the expression remains in the progenitors of 
the otic placode (Zou et al., 2004).  In the experiments presented in Figure 5.10 it was 
demonstrated that inhibition of canonical Wnt inhibition through to day 8 of the 
protocol significantly upregulates gene expression of the markers of the in vivo PPR 
region compared to the standard FGF protocol, and this level of gene expression is 
maintained through to the end of the protocol on day 12. 
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5.3.4 Epidermal differentiation is expanded with canonical Wnt inhibition and 
downregulated with canonical Wnt activation 
 
Figure 5.11 illustrates that along with upregulation of the markers of the PPR region, 
canonical Wnt inhibition by day 8 of Modified Protocol 3 also gives rise to an increase 
in the gene expression of the epidermal marker FOXI2, with a strong downregulation 
occurring between day 8 and day 12 when canonical Wnt activation takes place.  This 
change of fate in the epidermal differentiation has previously been reported in mouse 
(Ohyama et al., 2006) and Xenopus (Park and Saint-Jeannet, 2008) in vivo studies.  In 
the findings published by Ohyama et al. (2006) canonical Wnt signalling was found 
to play a role in the decision between adoption of an otic or epidermal fate in the 
developing OEPD.  It was noted that β-catenin inactivation by conditional deletion in 
the mouse embryo led to the expansion of the epidermal region marked by Foxi2 
expression, akin to canonical Wnt inhibition through to day 8 of Modified Protocol 3.  
Likewise a constitutively active stable form of β-catenin was found to promote otic 
placode expansion at the expense of epidermal differentiation and Foxi2 expression.  
In the Xenopus study E-cadherin expression was used as the marker for epidermal 
differentiation, and E-cadherin expression was decreased upon canonical Wnt 
activation with both Wnt 1 and Wnt 8 with a concomitant expansion of the otic 
placodal expansion of Pax8.  These observations could be likened to the finding 
presented in Figure 5.11 in which a significant upregulation of FOXI2 expression was 
seen following canonical Wnt inhibition at day 8, which is then lost as canonical Wnt 
activation occurs through to day 12. 
 
This chapter has demonstrated how the various roles of canonical Wnt signalling 
established in in vivo findings can be utilised to build upon our standard FGF-based in 
vitro otic differentiation protocol to significantly improve the efficiency of otic 
differentiation from hES cells.  The impact of this improved efficiency on the further 
differentiation of the otic progenitors into the more mature cell types of the inner ear 
(hair cells and auditory neurons) will be investigated in the next chapter. 
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CHAPTER 6: IN VITRO HAIR CELL AND AUDITORY NEURON 
DIFFERENTIATION FROM FGF AND WNT MANIPULATED OTIC 
PROGENITORS 
 
6.1 Introduction 
 
6.1.1 Development of the mature cell types of the inner ear; hair cells and auditory 
neurons 
 
Succeeding the initiation and further maturation of the otic placode, morphological 
changes occur in order to bring about the more mature differentiated structures of the 
cochlea and inner ear.  As discussed in greater detail in Chapter 1, the thickened 
surface ectoderm housing the otic placode invaginates to form the otic vesicle and 
otocyst, containing SOX2 positive prosensory regions which go on to develop into 
structures of both the vestibular and auditory systems.  The organ of Corti is the 
sensory epithelium of the organ of hearing, the cochlea, and contains an exquisite 
coordination of a number of different cell types.  Sensory hair cells, responsible for 
relaying mechanical sound stimulation into an electrical impulse, are believed to be 
induced initially by the transcription factor ATOH1 (Chen et al., 2002).  ATOH1 is 
the first detectable marker of hair cell differentiation, and is transiently expressed 
before being rapidly downregulated (reviewed in Mulvaney and Dabdoub, 2012).  It 
is thought that expression of SOX2 is required for ATOH1 expression, as mice 
deficient in SOX2 fail to form sensory hair cells as a result of the loss of ATOH1 
(Kiernan et al., 2005).  ATOH1 is also thought to have an inductive role in the 
expression of POU4F3 (or BRN3C) (Erkman et al., 1996).  POU4F3 has been 
implicated in the mouse as not being necessary for hair cell induction and proliferation, 
but important for the further maturation and survival of the hair cells post-mitotically.  
POU4F3 knockout mice were shown to develop hair cells normally, with expression 
of other characteristic hair cell markers, yet they do not form the structures of the more 
mature hair cells, such as the stereocilia bundles (Xiang et al., 2008).  Mutations in 
this gene therefore contribute to some genetic forms of deafness.  Likewise the 
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expression of an additional early key hair cell marker, MYO7A, has also been shown 
to be important for normal stereocilia bundle structure, organisation and function.  The 
Myo7a mouse mutant Shaker-1 (Gibson et al., 1995) has disorganised stereocilia and 
consequent disorders of hearing. 
Within the anteroventral portion of the developing otocyst, a subset of cells adopt a 
neuroblast fate and subsequently delaminate from the otocyst, going on to develop the 
spiral ganglion neurons and cochleovestibular ganglion.  For this auditory neuronal 
differentiation to take place within the developing cochlea, the basic helix-loop-helix 
transcription factor NEUROG1 is required (Ma et al., 1998).  Notch signalling has 
been implicated in governing the cell fate decisions of neuronal differentiation by 
lateral inhibition of neighbouring sensory cells (Morrison et al., 1999).  When Notch 
signalling is inhibited it has been shown in the mouse that cells within the prosensory 
patch are shifted from an epithelial fate to a more neuronal fate.  This has been 
demonstrated in mouse mutants for Delta1, a key mediator of Notch signalling 
(Brooker et al., 2006) and also in zebrafish studies (Haddon et al., 2008).  Knockout 
of Delta1 causing loss of Notch-mediated lateral inhibition in the mouse led to a 
significant increase in the number of cells adopting a neuronal fate, and a consequent 
increase in the size of the cochleovestibular ganglion. 
 
 
6.1.2 Development of in vitro hair cell and auditory neuron differentiation protocols 
 
The identification and isolation of human auditory stem cells from the fetal cochlea 
(Chen et al., 2007; Chen et al., 2009) (hFASCs) provided a model system in which to 
begin the investigation of in vitro differentiation protocols to generate auditory hair 
cells and neurons.  Using the hFASCs it was found that exposure to low concentrations 
of all-trans retinoic acid and epidermal growth factor (EGF) in serum free media 
(Chapter 2) caused approximately 85 to 90% of the hFASCs to retain their epithelial-
like morphology and express key markers of auditory hair cell differentiation such as 
ATOH1, MYOSIN VIIA and POU4F3.  EGF and all-trans retinoic acid were chosen 
as a result of their established roles in the development of the cochlea.  The role of 
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retinoic acid in the developing inner ear has been shown by the work of Kelley et al. 
(1993).  Mouse cochlea explants were used to determine the effects of applying 
exogenous retinoic acid, and it was reported that a significant increase in the number 
of hair cells and supporting cells was produced.  Retinoic acid receptors have also been 
previously identified in mouse cochlea studies (Mendelsohn et al., 1991).  More 
recently retinoic acid has been used to aid the differentiation of human bone marrow 
derived mesenchymal stem cells into hair cells in vitro (Boddy et al., 2012; Duran 
Alonso et al., 2012).  EGF has been implicated in hair cell initiation by being involved 
in the induction of ATOH1, a key initiator of hair cell differentiation (Doetzlhofer et 
al., 2004), and the EGF receptor has been identified in the developing chick and mouse 
inner ears (White et al., 2012). 
For auditory neuron differentiation from the hFASCs (Chapter 2) it was found that 
trypsinisation of the cells was required in order to initiate the formation of a bipolar 
morphology.  Differentiating cells were maintained in serum free media with 
supplemented basic FGF and Sonic hedgehog, followed by the addition of the 
neurotrophic factors neurotrophin-3 (NT3) and brain-derived neurotrophic factor 
(BDNF).  Neuronal cells resulting from this process were found to express 
NEUROG1, POU4F1, β-TUBULIN III and NEUROFILAMENT 200.  In vivo the 
auditory neurons, or spiral ganglion neurons (SGNs) are responsible for relaying 
sound information from the sensory hair cells to the brain.  SGN precursor 
development in the embryo is believed to be initially induced in the prosensory patches 
by upregulation of NEUROG1 (Ma et al., 2000).  Later NEUROD is expressed in the 
mature post-mitotic neurons, and it is thought that NEUROD expression enhances 
neuronal differentiation via inhibition of non-neural fate (Lawoko-Kerali et al., 2004). 
The protocols for differentiating hFASCs into hair cells and auditory neurons have 
also been tested on otic progenitors derived from hES cells (Chen et al., 2012), with 
similar results.  The ability to reproducibly and efficiently produce hair cell-like cells 
and auditory neurons in vitro has potentially invaluable implications.  It could, for 
example, provide a tool to aid in the identification of factors involved in increasing 
proliferation, drug screening assays to test potential ototoxic compounds, and even 
harbours potential for cell-based transplantation into the damaged cochlea. 
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6.1.3 General objectives of the chapter 
 
In the previous chapters an improved method to produce otic progenitors from hESCs 
combining manipulation of the Wnt and FGF signalling pathways has been described. 
In this chapter, the ability of the progenitors generated by this new method to further 
differentiate into hair cell-like cells and auditory neurons in vitro, comparing it to those 
produced by the former FGF-based protocol, will be explored.  This will allow us to 
determine if the increased efficiency of otic progenitors generated from Modified 
Protocol 3 is reflected with an increase in efficiency of hair cell and auditory neuronal 
differentiation. 
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6.2 Results 
 
6.2.1 Hair cell differentiation was not enhanced in otic progenitors generated by the 
manipulation of canonical Wnt signalling 
 
The differentiation process of generating otic progenitors from hES cells was made 
more efficient by combining FGF signalling with canonical Wnt signalling 
manipulation.  This improved protocol comprised of an eight day period of FGF 3 and 
FGF 10 signalling in combination with canonical Wnt signalling inhibition, followed 
by a four day period of canonical Wnt activation with an attenuated FGF 3 and FGF 
10 signalling (Modified Protocol 3, Chapter 5).  This more efficient protocol led to the 
differentiation of otic progenitors with an increase in the expression of the 
characteristic otic placodal markers, PAX2, PAX8, FOXG1 and SOX2.  Ultimately it 
was then important to determine if this generation of improved otic progenitors 
possess a greater capacity to differentiate further into the more mature cells types of 
the inner ear, such as the hair cells and auditory neurons.  This second phase of 
differentiation is referred to as Phase 2 differentiation. 
The in vitro hair cell differentiation protocol is described in greater detail in Chapter 
2.  In brief, during the first phase of otic differentiation, differentiating hES cells were 
manually purified to generate a pure culture of otic epithelial progenitor (OEP) cells.  
This was carried out with cells differentiating in the standard FGF condition and also 
in Modified Protocol 3.  At the end of the 12 day differentiation period, the OEPs were 
lightly trypsinised with dilute trypsin and seeded onto gelatin coated flasks or dishes 
at a density of 1x104/cm2.  For the following 14 days the OEPs were maintained in 
DFNB medium supplemented with EGF and all-trans retinoic acid.  RNA was 
subsequently extracted, converted to cDNA and QPCR analysis of the gene expression 
of markers of hair cell differentiation, POU4F3 (BRN3C), MYO7A and ATOH1, was 
carried out. OEPs at the end of the first phase of differentiation were also harvested 
for RNA to determine the gene expression of the hair cell markers prior to undergoing 
hair cell differentiation.  Alternatively cells after hair cell differentiation were fixed in 
4% paraformaldehyde and immunolabelled with antibodies against the combinations 
of POU4F3/ATOH1 and POU4F3/MYO7A.  Nuclei were counterstained with 4’,6-
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diamidino-2-phenylindole (DAPI).  QPCR results are displayed in Figure 6.1A.  
Representative images of the immunolabelling with hair cell markers are displayed in 
Figure 6.1B, and quantification of this immunolabelling is shown in Figure 6.1B’. 
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Figure 6.1A: Gene expression of hair cell markers POU4F3, MYO7A and ATOH1 
following a 14 day hair cell differentiation protocol.  H14S9 OEPs were seeded at 
1x104/cm2.  Hair cell differentiation media consists of DFNB supplemented with 20 
ng/ml EGF and 10-6 molar all-trans retinoic acid.  Gene expression is presented as 
relative to that of baseline DFNB control OEPs after 12 days culture.  Phase 1 refers 
to the end of the standard 12 day FGF or Modified Protocol 3 protocol.  Phase 2 HC 
refers to the end of hair cell differentiation.  Bar charts denote mean and standard 
deviation of gene expression relative to that of the DFNB control condition (n=3 
independent experiments).  Statistical significance was determined by one way 
ANOVA with Bonferroni’s multiple comparison post-test.  ns = no significant 
difference.  *P<0.05, **P<0.01. 
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Figure 6.1B: Immunolabelling of OEPs following the 14 day hair cell 
differentiation protocol.  Cells were labelled with a combination of POU4F3 
(green) and ATOH1 (red), or POU4F3 (green) and MYO7A (red). Nuclei 
counterstained with DAPI.  Single representative field of view, 10x magnification.  
Scale bar is 400 µM. 
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POU4F3 (green)/MYO7A (red) 
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Figure 6.1B’: Quantification of hair cell marker immunolabelling.  Bar charts 
show the mean percentage of double positive cells labelled with the antibody 
combinations POU4F3/ATOH1 and POU4F3/MYO7A from n=3 independent 
experiments.  Error bars denote mean and standard deviation.  Statistical significance 
was determined using Chi-square with Yates’ continuity correction.  ns = no 
significant difference. 
 
 
P
O
U
4
F
3
/A
T
O
H
1
P
O
U
4
F
3
/M
Y
O
7
A
0
2 0
4 0
6 0
A n tib o d y  c o m b in a tio n s
D
o
u
b
le
 p
o
s
it
iv
e
s
 (
%
) F G F
M o d ifie d  P ro to c o l 3
n s
n s
 
 
 
 
 
 
 
 
 
  Chapter 6 
172 
 
As highlighted in Figure 6.1A, it was observed that there was no significant difference 
in the gene expression of POU4F3 and MYO7A between any of the conditions 
investigated.  In one of the three independent experiments carried out (Appendix 3) 
there was a substantial upregulation of the gene expression of all three hair cell 
markers investigated, however the following two replicate experiments did not 
produce this upregulation.  Significant differences were however observed with the 
gene expression of ATOH1 in some conditions investigated.  The OEPs generated 
from the Modified Protocol 3 differentiation protocol had significantly higher ATOH1 
gene expression than the OEPs produced from the standard FGF condition, prior to 
further differentiation.  Moreover there was a significant downregulation of ATOH1 
gene expression after the Modified Protocol 3 OEPs were differentiated for 14 days in 
hair cell media, compared to the expression in their progenitor state.  With the FGF 
OEPs no significant difference in the gene expression of ATOH1 was seen between 
before and after hair cell media differentiation.  At the end of the 14 day hair cell 
media differentiation phase no differences were observed between FGF-derived and 
Modified Protocol 3-derived OEPs. 
Figure 6.1B and 6.1B’ also demonstrate that in the protein expression with antibody 
immunolabelling at the end of hair cell media treatment, for the combinations of 
POU4F3/ATOH1 (42.61% ± 4.19% and 41.33% ± 5.56% double positive cells in FGF 
and Modified Protocol 3, respectively) and POU4F3/MYO7A (46.28% ± 4.94% and 
49.20% ± 2.78% double positive cells in FGF and Modified Protocol 3, respectively), 
no significant differences were seen in the percentage of double positive cells between 
the two otic progenitor induction protocols. 
In addition the H14S9 Atoh1nGFP reporter generated and discussed in Chapter 3, 
appeared to have a rapid downregulation of enhancer activity upon differentiating the 
OEPs in hair cell media.  This was the case for OEPs produced in either the standard 
FGF or Modified Protocol 3 conditions.  Enhancer-driven GFP positive cells could not 
be detected by fluorescent microscopy throughout the 14 days of hair cell media 
treatment. 
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6.2.2 Neuronal differentiation was more efficient with otic progenitors generated from 
manipulation of canonical Wnt signalling 
 
Described in greater detail in Chapter 2, an in vitro differentiation protocol was 
developed in order to promote the differentiation of the immature otic progenitors into 
the more mature auditory neurons.  In brief the 12 day protocol consists of dissociating 
the manually purified otic neural progenitors (ONPs) with trypsin and then culturing 
the cells in DFNB media supplemented with basic FGF and Sonic hedgehog ligands 
for three days.  On day four the media is supplemented further with the neurotrophic 
factors BDNF and NT-3 until day 6.  From day 6 to the end of differentiation the cells 
are maintained in DFNB with the supplemented neurotrophic factors only (Sonic 
hedgehog is removed from day 6).  After differentiation cells were either fixed for 
antibody immunolabelling or lysed for RNA extraction and QPCR analysis (Figure 
6.2A).  Gene expression of the sensory neural markers POU4F1 (BRN3A), SYP 
(Synaptophysin), and SLC17A7 (VGLUT1) was investigated.  ONP cells prior to 
further neural differentiation were also used in QPCR analysis to determine the gene 
expression of neuronal markers at the progenitor stage.  Immunolabelling was carried 
out using the antibody combinations POU4F1/NKAα3 (sodium/potassium-ATPase 
subunit 3) and β-tubulin III/Neurofilament200 (NF200).  Representative images are 
displayed in Figure 6.2B, with quantification highlighted in Figure 6.2B’. 
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Figure 6.2A: Gene expression of sensory neuronal cell markers POU4F1, SYP 
and SLC17A7 following a 12 day neural differentiation protocol.  H14S9 ONPs 
were seeded at 4x103/cm2.  Neural differentiation media (day 1-3) consists of DFNB 
supplemented with 20 ng/ml basic FGF and 500ng/ml Sonic hedgehog C24II; day 4 
and 5 with supplemented BDNF and NT-3 at 10 ng/ml; day 6 – 12 removal of Sonic 
hedgehog.  Gene expression is presented as relative to that of baseline DFNB control 
ONPs after 12 days culture.  Phase 1 refers to the end of the standard 12 day FGF or 
Modified Protocol 3 protocol.  Phase 2 NM refers to the end of neural differentiation.  
Bar charts denote mean and standard deviation of gene expression relative to that of 
the DFNB control condition (n=3 independent experiments).  Statistical significance 
was determined by one way ANOVA with Bonferroni’s multiple comparison post-
test.  ns = no significant difference.  *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. 
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Figure 6.2B: Immunolabelling of ONPs following the 12 day neural 
differentiation protocol.  Cells were labelled with a combination of NKAα3 
(green) and POU4F1 (red), or β-tubulin III (green) and NF200 (red). Nuclei 
counterstained with DAPI.  Single representative field of view, 20x magnification.  
Scale bar is 200 µM. 
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Figure 6.2B’: Quantification of neural marker immunolabelling.  Bar charts show 
the mean percentage of double positive cells labelled with the antibody combinations 
NKAα3/POU4F1 and β-tubulin III/NF200 from n=3 independent experiments.  Error 
bars denote mean and standard deviation.  Statistical significance was determined 
using Chi-square with Yates’ continuity correction.  ns = no significant difference.  
****P<0.0001. 
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Gene expression of all three neural markers investigated by QPCR (POU4F1, SYP and 
SLC17A7) was found to be significantly upregulated in the cells generated from 
Modified Protocol 3 compared to the standard FGF condition following the 12 day 
neutralising protocol (Figure 6.2A).  There was also a significant upregulation of the 
gene expression of all three markers between the Modified Protocol 3 progenitors pre- 
and post-neural differentiation.  In the case of the FGF progenitors, only POU4F1 was 
significantly upregulated after neural differentiation compared to the expression in the 
progenitor state. 
The percentage of double positive cells observed by immunolabelling (Figure 6.2B 
and 6.2B’) also highlights differences between the neural differentiation outcome of 
FGF and Modified Protocol 3 generated otic progenitors.  Although there was no 
significant difference in the percentage of double positive NKAα3/POU4F1 cells 
between FGF and Modified Protocol 3, the fluorescent intensity of the neuralised cells 
from Modified Protocol 3 generally looked brighter than from the standard FGF 
condition.  In the case of β-tubulin III/NF200 there was a highly significant increase 
in the percentage of double positive cells from Modified Protocol 3, and also the 
intensity of the immunolabelling appeared visually brighter with these cells compared 
to the FGF cells. 
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6.3 Discussion 
 
6.3.1 OEPs obtained with Modified Protocol 3 can differentiate into hair cell-like cells 
at a similar level of efficiency as conventional OEPs obtained from the FGF-based 
protocol 
 
However, despite the substantial upregulation of the characteristic otic markers, PAX2, 
PAX8, FOXG1 and SOX2 (seen at both the gene transcript and protein expression 
levels), induced by differentiating hES cells in Modified Protocol 3 conditions, hair 
cell differentiation was not subsequently improved overall compared to differentiating 
the otic progenitors produced from the standard FGF protocol.  Gene expression of 
POU4F3, ATOH1 and MYO7A did not significantly alter in level when comparing the 
expression in the FGF-produced otic progenitors prior to and after undergoing hair 
cell differentiation.  From Modified Protocol 3, POU4F3 and MYO7A gene expression 
was also not significantly different between the progenitor and hair cell media treated 
state.  Interestingly the gene expression of ATOH1 was significantly increased in the 
Modified Protocol 3 progenitor state over the progenitors emanating from the FGF 
condition, and moreover, this increased gene expression of ATOH1 was significantly 
downregulated following hair cell media treatment. 
Expression of ATOH1 has been shown to be necessary and sufficient for the induction 
of hair cell differentiation in vivo, with the Math1-null mouse failing to form inner or 
outer hair cells in the organ of Corti (Bermingham et al., 1999).  ATOH1 expression 
is known to be early and transient, rapidly being downregulated once hair cell 
differentiation progresses and matures.  With a significant upregulation of ATOH1 
gene expression observed in the Modified Protocol 3 progenitors by day 12 of 
differentiation, this could suggest that the OEPs are becoming primed for 
differentiation into hair cells, and consequently the gene expression of ATOH1 is 
downregulated by the end of the 14 day hair cell differentiation period.  This 
downregulation is not a complete loss of ATOH1 expression however and this could 
perhaps explain the presence of ATOH1-positive cells detected by immunolabelling 
at day 14.  Studies investigating the in vitro generation of hair cells from mouse (Ouji 
et al., 2013) and human ES and IPS cells (Ronaghi et al., 2014) tend to see gene 
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expression of ATOH1 peaking after hair cell differentiation, rather than at the otic 
progenitor stage.  Ronaghi et al. (2014) for example showed downregulation of 
ATOH1 expression following a phase of otic induction, with significant upregulation 
of ATOH1 after hair cell differentiation.  It must be noted however that the hair cell 
differentiation strategy used by Ronaghi et al. (2014) was very different to the one 
used in this work.  Otic induction was carried out in an embryoid body format rather 
than in monolayer, and following a period of otic induction hair cell differentiation 
occurred via a phase of gradual serum depletion; EGF or retinoic acid were not 
supplemented.  It is possible that hair cell induction favours a more three dimensional 
differentiation format rather than in monolayer. 
 
6.3.2 Sensory neuronal differentiation was improved from canonical Wnt signalling-
manipulated otic progenitors 
 
Sensory spiral ganglion neurons in the developing cochlea are crucial for the 
conveying of sound information from the cochlear hair cells to the brain.  Important 
to the differentiation, survival and migration of these auditory neurons is POU4F1 
(BRN3A).  Emphasising the importance of POU4F1 in promoting sensory neural 
differentiation and survival, it was demonstrated in the Pou4f1 knockout mouse 
(Huang et al., 2001) that loss of Pou4f1 leads to subsequent downregulation of TrkC, 
the receptor for the neurotrophic factor NT-3, leading to massive neuronal cell loss 
within the developing cochlea. 
The afferent spiral ganglion neurons innervating the inner hair cells in the organ of 
Corti are known as type I spiral ganglion neurons, and aid in the quick relaying of 
sound information to the brain.  Important to these fast firing neurons is the presence 
of the sodium/potassium-ATPase (NKA), a membrane bound protein that maintains 
the hyperpolarized membrane potential of the neurons.  Inhibitors of NKA, such as 
ouabain, have previously been shown to decrease the endocochlear potential (Konishi 
and Mendelsohn, 1970) and consequently reduce the rate of firing of the type I spiral 
ganglion neurons.  A study conducted in the rat by McLean et al. (2009) identified the 
α3 subunit of NKA (NKAα3) is expressed only in the organ of Corti where the type I 
afferent neurons innervate the inner hair cells.  Moreover it is restricted from the type 
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II spiral ganglion neurons.  SLC17A7 (VGLUT1) and SYP (Synaptophysin) are also 
found to be expressed in the developing cochlea, and are both important in the 
innervation of the inner hair cells of the organ of Corti by the type I spiral ganglion 
neurons. 
The gene expression of POU4F1, SYP and SLC17A7 in the Modified Protocol 3-
produced ONPs after further differentiation in the 12 day neuralisation protocol was 
observed to be significantly upregulated compared to the cells in the progenitor state, 
and also with the ONPs produced from the standard FGF condition, pre- or post-neural 
differentiation (Figure 6.2A).  This is suggesting that the otic progenitors produced 
from manipulating canonical Wnt signalling in Modified Protocol 3 differentiate more 
efficiently into sensory neurons than the progenitors generated under the standard FGF 
induction protocol.  The percentage of cells co-expressing POU4F1 and NKAα3 was 
not significantly different between the two otic progenitor-generating conditions, 
however, although it could be argued that the fluorescent intensity of the 
immunolabelling is brighter in the Modified Protocol 3 cells, at least visually (Figure 
6.2B and 6.2B’).  β-tubulin III and NF200, general markers of neuronal differentiation, 
were also significantly upregulated in the Wnt manipulated cells than the FGF cells, 
as observed in both the percentage of double positive immunolabelling and in visual 
fluorescent intensity. 
Canonical Wnt signalling-manipulated OEPs differentiated into hair cell-like cells as 
efficiently as the OEPs generated from the standard FGF protocol.  Further 
enhancement of in vitro hair cell differentiation warrants further investigation.  There 
are a number of more sophisticated methodologies for hair cell differentiation in vitro 
(Koehler et al., 2013; Ronaghi et al., 2014), producing a substantial improvement in 
hair cell generation.  Thus our current hair cell differentiation protocol could be a 
limiting factor.  Nevertheless the impact on sensory neural differentiation was 
significant.  Generating otic progenitors with the potential to efficiently undergo 
neural differentiation, especially towards the more sensory neurons, could have great 
potential in improving cell-based transplantations to regenerate lost or damaged spiral 
ganglion neurons in vivo. 
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CHAPTER 7: CONCLUSION 
 
7.1 Conclusion and future implications 
  
Deafness as a consequence of sensorineural hearing loss, is a major target for 
regenerative medicine and potential cell-based therapies, due to the lack of 
conventional medical treatments.  The ability to repair or replace the damaged cells of 
the organ of Corti and its associated neurons is currently being explored in a number 
of ways.  Avenues of research include neurotrophic factor supplementation along with 
cochlear implantation to aid in the survival of the spiral ganglion neurons (Jiao et al., 
2014; Zanin et al., 2014), targeting Wnt-responsive Lgr5-positive stem cells within 
the mature cochlea to promote hair cell generation and proliferation in vivo (Shi et al., 
2012; Shi et al., 2013), and in our case, the exogenous production of otic progenitor 
cells for use in cellular transplantation to restore lost spiral ganglion neurons and 
improve functional hearing (Chen et al., 2012).   
Human embryonic and induced pluripotent stem cells, and their differentiated 
derivatives, are fast approaching the clinic as sources of transplantable cells for 
regenerative purposes in the inner ear.  The ability to efficiently direct the 
differentiation of human pluripotent stem cells into a differentiated progeny of choice, 
with minimal contamination of extraneous cell types, is the ideal outcome for stem 
cell based therapeutics, and will aid in the scaling up of production to meet clinical 
need.  Based on our current differentiation protocol, otic progenitors are generated 
with approximately 20% efficiency as measured by the expression of PAX2, PAX8, 
FOXG1 and SOX2.  Modified Protocol 3, developed in this thesis, substantially 
improved this efficiency to approximately 50-60%.  The basis of Modified Protocol 3 
has been to incorporate the manipulation of canonical Wnt signalling into our 
previously established otic differentiation protocol.  Canonical Wnt signalling has 
been shown to play a role in the induction and further expansion of the otic placode in 
vivo (Freter et al., 2008; Ohyama et al., 2006), and in combination with the crucial 
ligands FGF 3 and FGF 10, has helped us generate a more developmentally informed 
methodology. 
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Since the initial derivation of human embryonic stem cell lines in 1998 (Thomson et 
al., 1998) vast amounts of research have been undertaken attempting to efficiently 
produce transplantable differentiated cells.  The directed differentiation into cell types 
of the central nervous system was one of the first target areas.  Simple differentiation 
protocols were derived based on supplementing differentiation media with basic FGF 
(Zhang et al., 2001) or a modest cocktail of basic FGF and EGF (Reubinoff et al., 
2001).  Similarities between these studies and our otic induction protocol are apparent; 
differentiation of human embryonic stem cells with just one or two key ligands can 
generate a progenitor type of interest, but usually with limited efficacy.  
Since the early differentiation studies, and as knowledge of embryonic development 
has widened, research into the derivation of specific cell types from human pluripotent 
stem cells has now begun to adopt an approach involving the manipulation of the 
multiple signalling pathways known to work in synchrony during development, either 
simultaneously or sequentially.  This is being carried out in the hope that a greater 
proportion of the differentiating pluripotent stem cells will generate the cell type of 
interest by being induced through an in vivo-like series of events, as with Modified 
Protocol 3 presented in this thesis.  One such example is the study conducted by 
Chambers et al. (2009) which set out to improve the efficiency of the differentiation 
of human pluripotent stem cells towards the neural lineage.  Human pluripotent stem 
cells were exposed to inhibitors of the transforming growth factor (TGF-β) 
(SB413542) and BMP (Noggin) pathways, either alone or in combination.  Compared 
to differentiation with the supplementation of SB413542 or Noggin alone, the 
combined treatment significantly increased the efficiency and rate of neural 
conversion.  Using PAX6 as a positive marker for neuroectodermal differentiation, 
approximately 10% of the cells expressed PAX6 when treated with SB413542 or 
Noggin alone, compared to above 80% when the two inhibitors were exposed to the 
cells in combination.  Another finding of the study relevant to our work was the effect 
of cell density on the differentiation phenotype.  It was found that seeding the human 
embryonic stem cells into differentiation media at high density promoted the cells to 
almost exclusively become PAX6 positive, compared to a more SOX10 neural crest 
positive population at lower densities.  Previous work in our laboratory has 
demonstrated a shift towards OEP differentiation when they the human embryonic 
stem cells are seeded at high densities, compared to a more ONP fate when low 
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densities are used.  As this study also utilises a monolayer culture system, this allows 
for easier isolation of a cell phenotype of interest.  In agreement with data presented 
in this thesis, a germ layer lineage bias away from endodermal and mesodermal 
differentiation was also promoted by inhibition of BMP and TGF-β signalling, similar 
to the effect of inhibition of canonical Wnt signalling highlighted in the previous 
chapters. 
Dincer et al. (2013) expanded upon this work by Chambers et al. (2009) by 
investigating if this enhancement of neural lineage differentiation could be modified 
to produce cranial placodal precursors from the neuroectodermal progenitors initially 
induced by the dual inhibition with SB413542 and Noggin.  BMP signalling has been 
implicated in the induction of the pre-placodal region of the ectoderm (Kwon et al., 
2010), and it was found in this work that derepression of BMP signalling by removal 
of Noggin after three days of differentiation promoted a significant increase 
(approximately 70%) in the number of SIX1 positive cells, marking the anterior pre-
placodal region.  Given the correct set of signals these placodal precursors could be 
directed to differentiate further into pituitary, trigeminal and lens placode derivatives.  
These findings provide us with options to further enhance Modified Protocol 3 by 
incorporating the manipulation of other pathways such as BMP and TGF-β to more 
readily generate anterior pre-placodal ectoderm.  Anteriorising the ectoderm would be 
beneficial for us as the otic placode is induced in the anterior ectoderm.  In studies 
looking into retinal differentiation from human embryonic stem cells (Lamba et al., 
2006) insulin-like growth factor-1 (IGF-1) has been supplemented into culture media 
to explore this notion of anteriorising the induced ectoderm.  The effect of IGF-1 in 
inner ear research has been explored by Oshima et al. (2010).  Inhibition of canonical 
Wnt and TGF-β signalling with concomitant exposure to IGF-1 caused the ectodermal 
differentiation of mouse pluripotent stem cells towards an anteriorised fate.  Thus there 
is still potential for a number of factors to be manipulated, enhancing the 
developmental accuracy of Modified Protocol 3. 
The work to restore vision is perhaps a step closer to the clinic than strategies to help 
restore hearing.  A landmark study reported by Eiraku et al. (2011) reported using 
mouse embryonic stem cells in a three dimensional embryoid body assay and found a 
self-directed differentiation and formation of optic cup-like structures within the 
embryoid bodies.  Taking advantage of this phenomenon Gonzalez-Cordero et al. 
  Chapter 7 
187 
 
(2013) used this three dimensional method to isolate photoreceptor precursors for 
transplantation into adult mouse models of visual impairment.  Following protracted 
differentiation in embryoid bodies, photoreceptor cells (expressing GFP driven by the 
Rhodopsin gene promoter) were isolated and transplanted into the retina of adult 
visually impaired mice.  It was found that only 0.3% GFP positive cells had 
transplanted and grafted successfully, limiting the functional recovery effect provided 
by these cells.  Within the field of inner ear research itself, a similar phenomenon of 
self-directed differentiation in three dimensional embryoid bodies has been reported.  
The work carried out by Koehler et al. (2013) aggregated mouse embryonic stem cells 
and using a combination of various molecules, directed the differentiation through 
phases of non-neural ectoderm, pre-placodal ectoderm and otic placode identities 
before self-directed differentiation led to the abundant formation of sensory hair cells.  
Non-neural ectoderm was induced by activation of BMP (with BMP 4) and inhibition 
of TGF-β signalling (with SB413542), followed by a phase of BMP inhibition (with 
LDN193189) and activation of FGF signalling (with basic FGF) to induce pre-
placodal and otic placodal differentiation.  This process was carried out over 8 days 
before the cells were left to self-differentiate until day 30.  By this time aggregates 
were found which contained approximately 1500 sensory hair cells.  I have performed 
a few exploratory experiments (not included in this thesis) to attempt to adapt this 
protocol to the use of hES cells with limited success thus far. 
What is important to highlight here is that most of the studies described in the former 
paragraphs involve differentiating embryonic stem cells via aggregation into embryoid 
bodies (and the Oshima et al. (2010) and Koehler et al. (2013) are performed in mouse, 
and therefore still needing validation with hES cells).  This differentiation approach, 
unlike the monolayer culture system used in the experiments of this thesis, have a 
number of caveats.  Embryoid body differentiation protocols tend to be protracted and 
feature many different permutations, for example up to 30 days long as in the research 
by Koehler et al. (2013).  Not only does this add a level of complexity to the 
differentiation process, the cost of such experiments is also high.  Our monolayer 
culture system takes places over just 12 days by comparison.  Embryoid bodies also 
take away an element of control.  Despite manipulating various signalling pathways 
to direct differentiation, there may be cells present within the aggregates that 
spontaneously differentiate, or receive a lower amount of signal due to concentration 
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gradients imposed throughout the aggregate which will have implications on the 
outcome of the differentiation.  A monolayer system avoids this pitfall by ensuring a 
much greater proportion of cells receive the same molecular signals, and this could 
potentially lead to a better yield of the cell derivate of choice.  Following on from this, 
isolation of the differentiated cells in monolayer is much easier and cleaner than from 
embryoid bodies which usually require harsher dissociation methods to generate single 
cells.  The low amount of engrafted cells transplanted into the mouse retinas 
(Gonzalez-Cordero et al., 2013) may have been a result of sub-optimal dissociation of 
the aggregates.  Although, in fairness, the three dimensional methods appear to 
produce more matured phenotypes, their complexity and difficulty for purification 
may prevent their application for scale-up production needed for clinical application.  
While they remain valuable as developmental models, perhaps in the road to 
translation they should be adapted as an assay post-production, for testing the true 
potential of the progenitors obtained by simpler, two dimensional protocols. 
The majority of these studies also use differentiation media and matrices which are of 
animal origin, for example fetal bovine serum, gelatin, mouse laminins, and matrigel.  
These components are essential for embryoid body formation, and as such this will 
hinder the translation of the research into a clinical setting (Fink, 2009).  Although our 
culture system currently uses mouse laminin and gelatin for differentiation, and the 
human embryonic stem cells are cultured on mouse fibroblast feeders or on matrigel, 
the monolayer nature of the system will allow for easy transition to xeno-free 
materials.  For example there are a number of newly established xeno-free substrates 
for human embryonic stem cell cultivation which abide by the Good Manufacturing 
Practice guidelines (Menasche et al., 2014), and a vast amount of research has 
discovered new synthetic extracellular matrices for differentiation in monolayer 
(Alamein et al., 2013; Rowland et al., 2013). 
The generation of an otic placode-specific hES cell reporter line also has great 
implications for future research.  It will help to provide a visual readout of otic 
differentiation in vitro, and as such, screening of compounds which may boost the 
differentiation process or for toxicity testing, will be made easier and potentially 
adaptable to a high throughput screening system.  Further validation of the reporter 
would be required initially however. 
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7.2 Next experimental steps 
 
For further validation of the otic placode-specific hES cell reporter line it would be 
beneficial to purify a population of reporter GFP positive cells by flow cytometry and 
determine the gene expression levels of the various otic markers (PAX2, PAX8, 
FOXG1, SOX2) compared to the unpurified population of progenitors.  It would be 
anticipated that the expression of the otic markers would be enriched in the GFP 
reporting cells.  Following on from this, another reporter line validation experiment 
would be to sort the reporter GFP positive ONPs and OEPs by flow cytometry, and 
set these fractions of progenitors to differentiate with the mature neuronal and hair cell 
differentiation protocols, respectively (as described in detail in Chapters 2 and 6).  If 
the reporter positive fractions truly represent the otic progenitors then their capacity 
for more mature differentiation should be greater than that of an unsorted or reporter 
negative fraction. 
The neuronal and hair cell differentiation protocols should also be investigated further 
in order to improve the efficiency of our second phase of in vitro otic differentiation.  
For both of these protocols, currently gelatin is used as the growth matrix.  Extensive 
research has been carried out in order to determine the most effective extracellular 
matrices for spiral ganglion neuron explant growth and survival (Aletsee et al., 2002; 
Brors et al., 2002; Evans et al., 2007) and the findings from such studies could be used 
to inform an improved neural differentiation protocol in vitro.  As demonstrated in 
Chapter 6 the OEPs produced from Modified Protocol 3 were only as efficient in 
producing hair cells as the OEPs from the standard FGF-based protocol.  As with the 
neuronal differentiation, this could be partly due to the matrix used in the hair cell 
differentiation process, or perhaps due to the inefficient and variable protocol currently 
being used.  Studies such as those carried out by Ronaghi et al. (2014), Oshima et al. 
(2010) and Koehler et al. (2013) have all attempted to improve in vitro hair cell 
differentiation from pluripotent stem cells by using more sophisticated, 
developmentally informed protocols.  It is possible, therefore, that subjecting the 
Modified Protocol 3 OEPs to such protocols may then lead to more robust and efficient 
hair cell differentiation. 
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7.3 Summary 
 
To summarise, canonical Wnt signalling manipulation has been utilised in order to 
more efficiently direct the differentiation of human embryonic stem cells into otic 
placodal progenitors in vitro, by following developmentally informed cues in a 
monolayer culture system.  The expression level of characteristic otic markers induced 
by this manipulation is higher and the number of otic progenitors has been shown to 
be substantially greater than those obtained with the method previously reported based 
on FGF signalling alone (Chen et al., 2012).  These improved otic progenitors are 
capable of further differentiating into the more mature cell types of the inner ear, 
especially observed in the improved efficiency of sensory neuronal differentiation.  
This improved generation of otic progenitors, and the human embryonic stem cell 
reporter lines created, will also help in future investigations, such as small molecule 
screening and the identification of cell surface markers for isolating progenitors of 
interest.  The impact of the findings of this work could be crucial for improving the 
repair of auditory function in vivo, and the methodology could easily be translated to 
a xeno-free system to pave the way for transition into the clinic, potentially bringing 
a cell-based therapy for deafness one step closer. 
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APPENDIX 1: Pluripotency gene expression in the parental H14S9 cell line and 
the H14S9 NOP-SOX2 reporter (Sarah Jacob Eshtan, PhD thesis).  Bar charts 
denote mean and standard deviation of gene expression (n=3 independent 
experiments).  Statistical significance was determined by two way ANOVA.  ns = no 
significant difference. 
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APPENDIX 2:  Gene expression of otic markers PAX2, PAX8, FOXG1 and SOX2 
following a 12 day differentiation protocol with Shef3 hES cells, seeded at 8x103 
cells/cm2.  Canonical Wnt inhibition was via 10 µM IWR-1-endo and activation via 2 
µM BIO.  FGF 3 and FGF 10 ligands were supplemented at 50 ng/ml or 25 ng/ml 
where appropriate.  Gene expression is presented as relative to that of the DFNB 
baseline control.  Bar charts denote mean and standard deviation of gene expression 
relative to that of the DFNB control condition (n=3 independent experiments).  
Statistical significance was determined by one way ANOVA with Bonferroni’s 
multiple comparison post-test.  ns = no significant difference.  *P<0.05, **P<0.01, 
****P<0.0001. 
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APPENDIX 3: Single experiment results to demonstrate the variability seen in 
hair cell differentiation experiments.  After treatment for 14 days in hair cell 
media Modified Protocol 3 OEPs appeared to have upregulation of POU4F3, 
MYO7A, and ATOH1. 
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